Document and Entity Information (USD $) In Millions, except Share data, unless otherwise specified	12 Months Ended
	Mar. 31, 2013	May 06, 2013	Sep. 30, 2012
Entity Information [Line Items]
Entity Registrant Name	Prestige Brands Holdings, Inc.
Entity Central Index Key	0001295947
Current Fiscal Year End Date	--03-31
Entity Filer Category	Accelerated Filer
Document Type	10-K
Document Period End Date	Mar. 31, 2013
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	FY
Amendment Flag	false
Entity Common Stock, Shares Outstanding		51,147,329
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Public Float			$ 850.6

Consolidated Statements of Income and Comprehensive Income (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended								12 Months Ended
	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2011
Revenues
Net sales									$ 620,394	$ 437,838	$ 333,715
Other revenues									3,203	3,247	2,795
Total revenues	154,513	160,232	161,855	146,997	133,996	106,250	105,544	95,295	623,597	441,085	336,510
Cost of Sales
Cost of sales (exclusive of depreciation shown below)	66,443	75,235	71,310	63,393	65,508	51,128	51,638	45,427	276,381	213,701	165,632
Gross profit	88,070	84,997	90,545	83,604	68,488	55,122	53,906	49,868	347,216	227,384	170,878
Operating Expenses
Advertising and promotion	23,259	23,538	23,508	20,325	18,547	15,274	13,073	10,233	90,630	57,127	42,897
General and administrative	11,353	11,378	12,585	16,151	24,334	13,655	8,861	9,850	51,467	56,700	41,960
Depreciation and amortization	3,285	3,359	3,296	3,295	3,051	2,563	2,570	2,550	13,235	10,734	9,876
Total operating expenses	37,897	38,275	39,389	39,771	45,932	31,492	24,504	22,633	155,332	124,561	94,733
Operating income	50,173	46,722	51,156	43,833	22,556	23,630	29,402	27,235	191,884	102,823	76,145
Other (income) expense
Interest income									(13)	(18)	(1)
Interest expense									84,420	41,338	27,318
Gain on settlement	0	0	0	0	0	0	0	(5,063)	0	(5,063)	0
Loss on extinguishment of debt	1,443	0	0	0	5,409	0	0	0	1,443	5,409	300
Total other expense									85,850	41,666	27,617
Income from continuing operations before income taxes	30,492	20,061	31,496	23,985	800	15,514	21,123	23,720	106,034	61,157	48,528
Provision for income taxes	11,143	7,804	12,252	9,330	815	6,004	8,174	8,952	40,529	23,945	19,349
Income from continuing operations									65,505	37,212	29,179
Discontinued Operations
Loss on sale of discontinued operations, net of income tax									0	0	591
Loss on sale of discontinued operations, net of income tax									0	0	(550)
Net income	19,349	12,257	19,244	14,655	(15)	9,510	12,949	14,768	65,505	37,212	29,220
Basic earnings per share:
Income from continuing operations (in USD per share)									$ 1.29	$ 0.74	$ 0.58
Income from discontinued operations and loss from sale of discontinued operations (in USD per share)									$ 0.00	$ 0.00	$ 0.00
Net income (in USD per share)	$ 0.38	$ 0.24	$ 0.38	$ 0.29	$ 0.00	$ 0.19	$ 0.26	$ 0.29	$ 1.29	$ 0.74	$ 0.58
Diluted earnings per share:
Income from continuing operations (in USD per share)									$ 1.27	$ 0.73	$ 0.58
Income from discontinued operations and loss from sale of discontinued operations (in USD per share)									$ 0.00	$ 0.00	$ 0.00
Net income (in USD per share)	$ 0.37	$ 0.24	$ 0.38	$ 0.29	$ 0.00	$ 0.19	$ 0.26	$ 0.29	$ 1.27	$ 0.73	$ 0.58
Weighted average shares outstanding:
Basic (in shares)	51,147	50,686	50,364	50,342	50,314	50,307	50,278	50,183	50,633	50,270	50,081
Diluted (in shares)	51,913	51,523	51,225	51,106	50,992	50,684	50,671	50,646	51,440	50,748	50,338
Comprehensive income, net of tax:
Currency translation adjustments	(114)	(1)	66	(42)	57	(18)	(42)	(10)	(91)	(13)	0
Total other comprehensive loss	(114)	(1)	66	(42)	57	(18)	(42)	(10)	(91)	(13)	0
Comprehensive income	$ 19,235	$ 12,256	$ 19,310	$ 14,613	$ 42	$ 9,492	$ 12,907	$ 14,758	$ 65,414	$ 37,199	$ 29,220

Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Mar. 31, 2013	Mar. 31, 2012
Current assets
Cash and cash equivalents	$ 15,670	$ 19,015
Accounts receivable, net	73,053	60,228
Inventories	60,201	51,113
Deferred income tax assets	6,349	5,283
Prepaid expenses and other current assets	8,900	11,396
Total current assets	164,173	147,035
Property and equipment, net	9,896	1,304
Goodwill	167,546	173,702
Intangible assets, net	1,373,240	1,400,522
Other long-term assets	24,944	35,713
Total Assets	1,739,799	1,758,276
Liabilities and Stockholders' Equity
Accounts payable	51,376	26,726
Accrued interest payable	13,894	13,889
Other accrued liabilities	31,398	23,308
Total current liabilities	96,668	63,923
Long-term debt
Principal amount	978,000	1,135,000
Less unamortized discount	(7,100)	(11,092)
Long-term debt, net of unamortized discount	970,900	1,123,908
Deferred income tax liabilities	194,288	167,717
Total Liabilities	1,261,856	1,355,548
Stockholders' Equity
Preferred stock – $0.01 par value; Authorized – 5,000 shares; Issued and outstanding – None	0	0
Preferred share rights	283	283
$0.01 par value; Authorized – 250,000 shares; Issued – 51,311 shares and 50,466 shares at March 31, 2013 and 2012, respectively	513	505
Additional paid-in capital	401,691	391,898
Treasury stock, at cost – 181 shares at March 31, 2013 and March 31, 2012	(687)	(687)
Accumulated other comprehensive loss, net of tax	(104)	(13)
Retained earnings	76,247	10,742
Total Stockholders’ Equity	477,943	402,728
Total Liabilities and Stockholders’ Equity	$ 1,739,799	$ 1,758,276

Consolidated Balance Sheets (Parentheticals) (USD $)	Mar. 31, 2013	Mar. 31, 2012
Stockholders' Equity:
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	250,000,000	250,000,000
Common stock, shares issued	50,466,000	50,276,000
Treasury stock, shares	181,000	160,000

- Definition

Face amount or stated value per share of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer); generally not indicative of the fair market value per share.

+ References+ Details

Consolidated Statements of Changes in Stockholders' Equity and Comprehensive Income (USD $) In Thousands, except Share data, unless otherwise specified	Total	Common Stock	Additional Paid-in Capital	Treasury Stock	Accumulated Other Comprehensive Loss	Preferred Share Rights	Retained Earnings (Accumulated Deficit)
Balances at Mar. 31, 2010	$ 329,059	$ 502	$ 384,027	$ (63)	$ 0	$ 0	$ (55,407)
Treasury stock, shares at Mar. 31, 2010				124,000
Common stock, shares at Mar. 31, 2010		50,154,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	3,575		3,575
Exercise of stock options	331		331
Exercise of stock options, shares	86,900	34,000
Issuance of shares related to restricted stock		1	(1)
Issuance of shares related to restricted stock, shares		88,000
Shares surrendered as payment of tax withholding	(353)			(353)
Shares surrendered as payment of tax withholding, shares				36,000
Components of comprehensive income:
Net income	29,220						29,220
Total comprehensive income	29,220
Balances at Mar. 31, 2011	361,832	503	387,932	(416)	0	0	(26,187)
Treasury stock, shares at Mar. 31, 2011				160,000
Common stock, shares at Mar. 31, 2011		50,276,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	3,078		3,078
Exercise of stock options	889	1	888
Exercise of stock options, shares	786,500	87,000
Preferred share rights						283	(283)
Issuance of shares related to restricted stock		1
Issuance of shares related to restricted stock, shares	1,000	103,000
Shares surrendered as payment of tax withholding	(271)			(271)
Shares surrendered as payment of tax withholding, shares				21,000
Components of comprehensive income:
Net income	37,212						37,212
Translation adjustments	(13)				(13)
Total comprehensive income	37,199
Balances at Mar. 31, 2012	402,728	505	391,898	(687)	(13)	283	10,742
Treasury stock, shares at Mar. 31, 2012	160,000			181,000
Common stock, shares at Mar. 31, 2012		50,466,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	3,772		3,772
Exercise of stock options	6,029	7	6,022
Exercise of stock options, shares		786,000
Preferred share rights	0					0	0
Issuance of shares related to restricted stock	0	1	(1)
Issuance of shares related to restricted stock, shares		59,000
Components of comprehensive income:
Net income	65,505						65,505
Translation adjustments	(91)				(91)
Total comprehensive income	65,414
Balances at Mar. 31, 2013	$ 477,943	$ 513	$ 401,691	$ (687)	$ (104)	$ 283	$ 76,247
Treasury stock, shares at Mar. 31, 2013	181,000			181,000
Common stock, shares at Mar. 31, 2013		51,311,000

Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2011	Mar. 31, 2013 GSK Brands	Mar. 31, 2012 GSK Brands	Mar. 31, 2011 GSK Brands
Operating Activities
Net income	$ 65,505	$ 37,212	$ 29,220
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	13,235	10,734	10,108
Loss on sale of discontinued operations	0	0	890
Deferred income taxes	25,505	13,793	9,324
Amortization of deferred financing costs	9,832	1,630	1,043
Stock-based compensation costs	3,772	3,078	3,575
Loss on extinguishment of debt	1,443	5,409	300
Amortization of debt discount	4,632	1,030	702
Lease termination costs	975	0	0
Loss on disposal of equipment	103	0	153
Changes in operating assets and liabilities, net of effects from acquisitions
Accounts receivable	(12,882)	(15,854)	4,918
Inventories	(9,342)	3,710	12,443
Prepaid expenses and other current assets	3,096	(3,009)	154
Accounts payable	24,677	5,127	1,784
Accrued liabilities	7,054	4,592	12,056
Net cash provided by operating activities	137,605	67,452	86,670
Investing Activities
Purchases of property and equipment	(10,268)	(606)	(655)
Proceeds from sale of property and equipment	15	0	12
Proceeds from sale of brands	21,700		4,122
Acquisition of brands		(662,800)		0	(662,800)	0
Proceeds from escrow of Blacksmith acquisition	0	1,200	0
Acquisition of brands from GSK purchase price adjustments	(226)	0	0
Net cash provided by (used in) investing activities	11,221	(662,206)	(275,680)
Financing Activities
Proceeds from issuance of Senior Notes	0	250,000	100,250
Proceeds from issuance of 2012 Term Loan and 2010 Term Loan	0	650,100	112,936
Repayment of 2010 Term Loan	0	(242,000)	0
Payment of deferred financing costs	(1,146)	(33,284)	(830)
Repayment of long-term debt	(190,000)	(25,000)	(51,087)
Repayments under revolving credit agreement	(15,000)	0	0
Borrowings under revolving credit agreement	48,000	0	0
Proceeds from exercise of stock options	6,029	889	331
Shares surrendered as payment of tax withholding	0	(271)	(353)
Net cash (used in) provided by financing activities	(152,117)	600,434	161,247
Effects of exchange rate changes on cash and cash equivalents	(54)	1	0
(Decrease) increase in cash and cash equivalents	(3,345)	5,681	(27,763)
Cash - beginning of year	19,015	13,334	41,097
Cash - end of year	15,670	19,015	13,334
Interest paid	69,641	34,977	17,509
Income taxes paid	$ 10,624	$ 12,865	$ 11,894

Business and Basis of Presentation

12 Months Ended

Mar. 31, 2013

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Business and Basis of Presentation

Nature of Business

Prestige Brands Holdings, Inc. (referred to herein as the “Company” or “we” which reference shall, unless the context requires otherwise, be deemed to refer to Prestige Brands Holdings, Inc. and all of its direct and indirect 100% owned subsidiaries on a consolidated basis) is engaged in the marketing, sales and distribution of over-the-counter (“OTC”) healthcare and household cleaning brands to mass merchandisers, drug stores, supermarkets, club and dollar stores in the United States, Canada and certain other international markets. Prestige Brands Holdings, Inc. is a holding company with no operations and is also the parent guarantor of the senior credit facility and the senior notes described in Note 11 to the Consolidated Financial Statements.

Basis of Presentation

Our Consolidated Financial Statements are prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP"). All significant intercompany transactions and balances have been eliminated in consolidation. Our fiscal year ends on March 31st of each year. References in these Consolidated Financial Statements or notes to a year (e.g., “2013”) mean our fiscal year ended on March 31st of that year.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Although these estimates are based on our knowledge of current events and actions that we may undertake in the future, actual results could differ from those estimates. As discussed below, our most significant estimates include those made in connection with the valuation of intangible assets, sales returns and allowances, trade promotional allowances and inventory obsolescence.

Cash and Cash Equivalents

We consider all short-term deposits and investments with original maturities of three months or less to be cash equivalents. Substantially all of our cash is held by a large regional bank with headquarters in California. We do not believe that, as a result of this concentration, we are subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships. The Federal Deposit Insurance Corporation (“FDIC”) and Securities Investor Protection Corporation (“SIPC”) insure these balances, up to $250,000 and $500,000, with a $250,000 limit for cash, respectively. Substantially all of the Company's cash balances at March 31, 2013 are uninsured.

Accounts Receivable

We extend non-interest-bearing trade credit to our customers in the ordinary course of business. We maintain an allowance for doubtful accounts receivable based upon historical collection experience and expected collectability of the accounts receivable. In an effort to reduce credit risk, we (i) have established credit limits for all of our customer relationships, (ii) perform ongoing credit evaluations of customers’ financial condition, (iii) monitor the payment history and aging of customers’ receivables, and (iv) monitor open orders against an individual customer’s outstanding receivable balance.

Inventories

Inventories are stated at the lower of cost or market value, where cost is determined by using the first-in, first-out method. We reduce inventories for the diminution of value resulting from product obsolescence, damage or other issues affecting marketability, equal to the difference between the cost of the inventory and its estimated market value. Factors utilized in the determination of estimated market value include (i) current sales data and historical return rates, (ii) estimates of future demand, (iii) competitive pricing pressures, (iv) new product introductions, (v) product expiration dates, and (vi) component and packaging obsolescence.

Property and Equipment

Property and equipment are stated at cost and are depreciated using the straight-line method based on the following estimated useful lives:



	Years
Machinery	5
Computer equipment	3
Furniture and fixtures	7
Leasehold improvements	*

*Leasehold improvements are amortized over the lesser of the lease-term or the estimated useful life of the related asset.

Expenditures for maintenance and repairs are charged to expense as incurred. When an asset is sold or otherwise disposed of, we remove the cost and associated accumulated depreciation from the accounts and recognize the resulting gain or loss in the Consolidated Statements of Income and Comprehensive Income.

Property and equipment are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. An impairment loss is recognized if the carrying amount of the asset exceeds its fair value.

Goodwill

The excess of the purchase price over the fair market value of assets acquired and liabilities assumed in purchase business combinations is classified as goodwill. Goodwill is not amortized, although the carrying value is tested for impairment at least annually in the fourth fiscal quarter of each year, or more frequently if events or changes in circumstances indicate that the asset may be impaired. Goodwill is tested for impairment at the reporting unit “brand” level, which is one level below the operating segment level.

Intangible Assets

Intangible assets, which are comprised primarily of trademarks, are stated at cost less accumulated amortization. For intangible assets with finite lives, amortization is computed using the straight-line method over estimated useful lives ranging from 3 to 30 years.

Indefinite-lived intangible assets are tested for impairment at least annually in the fourth fiscal quarter of each year. Intangible assets with finite lives are reviewed for impairment whenever events or changes in circumstances indicate that their carrying amounts exceed their fair values and may not be recoverable. An impairment loss is recognized if the carrying amount of the asset exceeds its fair value.

Deferred Financing Costs

We have incurred debt origination costs in connection with the issuance of long-term debt. These costs are capitalized as deferred financing costs and amortized over the term of the related debt using the effective interest method. For a further discussion regarding accelerated amortization, refer to Note 11.

Revenue Recognition

We recognize revenue when the following criteria are met: (i) persuasive evidence of an arrangement exists; (ii) the selling price is fixed or determinable; (iii) the product has been shipped and the customer takes ownership and assumes the risk of loss; and (iv) collection of the resulting receivable is reasonably assured. We have determined that these criteria are met and the transfer of the risk of loss generally occurs when product is received by the customer and, accordingly, we recognize revenue at that time. Provision is made for estimated discounts related to customer payment terms and estimated product returns at the time of sale based on our historical experience.

As is customary in the consumer products industry, we participate in the promotional programs of our customers to enhance the sale of our products. The cost of these promotional programs varies based on the actual number of units sold during a finite period of time. These promotional programs consist of direct-to-consumer incentives, such as coupons and temporary price reductions, as well as incentives to our customers, such as allowances for new distribution, including slotting fees, and cooperative advertising. Estimates of the costs of these promotional programs are based on (i) historical sales experience, (ii) the current promotional offering, (iii) forecasted data, (iv) current market conditions, and (v) communication with customer purchasing/marketing personnel. We recognize the cost of such sales incentives by recording an estimate of such cost as a reduction of revenue, at the later of (a) the date the related revenue is recognized, or (b) the date when a particular sales incentive is offered. At the completion of the promotional program, the estimated amounts are adjusted to actual results.

Due to the nature of the consumer products industry, we are required to estimate future product returns. Accordingly, we record an estimate of product returns concurrent with recording sales, which is made after analyzing (i) historical return rates, (ii) current economic trends, (iii) changes in customer demand, (iv) product acceptance, (v) seasonality of our product offerings, and (vi) the impact of changes in product formulation, packaging and advertising.

Cost of Sales

Cost of sales includes product costs, warehousing costs, inbound and outbound shipping costs, and handling and storage costs. Shipping, warehousing and handling costs were $30.6 million for 2013, $27.8 million for 2012 and $23.5 million for 2011.

Advertising and Promotion Costs

Advertising and promotion costs are expensed as incurred. Allowances for new distribution costs associated with products, including slotting fees, are recognized as a reduction of sales. Under these new distribution arrangements, the retailers allow our products to be placed on the stores’ shelves in exchange for such fees.

Stock-based Compensation

We recognize stock-based compensation by measuring the cost of services to be rendered based on the grant-date fair value of the equity award. Compensation expense is to be recognized over the period an employee is required to provide service in exchange for the award, generally referred to as the requisite service period.

Income Taxes

Deferred tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is established when necessary to reduce deferred tax assets to the amounts expected to be realized.

The Income Taxes topic of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) prescribes a recognition threshold and measurement attributes for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. As a result, we have applied a more-likely-than-not recognition threshold for all tax uncertainties. The guidance only allows the recognition of those tax benefits that have a greater than 50% likelihood of being sustained upon examination by the various taxing authorities.

We are subject to taxation in the United States and various state and foreign jurisdictions.

We classify penalties and interest related to unrecognized tax benefits as income tax expense in the Consolidated Statements of Income and Comprehensive Income.

Earnings Per Share

Basic earnings per share is calculated based on income available to common stockholders and the weighted-average number of shares outstanding during the reporting period. Diluted earnings per share is calculated based on income available to common stockholders and the weighted-average number of common and potential common shares outstanding during the reporting period. Potential common shares, composed of the incremental common shares issuable upon the exercise of stock options, stock appreciation rights and unvested restricted shares, are included in the earnings per share calculation to the extent that they are dilutive.

Recently Issued Accounting Standards

In March 2013, the FASB issued guidance relating to the release of cumulative translation adjustments into net income when a parent either sells a part or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets. The guidance is effective prospectively for annual reporting periods beginning after December 15, 2013, and interim periods within those annual periods. Early adoption is permitted. The adoption of this new guidance is not expected to have a material impact on our Consolidated Financial Statements.

In July 2012, the FASB issued guidance regarding testing the impairment of indefinite-lived intangible assets other than goodwill. The new guidance is intended to simplify how entities test impairment of indefinite-lived intangible assets other than goodwill. The new guidance permits an entity to first assess qualitative factors to determine whether it is "more-likely-than-not" that the fair value of the asset is less than its carrying amount as a basis for determining whether it is necessary to perform the impairment test described in the ASC Intangibles-Goodwill and Other topic. The more-likely-than-not threshold is defined as having a likelihood of more than 50%. The new guidance is effective for annual and interim impairment tests performed for fiscal years beginning after September 15, 2012. Early adoption is permitted. We do not expect that the adoption of this new guidance will have a material impact on our Consolidated Financial Statements.

In December 2011, the FASB issued guidance regarding disclosures about offsetting assets and liabilities. The new disclosure requirements mandate that entities disclose both gross and net information about instruments and transactions eligible for offset in the statement of financial position, as well as instruments and transactions subject to an agreement similar to a master netting arrangement. In addition, the standard requires disclosure of collateral received and posted in connection with master netting agreements or similar arrangements. An entity will be required to disclose the following information for assets and liabilities within the scope of the new standard: (i) the gross amounts of those recognized assets and those recognized liabilities; (ii) the amounts offset to determine the net amounts presented in the statement of financial position; (iii) the net amounts presented in the statement of financial position; (iv) the amounts subject to an enforceable master netting arrangement or similar agreement not otherwise included in (ii); and (v) the net amount after deducting the amounts in (iv) from the amounts in (iii). The standard affects all entities with balances presented on a net basis in the financial statements, derivative assets and derivative liabilities, repurchase agreements, and financial assets and financial liabilities executed under a master netting or similar arrangement. This guidance was effective for annual reporting periods beginning on or after January 1, 2013, and interim periods within those annual periods. The adoption of this new guidance is not expected tohave a material impact on our Consolidated Financial Statements. However, our transition services arrangement with GlaxoSmithKline plc ("GSK"), provided that, during the term of the arrangement, we would receive a net monthly remittance, and therefore, we have reported a net amount due from GSK in our accounts receivable at March 31, 2012 of $8.4 million. Since the arrangement ended June 30, 2012, we do not have any amounts due from GSK in our accounts receivable at March 31, 2013.

In June 2011, the FASB issued guidance regarding presentation of comprehensive income. Under the ASC Comprehensive Income topic, entities are allowed the option to present the total of comprehensive income, the components of net income, and the components of other comprehensive income either in a single continuous statement of comprehensive income or in two separate but consecutive statements. In both choices, an entity is required to present each component of net income along with total net income, each component of other comprehensive income along with a total for other comprehensive income, and a total amount for comprehensive income. This guidance eliminates the option to present the components of other comprehensive income as part of the statement of changes in stockholders' equity. This guidance does not change the items that must be reported in other comprehensive income or when an item of other comprehensive income must be reclassified to net income.

In December 2011, the FASB issued guidance to defer the new requirement to present components of reclassifications of other comprehensive income on the face of the income statement. Based on this guidance, entities are still required to adopt either the single continuous statement or the two-statement approach required by the new guidance. However, entities should continue to report reclassifications out of accumulated other comprehensive income consistent with the requirements in effect before the adoption of the new standard (i.e., by component of other comprehensive income, either by displaying each component on a gross basis on the face of the appropriate financial statement or by displaying each component net of other changes on the face of the appropriate financial statement with the gross change disclosed in the notes). The December 2011 deferral of the guidance issued in June 2011, as well as the June 2011 guidance, are effective at the same time. The new guidance and this deferral were effective for the Company beginning with the three months ended June 30, 2012, and full retrospective application is required. The adoption of this new guidance did not have a material impact on our Consolidated Financial Statements.

In February 2013, the FASB issued guidance relating to the disclosure of items reclassified out of accumulated other comprehensive income. The new guidance requires that for those items that are reclassified out of accumulated other comprehensive income and into net income in their entirety, the effect of the reclassification on each affected net income line item be disclosed. For accumulated other comprehensive income reclassification items that are not reclassified in their entirety into net income, a cross reference must be made to other required disclosures. The guidance is effective prospectively for annual reporting periods beginning after December 15, 2012, and interim periods within those annual periods. Early adoption is permitted. The update impacts presentation and disclosure only, and therefore adoption is not expected to have a material impact on our Consolidated Financial Statements.

In September 2011, the FASB issued guidance regarding testing goodwill for impairment. The new guidance is intended to simplify how entities test goodwill for impairment. The new guidance permits an entity to first assess qualitative factors to determine whether it is "more-likely-than-not" that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step goodwill impairment test described in the ASC Intangibles-Goodwill and Other topic. The more-likely-than-not threshold is defined as having a likelihood of more than 50%. The new guidance is effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011. The adoption of this new guidance did not have a material impact on our Consolidated Financial Statements.

Management has reviewed and continues to monitor the actions of the various financial and regulatory reporting agencies and is currently not aware of any other pronouncement that could have a material impact on our consolidated financial position, results of operations or cash flows.

- Definition

The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.

+ References+ Details

Discontinued Operations and Sale of Certain Assets (Cutex)

12 Months Ended

Mar. 31, 2013

Cutex

Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]

Discontinued Operations and Sale of Certain Assets

On September 1, 2010, we sold certain assets related to the Cutex nail polish remover brand for $4.1 million. In accordance with the Discontinued Operations topic of the ASC, we reclassified the related operating results as discontinued in the Consolidated Financial Statements and related notes for all periods presented. We recognized a loss of $0.9 million on a pre-tax basis and $0.6 million, net of related tax effects of $0.3 million, on the sale in 2011. As a result of the divestiture of Cutex, which comprised a substantial majority of the assets in our previously reported Personal Care segment, we reclassified the then remaining Personal Care segment assets to the OTC Healthcare segment for all periods presented.

The following table summarizes the results of discontinued operations:



(In thousands)	Year Ended March 31,
	2013		2012		2011
Components of Income
Revenues	$	—	$	—	$	4,027
Income (loss) from discontinued operations, net of income tax	—		—		591

- Definition

The entire disclosure for the facts and circumstances leading to the completed or expected disposal, manner and timing of disposal, the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss), amounts of revenues and pretax profit or loss reported in discontinued operations, the segment in which the disposal group was reported, and the classification (whether sold or classified as held for sale) and carrying value of the assets and liabilities comprising the disposal group. Includes all disposal groups, including those classified as components of the entity (discontinued operations).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6391110&loc=d3e2941-110230

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e957-107759

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1510-107760

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e1012-107759

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e1020-107759

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1474-107760

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=8077374&loc=d3e2443-110228

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1436-107760

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 144

-Paragraph 43-48

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Acquisitions

12 Months Ended

Mar. 31, 2013

Business Combinations [Abstract]

Acquisitions

Acquisition of GlaxoSmithKline OTC Brands

On December 20, 2011, we entered into two separate agreements with GSK to acquire a total of 17 North American OTC healthcare brands (the "GSK Brands") for $660.0 million in cash (the "GSK Agreement").

On January 31, 2012, we completed, subject to a post-closing inventory and apportionment adjustment, as defined in the GSK Agreement, the acquisition of the first 15 North American GSK Brands (the “GSK Brands I”) for $615.0 million in cash, including the related contracts, trademarks and inventory. The GSK Brands I include, among other brands, BC, Goody's and Ecotrin brands of pain relievers; Beano, Gaviscon, Phazyme, Tagamet and Fiber Choice gastrointestinal brands; and the Sominex sleep aid brand.

On March 30, 2012, we completed, subject to a post-closing inventory and apportionment adjustment, as defined in the GSK Agreement, the acquisition of the Debrox and Gly-Oxide brands (the “GSK Brands II”) in the United States for $45.0 million in cash, including the related contracts, trademarks and inventory.

Both the GSK Brands I and GSK Brands II are complementary to our existing OTC healthcare portfolio.

These acquisitions were accounted for in accordance with the Business Combinations topic of the ASC, which requires that the total cost of an acquisition be allocated to the tangible and intangible assets acquired and liabilities assumed based upon their respective fair values at the date of acquisition.

The purchase price of the GSK Brands I and GSK Brands II was funded by cash provided by the issuance of long-term debt and additional bank borrowings, which are discussed further in Note 11. In April 2012, we received the post-closing inventory and apportionment adjustments, attributable to both GSK Brands I and GSK Brands II, which required us to pay an additional $2.8 million to GSK, and in May 2012 we received a revised post-closing inventory and apportionment adjustment, attributable to GSK Brands II, which required us to pay an additional $0.2 million, for a total of $3.0 million, to GSK.

Concurrent with the closing of the GSK Brands I transaction, we entered into a Transitional Services Agreement with GSK (the “TSA”), whereby GSK provided us with various services including: marketing, operations, finance and other services from the GSK Brands I acquisition date primarily through June 30, 2012, with additional finance support through August 31, 2012. As part of the TSA, GSK, among other things, shipped products, invoiced customers, collected from customers and paid certain vendors on our behalf. Our initial costs under the TSA were approximately $2.5 million per month for the length of the agreement and were reduced during the service period as we removed certain services and transitioned those processes to us. We incurred $6.9 million in TSA costs for the year ended March 31, 2013. Pursuant to the TSA, we received on a monthly basis the amount owed to us for revenues and expenses, net of GSK's TSA fees and inventory that GSK purchased on our behalf.

The allocation of the purchase price to assets acquired is based on a valuation which we performed to determine the fair value of such assets as of the acquisition date. The following table summarizes our allocation of the $663.0 million purchase price to the assets we acquired on the GSK Brands acquisition dates:



(In thousands)	GSK Brands I (January 31, 2012)		GSK Brands II (March 30, 2012)		Total
Inventory	$	14,820	$	250	$	15,070
Prepaid expenses	3,575		—		3,575
Trade names	542,892		81,257		624,149
Goodwill	17,401		2,831		20,232
Total purchase price	$	578,688	$	84,338	$	663,026

We recorded goodwill based on the amount by which the purchase price exceeded the fair value of assets acquired. The amount of goodwill deductible for tax purposes is $20.2 million.

The fair value of the trade names is comprised of $556.9 million of non-amortizable intangible assets and $67.2 million of amortizable intangible assets. We are amortizing the purchased amortizable intangible assets on a straight-line basis over an estimated weighted average useful life of 19.3 years. The weighted average remaining life for amortizable intangible assets at March 31, 2013 was 18.0 years.

The operating results of the GSK Brands I have been included in our Consolidated Financial Statements beginning February 1, 2012, while the operating results of the GSK Brands II have been included in our Consolidated Financial Statements beginning April 1, 2012. Revenues of the acquired operations for the year ended March 31, 2013 were $211.2 million and net income was $27.4 million.

Blacksmith Acquisition

On November 1, 2010, we acquired 100% of the capital stock of Blacksmith Brands Holdings, Inc. (“Blacksmith”) for $190.0 million in cash, plus a working capital adjustment of $13.4 million, and we paid an additional $1.1 million on behalf of Blacksmith for the seller's transaction costs. In 2011, we brought to arbitration a matter regarding the working capital adjustment related to Blacksmith. On July 20, 2011, we received notification from the arbitrator that we would be awarded a working capital adjustment pending final resolution and distribution from the escrow agent. In September 2011, we received $1.2 million in settlement of this matter, which reduced the amount of recorded goodwill related to Blacksmith.

As a result of this acquisition, we acquired five leading consumer OTC brands: Efferdent, Effergrip, PediaCare, Luden's, and NasalCrom. The purchase price was funded by cash provided by the issuance of long-term debt and additional bank borrowings, which are discussed further in Note 11.

The acquisition was accounted for in accordance with the Business Combinations topic of the ASC, which requires that the total cost of an acquisition be allocated to the tangible and intangible assets acquired and liabilities assumed based upon their respective fair values at the date of acquisition.

The allocation of the purchase price to assets acquired and liabilities assumed is based on a valuation which we performed to determine the fair value of such assets as of the acquisition date. The following table summarizes our final allocation of the $203.4 million purchase price to the assets we acquired and liabilities assumed on the Blacksmith acquisition date:



(In thousands)	November 1, 2010
Cash acquired	$	2,507
Accounts receivable, net	17,473
Other receivables	1,198
Income taxes receivable	5
Inventories	22,155
Prepaids and other current assets	44
Property, plant and equipment, net	226
Goodwill	42,207
Trademarks	165,346
Other long-term assets	19
Total assets acquired	251,180

Accounts payable	7,060
Accrued expenses	5,212
Income taxes payable	2,031
Deferred income taxes	33,526
Total liabilities assumed	47,829

Total purchase price	$	203,351

We recorded goodwill based on the amount by which the purchase price exceeded the fair value of assets acquired and liabilities assumed. The amount of goodwill deductible for tax purposes is $4.6 million.

The fair value of the trademarks is comprised of $158.0 million of non-amortizable intangible assets and $7.3 million of amortizable intangible assets. We are amortizing the purchased amortizable intangible assets on a straight-line basis over an estimated weighted average useful life of 15 years. The weighted average remaining life for amortizable intangible assets at March 31, 2013 was 12.6 years.

The operating results of Blacksmith have been included in our Consolidated Financial Statements from November 1, 2010, the date of acquisition. Revenues of the acquired operations from November 1, 2010 through March 31, 2011 were $34.8 million and the net loss was $4.8 million.

The following table provides our combined unaudited pro forma revenues, income from continuing operations and income from continuing operations per basic and diluted common share as if the acquisitions of Blacksmith and the GSK Brands occurred on April 1, 2010. The pro forma results were prepared from financial information obtained from the sellers of the businesses, as well as information obtained during the due diligence processes associated with the acquisitions. The unaudited pro forma results reflect certain adjustments related to the acquisitions, such as increased depreciation and amortization expense resulting from the stepped-up basis to fair value of the assets acquired and adjustments to reflect the Company's borrowing and tax rates. This pro forma information is not necessarily indicative of either the combined results of operations that actually would have been realized by us had the acquisition of Blacksmith and the GSK Brands been consummated at the beginning of the period for which the pro forma information is presented, or of future results.



	Year Ended March 31,
(In thousands, except per share data)	2012		2011
	(Unaudited)
Revenues	$	616,849	$	599,543
Income from continuing operations	69,989		34,913

Basic earnings per share:
Income from continuing operations	$	1.39	$	0.70

Diluted earnings per share:
Income from continuing operations	$	1.38	$	0.69

Dramamine Acquisition

On January 6, 2011, we acquired certain assets comprising the Dramamine brand in the United States. The purchase price was $77.1 million in cash, after a $0.1 million post-closing inventory adjustment and including transaction costs of $1.2 million incurred in the acquisition. The purchase price was funded by cash on hand.

In accounting for the acquisition of the Dramamine brand, we considered the Business Combinations topic of the ASC. Accordingly, as the Dramamine assets acquired do not constitute a business, as defined in the ASC, we have accounted for the transaction as an asset acquisition. The total consideration paid, including transaction costs, has been allocated to the tangible and intangible assets acquired based upon their relative fair values at the date of acquisition.

The allocation of the purchase price to assets acquired is based on valuations which we performed to determine the fair value of such assets as of the acquisition date. The following table summarizes our allocation of the $77.1 million purchase price to the assets we acquired comprising the Dramamine brand:



(In thousands)	January 6, 2011
Inventories	$	1,249
Trademark	75,866
Total purchase price	$	77,115

The $75.9 million fair value of the acquired Dramamine trademark was comprised solely of non-amortizable intangible assets.

- Definition

The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141R

-Paragraph F4

-Subparagraph e

-Appendix F

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141

-Paragraph 51, 52

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1524-128463

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4934-128472

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141R

-Paragraph 67-73

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e6996-128479

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1383-128463

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e7000-128479

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4926-128472

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4922-128472

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 88-16

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1392-128463

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1486-128463

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1497-128463

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1490-128463

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e7008-128479

Reference 17: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e6927-128479

Reference 18: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4845-128472

Reference 19: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1500-128463

+ Details

Divestitures (Phazyme)

12 Months Ended

Mar. 31, 2013

Phazyme

Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]

Divestitures

Sale of the Phazyme Brand

On October 31, 2012, we divested the Phazyme gas treatment brand, which was a non-core OTC brand that we acquired from GSK in January 2012. We received $21.7 million from the divestiture on October 31, 2012 and the remaining $0.6 million on January 4, 2013. The proceeds were used to repay debt. No significant gain or loss was recorded as a result of the sale.

Concurrent with the completion of the sale of the Phazyme brand, we entered into a Transitional Services Agreement with the buyer (the “Phazyme TSA”), whereby we agreed to provide the buyer with various services including: marketing, operations, finance and other services from the date of the acquisition primarily through January 31, 2013, with an option for additional support for the Canadian portion of that business through October 31, 2013, at the buyer's discretion. All Phazyme United States TSA services ended, as agreed, on January 31, 2013. However, the buyer elected to extend the Canadian TSA support on a month to month basis. As part of the ongoing Phazyme TSA, our Canadian distributor, among other things, will ship products, invoice customers, collect from customers and pay certain vendors on the buyer's behalf.

The following table presents the assets sold at October 31, 2012 related to the Phazyme brand:



(In thousands)	October 31, 2012
Components of assets sold:
Inventory	$	220
Prepaid expenses	100
Trade names	15,604
Goodwill	6,382

- Definition

+ References

+ Details

Accounts Receivable

12 Months Ended

Mar. 31, 2013

Receivables [Abstract]

Accounts Receivable

Accounts receivable consist of the following:



(In thousands)	March 31,
	2013			2012
Components of Accounts Receivable
Trade accounts receivable	$	79,746		$	55,721
Other receivables	615			9,368
	80,361			65,089
Less allowances for discounts, returns and uncollectible accounts	(7,308		)	(4,861		)
Accounts receivable, net	$	73,053		$	60,228

- Definition

The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.3,4)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 3, 4

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=7512638&loc=d3e5074-111524

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=7512638&loc=d3e5066-111524

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Statement of Position (SOP)

-Number 01-6

-Paragraph 13

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 7

-Article 9

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph k

-Article 4

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section 50

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=7512638&loc=d3e5162-111524

+ Details

Inventories

12 Months Ended

Mar. 31, 2013

Inventory Disclosure [Abstract]

Inventories

Inventories consist of the following:



(In thousands)	March 31,
	2013		2012
Components of Inventories
Packaging and raw materials	$	1,875	$	1,189
Finished goods	58,326		49,924
Inventories	$	60,201	$	51,113

Inventories are carried and depicted above at the lower of cost or market, which includes a reduction in inventory values of $1.3 million and $1.6 million at March 31, 2013 and 2012, respectively, related to obsolete and slow-moving inventory.

- Definition

The entire disclosure for inventory. This may include, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the major classes of inventory, and the nature of the cost elements included in inventory. If inventory is stated above cost, accrued net losses on firm purchase commitments for inventory and losses resulting from valuing inventory at the lower-of-cost-or-market may also be included. For LIFO inventory, may disclose the amount and basis for determining the excess of replacement or current cost over stated LIFO value and the effects of a LIFO quantities liquidation that impacts net income.

+ References+ Details

Property and Equipment

12 Months Ended

Mar. 31, 2013

Property, Plant and Equipment [Abstract]

Property and Equipment

Property and equipment consist of the following:



(In thousands)	March 31,
	2013			2012
Components of Property and Equipment
Machinery	$	1,580		$	1,454
Computer equipment	6,559			2,693
Furniture and fixtures	1,510			241
Leasehold improvements	4,713			436
	14,362			4,824
Accumulated depreciation	(4,466		)	(3,520		)
Property and equipment, net	$	9,896		$	1,304

We recorded depreciation expense of $1.6 million for 2013 and $0.7 million for both 2012 and 2011. Additionally, during the year ended March 31, 2013, we wrote off leasehold improvements with a remaining net book value of less than $0.1 million due to the relocation of our corporate offices.

- Definition

The entire disclosure for long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software. This disclosure may include property plant and equipment accounting policies and methodology, a schedule of property, plant and equipment gross, additions, deletions, transfers and other changes, depreciation, depletion and amortization expense, net, accumulated depreciation, depletion and amortization expense and useful lives, income statement disclosures, assets held for sale and public utility disclosures.

+ References+ Details

Goodwill

12 Months Ended

Mar. 31, 2013

Goodwill [Abstract]

Goodwill

The following table summarizes the changes in the carrying value of goodwill by operating segment for each of 2011, 2012 and 2013:



(In thousands)	OTC Healthcare			Household Cleaning			Consolidated
Balance – March 31, 2010
Goodwill	$	234,270		$72,549			$306,819
Accumulated impairment losses	(130,170		)	(65,160		)	(195,330		)
Balance – March 31, 2010	104,100			7,389			111,489

2011 additions	43,407			—			43,407

Balance – March 31, 2011
Goodwill	277,677			72,549			350,226
Accumulated impairment losses	(130,170		)	(65,160		)	(195,330		)
Balance – March 31, 2011	147,507			7,389			154,896

2012 additions	20,006			—			20,006

Balance – March 31, 2012
Goodwill	296,483			72,549			369,032
Accumulated impairment losses	(130,170		)	(65,160		)	(195,330		)
	166,313			7,389			173,702

2013 additions	226			—			226
2013 reductions	(6,382		)	—			(6,382		)

Balance – March 31, 2013
Goodwill	290,327			72,549			362,876
Accumulated impairment losses	(130,170		)	(65,160		)	(195,330		)
	$	160,157		$	7,389		$	167,546

On November 1, 2010, we acquired 100% of the capital stock of Blacksmith. In connection with this acquisition, we recorded goodwill of $42.2 million, net of the $1.2 million settlement discussed in Note 3, based on the amount by which the purchase price exceeded the fair value of net assets acquired.

As discussed in Note 3, on January 31, 2012, we completed the acquisition of the GSK Brands I for $615.0 million in cash, and on March 30, 2012, we completed the acquisition of the GSK Brands II for $45.0 million in cash, in each case subject to certain post-closing adjustments. We recorded a post-closing adjustment of $2.8 million as of March 31, 2012, to reflect adjustments to certain inventory items and other current assets acquired. In connection with these acquisitions, we recorded goodwill of $20.0 million based on the amount by which the purchase price exceeded the fair value of assets acquired.

During the three months ended June 30, 2012, we received a revised post-closing inventory and apportionment adjustment from GSK for an additional amount of $0.2 million, which resulted in an increase to our recorded goodwill balance.

As more fully disclosed in Note 4, on October 31, 2012, we sold the Phazyme brand for $22.3 million. As a result of the divestiture of Phazyme, we reduced goodwill by $6.4 million.

At March 31, 2013 and March 31, 2012, in conjunction with the annual test for goodwill impairment, there were no indicators of impairment under the analysis. Accordingly, no impairment charge was recorded in 2013 or in 2012.

The discounted cash flow methodology is a widely-accepted valuation technique utilized by market participants in the transaction evaluation process and has been applied consistently. We also considered our market capitalization at March 31, 2013, 2012 and 2011, as compared to the aggregate fair values of our reporting units, to assess the reasonableness of our estimates pursuant to the discounted cash flow methodology. Although the impairment charges in the prior years were a result of utilizing management’s best estimate of fair value, the estimates and assumptions made in assessing the fair value of the our reporting units and the valuation of the underlying assets and liabilities are inherently subject to significant uncertainties. Consequently, changing rates of interest and inflation, declining sales or margins, increases in competition, changing consumer preferences, technical advances, or reductions in advertising and promotion may require additional impairments in the future. The Company has experienced revenue declines in regard to certain brands in its Household Cleaning segment during 2013, 2012 and 2011. Adverse changes in the expected operating results and/or unfavorable changes in other economic factors used to estimate fair values of these specific brands could result in a non-cash impairment charge in the future.

The aggregate fair value exceeded the carrying value by 57.6%. Two individual reporting units' fair value exceeded their carrying values by less than 10.0%. The first reporting unit's associated carrying value of goodwill and intangible assets amounted to $8.0 million at March 31, 2013. The second reporting unit's associated carrying value of goodwill and intangible assets amounted to $58.4 million at March 31, 2013. Additionally, certain brands, including certain of our household brands, have experienced recent revenue declines. While the fair value of these reporting units exceeds the carrying value by more than 10%, should such revenue declines continue, the fair value of the corresponding reporting units may no longer exceed their carrying value and we would be required to record an impairment charge.

As discussed in Note 1, in accordance with recent guidance from the FASB, an entity is permitted to first assess qualitative factors in testing goodwill for impairment prior to performing a quantitative assessment. The new guidance is effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011, and became effective for the Company in fiscal year 2013. The adoption of this new guidance did not have a material impact on our Consolidated Financial Statements.

Intangible Assets

12 Months Ended

Mar. 31, 2013

Intangible Assets [Abstract]

Intangible Assets

A reconciliation of the activity affecting intangible assets for each of 2011, 2012 and 2013 is as follows:



(In thousands)	Year Ended March 31, 2011
	Indefinite Lived Trademarks		Finite Lived Trademarks			Non Compete Agreement		Totals
Gross Amount
Balance – March 31, 2010 (including discontinued operations)	$	454,571	$	151,264		$	158	$	605,993
Additions	233,913		7,299			—		241,212
Disposals	—		(8,270		)	—		(8,270		)
Balance – March 31, 2011	$	688,484	$	150,293		$	158	$	838,935

Accumulated Amortization
Balance – March 31, 2010	$	—	$	46,606		$	158	$	46,764
Additions	—		9,210			—		9,210
Disposals	—		(3,400		)	—		(3,400		)
Balance – March 31, 2011	$	—	$	52,416		$	158	$	52,574

Intangibles, net – March 31, 2011	$	688,484	$	97,877		$	—	$	786,361



(In thousands)	Year Ended March 31, 2012
	Indefinite Lived Trademarks		Finite Lived Trademarks		Non Compete Agreement		Totals
Gross Amount
Balance – March 31, 2011	$	688,484	$	150,293	$	158	$	838,935
Additions	556,930		67,219		—		624,149
Balance – March 31, 2012	$	1,245,414	$	217,512	$	158	$	1,463,084

Accumulated Amortization
Balance – March 31, 2011	$	—	$	52,416	$	158	$	52,574
Additions	—		9,988		—		9,988
Balance – March 31, 2012	$	—	$	62,404	$	158	$	62,562

Intangibles, net – March 31, 2012	$	1,245,414	$	155,108	$	—	$	1,400,522



(In thousands)	Year Ended March 31, 2013
	Indefinite Lived Trademarks			Finite Lived Trademarks			Non Compete Agreement		Totals
Gross Amount
Balance – March 31, 2012	$	1,245,414		$	217,512		$	158	$	1,463,084
Reclassifications	(1,696		)	1,696			—		—
Reductions	—			(16,142		)	—		(16,142		)
Balance – March 31, 2013	$	1,243,718		$	203,066		$	158	$	1,446,942

Accumulated Amortization
Balance – March 31, 2012	$	—		$	62,404		$	158	$	62,562
Additions	—			11,678			—		11,678
Reductions	—			(538		)	—		(538		)
Balance – March 31, 2013	$	—		$	73,544		$	158	$	73,702

Intangibles, net – March 31, 2013	$	1,243,718		$	129,522		—		$	1,373,240

As discussed in Note 3, on January 31, 2012, we completed the acquisition of the GSK Brands I for $615.0 million in cash. On March 30, 2012, we completed the acquisition of the GSK Brands II for $45.0 million in cash. In connection with these acquisitions, we allocated $624.1 million of the purchase price to intangible assets.

As discussed in Note 4, on October 31, 2012, we sold the Phazyme brand for $22.3 million. As a result of this divestiture, we reduced the net book value of our intangible assets by $15.6 million.

During the year ended March 31, 2013, we reclassified a portion of trademarks related to the acquired GSK Brands in the amount of $1.7 million.

On January 6, 2011, we acquired certain assets related to the Dramamine brand in the United States. In connection with this acquisition, we allocated $75.9 million of the purchase price to intangible assets.

On November 1, 2010, we acquired 100% of the capital stock of Blacksmith. In connection with this acquisition, we allocated $165.3 million of the purchase price to intangible assets, which are comprised of acquired trademarks. The allocation is based on valuations performed to determine the fair value of such assets as of the acquisition date.

We completed our test for impairment of intangible assets during the fourth quarter of 2013, 2012 and 2011. For 2013, 2012 and 2011, we did not record any impairment charge, as facts and circumstances indicated that the fair values of the intangible assets for such segments exceeded their carrying values. The Company has experienced revenue declines in regard to certain brands in its Household Cleaning segment during 2013, 2012 and 2011. Adverse changes in the expected operating results and/or unfavorable changes in other economic factors used to estimate fair values of these specific brands could result in a non-cash impairment charge in the future.

The weighted average remaining life for finite-lived intangible assets at March 31, 2013 was approximately 12.0 years and the amortization expense for the year ended March 31, 2013 was $11.7 million. At March 31, 2013, finite-lived intangible assets are expected to be amortized over their estimated useful life, which ranges from a period of 3 to 30 years , and the estimated amortization expense for each of the five succeeding years and periods thereafter is as follows (in thousands):



Year Ending March 31,
2014	$	10,210
2015	8,834
2016	8,834
2017	8,834
2018	8,834
Thereafter	83,976
	$	129,522

- Definition

The entire disclosure for all or part of the information related to intangible assets.

+ References+ Details

Long-Term Debt

12 Months Ended

Mar. 31, 2013

Debt Disclosure [Abstract]

Long-Term Debt

On March 24, 2010, Prestige Brands, Inc. ("the Borrower") issued $150.0 million of senior unsecured notes, with an interest rate of 8.25% and a maturity date of April 1, 2018 (the "2010 Senior Notes"). On November 1, 2010, the Borrower issued an additional $100.0 million of the 2010 Senior Notes. The Borrower may earlier redeem some or all of the 2010 Senior Notes at redemption prices set forth in the indenture governing the 2010 Senior Notes . The 2010 Senior Notes issued in March and November 2010 were issued at an aggregate face value of $150.0 million and $100.0 million, respectively, with a discount to the initial purchasers of $2.2 million and a premium of $0.3 million, respectively, and net proceeds to the Company of $147.8 million and $100.3 million, respectively, yielding an 8.5% effective interest rate for the 2010 Senior Notes on a combined basis. The 2010 Senior Notes are unconditionally guaranteed by Prestige Brands Holdings, Inc. and its domestic 100% owned subsidiaries, other than the Borrower. Each of these guarantees is joint and several. There are no significant restrictions on the ability of any of the guarantors to make payments to Prestige Brands, Inc., or the Company or to obtain funds from their subsidiaries.

On March 24, 2010, the Borrower also entered into a senior secured term loan facility for $150.0 million, with an interest rate at LIBOR plus 3.25% with a LIBOR floor of 1.5%, and a maturity date of March 24, 2016 (the "2010 Senior Term Loan"). The $150.0 million 2010 Senior Term Loan was entered into with a discount to lenders of $1.8 million and net proceeds to the Company of $148.2 million, yielding a 5.0% effective interest rate. On November 1, 2010, Prestige Brands Holdings, Inc., together with the Borrower and certain of our other subsidiaries, executed an Increase Joinder to our credit agreement governing the 2010 Senior Term Loan (the "Increase Joinder"), pursuant to which the Borrower entered into an incremental term loan in the amount of $115.0 million. The 2010 Senior Term Loan was scheduled to mature on March 24, 2016 and was repaid in full on January 31, 2012 with the entry into the new senior secured credit facility described below. In connection with the refinancing and the payoff of the 2010 Senior Term Loan, we recognized a $5.4 million loss on the extinguishment of debt for 2012. The 2010 Senior Term Loan was unconditionally guaranteed by Prestige Brands Holdings, Inc. and its domestic 100% owned subsidiaries, other than the Borrower.

Additionally, on March 24, 2010, the Borrower entered into a non-amortizing senior secured revolving credit facility (“2010 Revolving Credit Facility” and, together with the 2010 Senior Term Loan, the “2010 Credit Facility”) in an aggregate principal amount of up to $30.0 million. On November 1, 2010, pursuant to the Increase Joinder, the amount of the 2010 Revolving Credit Facility was increased by $10.0 million, providing the Borrower with borrowing capacity under the 2010 Revolving Credit Facility in an aggregate principal amount of up to $40.0 million. On January 31, 2012, in connection with the entry into the new senior secured credit facility as described below, the Borrower terminated the 2010 Credit Facility. There were no material early termination penalties as a result of the termination of the 2010 Credit Facility.

On January 31, 2012, the Borrower issued $250.0 million of senior unsecured notes at par value, with an interest rate of 8.125% and a maturity date of February 1, 2020 (the "2012 Senior Notes"). The Borrower may earlier redeem some or all of the 2012 Senior Notes at redemption prices set forth in the indenture governing the 2012 Senior Notes. The 2012 Senior Notes are guaranteed by Prestige Brands Holdings, Inc. and certain of its domestic 100% owned subsidiaries. Each of these guarantees is joint and several. There are no significant restrictions on the ability of any of the guarantors to obtain funds from their subsidiaries. In connection with the 2012 Senior Notes offering, we incurred $12.6 million of costs which were capitalized as deferred financing costs and are being amortized over the term of the 2012 Senior Notes.

On January 31, 2012, the Borrower also entered into a new senior secured credit facility, which consists of (i) a $660.0 million term loan facility (“2012 Term Loan”) with a seven-year maturity and (ii) a $50.0 million asset-based revolving credit facility (“2012 ABL Revolver”) with a five-year maturity. In September 2012, we utilized a portion of our accordion feature to increase the amount of our borrowing capacity under the 2012 ABL Revolver by $25.0 million to $75.0 million. The 2012 Term Loan was issued with an original issue discount of 1.5% of the principal amount thereof, resulting in net proceeds to Company of $650.1 million. In connection with these loan facilities, we incurred $20.6 million of costs which were capitalized as deferred financing costs and are being amortized over the terms of the facilities. The 2012 Term Loan is unconditionally guaranteed by Prestige Brands Holdings, Inc. and its domestic 100% owned subsidiaries, other than the Borrower. Each of these guarantees is joint and several. There are no significant restrictions on the ability of any of the guarantors to obtain funds from their subsidiaries.

On February 21, 2013, the Borrower entered into Amendment No. 1 (the "Amendment") to the 2012 Term Loan. The Amendment provides for the refinancing of all of the Borrower's existing Term B Loans with new Term B-1 Loans. The interest rate on the Term B-1 Loans is based, at the Borrower's option, on a LIBOR rate, plus a margin of 2.75% per annum, with a LIBOR floor of 1.00%, or an alternate base rate, plus a margin. The new Term B-1 Loans will mature on the same date as the Term B Loans original maturity date. In addition, the Amendment provides the Borrower with certain additional capacity to prepay subordinated debt, the 2012 Senior Notes and certain other unsecured indebtedness permitted to be incurred under the credit agreement. In connection with the refinancing, during the fourth quarter ended March 31, 2013, we recognized a $1.4 million loss on the extinguishment of debt.

The 2012 Term Loan, as amended, bears interest at a rate per annum equal to an applicable margin plus, at our option, either (i) a base rate determined by reference to the highest of (a) the Federal Funds rate plus 0.50%, (b) the prime rate of Citibank, N.A., (c) the LIBOR rate determined by reference to the cost of funds for U.S. dollar deposits for an interest period of one month adjusted for certain additional costs, plus 1.00% and (d) a floor of 2.00% or (ii) a LIBOR rate determined by reference to the costs of funds for U.S. dollar deposits for the interest period relevant to such borrowing adjusted for certain additional costs, provided that LIBOR shall not be lower than 1.00%. For the year ended March 31, 2013, the average interest rate on the 2012 Term Loan was 5.2%.

Under the 2012 Term Loan, we are required to make quarterly payments each equal to 0.25% of the original principal amount of the 2012 Term Loan, with the balance expected to be due on the seventh anniversary of the closing date. However, since we made a $25.0 million payment in March 2012, and additional payments totaling $190.0 million during the year ended March 31, 2013, we will not be required to make a quarterly payment until the maturity date of January 31, 2019.

Borrowings under the 2012 ABL Revolver bear interest at a rate per annum equal to an applicable margin, plus, at our option, either (i) a base rate determined by reference to the highest of (a) the Federal Funds rate plus 0.50%, (b) the prime rate of Citibank, N.A., (c) the LIBOR rate determined by reference to the cost of funds for U.S. dollar deposits for an interest period of one month adjusted for certain additional costs, plus 1.00% or (ii) a LIBOR rate determined by reference to the costs of funds for U.S. dollar deposits for the interest period relevant to such borrowing adjusted for certain additional costs. The initial applicable margin for borrowings under the 2012 ABL Revolver is 1.75% with respect to LIBOR borrowings and 0.75% with respect to base-rate borrowings. The applicable margin for borrowings under the 2012 ABL Revolver may be increased to 2.00% or 2.25% for LIBOR borrowings and 1.00% or 1.25% for base-rate borrowings, depending on average excess availability under the 2012 ABL Revolver during the prior fiscal quarter. In addition to paying interest on outstanding principal under the 2012 ABL Revolver, we are required to pay a commitment fee to the lenders under the 2012 ABL Revolver in respect of the unutilized commitments thereunder. The initial commitment fee rate is 0.50% per annum. The commitment fee rate will be reduced to 0.375% per annum at any time when the average daily unused commitments for the prior quarter is less than the percentage of total commitments set forth in the credit agreement covering the 2012 ABL Revolver. We may voluntarily repay outstanding loans under the 2012 ABL Revolver at any time without a premium or penalty. For the year ended March 31, 2013, the average interest rate on the 2012 ABL Revolver was 2.2%.

We used the net proceeds from the 2012 Senior Notes offering, together with borrowings under the 2012 Term Loan to finance the acquisition of the GSK Brands, to repay the 2010 Credit Facility, to pay fees and expenses incurred in connection with these transactions and for general corporate purposes. The acquisition of the GSK Brands is discussed in Note 3 .

In connection with the financing activities of March 2010 relating to the 2010 Senior Notes, the 2010 Senior Term Loan and the 2010 Revolving Credit Facility, we incurred $7.3 million in issuance costs, of which $6.6 million was capitalized as deferred financing costs and $0.7 million was expensed. In connection with the financing activities of November 2010 relating to the 2010 Senior Notes and the Increase Joiner, we incurred $0.6 million in issuance costs, all of which was capitalized as deferred financing costs. In connection with the financing activities of January 2012 relating to the 2012 Senior Notes, the 2012 Term Loan and the 2012 ABL Revolver, we incurred $12.6 million, $18.8 million and $1.8 million, respectively, in issuance costs, which were capitalized as deferred financing costs. The deferred financing costs are being amortized over the terms of the related loan and notes. During the three months ended December 31, 2012, we made significant payments toward our outstanding indebtedness under our 2012 Term Loan. As such, we accelerated a portion of the deferred financing costs related to the 2012 Term Loan in the amount of $5.1 million.

On March 24, 2010, we retired our then-existing senior secured term loan facility with an original maturity date of April 6, 2011. In addition, on March 24, 2010, we repaid a portion and, on April 15, 2010, redeemed in full the remaining outstanding indebtedness under our previously outstanding senior subordinated notes due in 2012, which bore interest at 9.25% with a maturity date of April 15, 2012. In connection with the refinancing, we recognized a $0.3 million loss on the extinguishment of debt for 2011.

The 2010 Senior Notes are secured on a pari passu basis with the 2012 Term Loan and are guaranteed on a senior unsecured basis. The 2012 Senior Notes are senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis. The 2010 Senior Notes are effectively junior in right of payment to all existing and future secured obligations of the Company , equal in right of payment with all existing and future senior unsecured indebtedness of the Company, and senior in right of payment to all future subordinated debt of the Company. The 2012 Senior Notes are effectively subordinated to secured obligations of the Company, including the 2012 Term Loan and the 2012 ABL Revolver and the 2010 Senior Notes, equal in right of payment to all existing and future unsecured obligations of the Company, and senior in right of payment to all existing and future subordinated obligations of the Company.

At any time prior to April 1, 2014, we may redeem the 2010 Senior Notes in whole or in part at a redemption price equal to 100% of the principal amount of the notes redeemed, plus a “make-whole premium” calculated as set forth in the indenture governing the 2010 Senior Notes, together with accrued and unpaid interest, if any, to the date of redemption. We may redeem the 2010 Senior Notes in whole or in part at any time on or after the 12-month period beginning April 1, 2014 at a redemption price of 104.125% of the principal amount thereof, at a redemption price of 102.063% of the principal amount thereof if the redemption occurs during the 12-month period beginning on April 1, 2015, and at a redemption price of 100% of the principal amount thereof if the redemption occurs on and after April 1, 2016, in each case, plus accrued and unpaid interest, if any, to the redemption date. In addition, prior to April 1, 2013, with the net cash proceeds from certain equity offerings, we could have redeemed up to 35% in aggregate principal amount of the 2010 Senior Notes at a redemption price of 108.250% of the principal amount of the 2010 Senior Notes to be redeemed, plus accrued and unpaid interest, if any, to the redemption date.

At any time prior to February 1, 2016, we may redeem the 2012 Senior Notes in whole or in part at a redemption price equal to 100% of the principal amount of the notes redeemed, plus a "make-whole premium" calculated as set forth in the indenture governing the 2012 Senior Notes, together with accrued and unpaid interest, if any, to the date of redemption. On or after February 1, 2016, we may redeem the 2012 Senior Notes in whole or in part at redemption prices set forth in the indenture governing the 2012 Senior Notes. In addition, at any time prior to February 1, 2015, we may redeem up to 35% of the aggregate principal amount of the 2012 Senior Notes at a redemption price equal to 108.125% of the principal amount plus accrued and unpaid interest, if any, to the redemption date, with the net cash proceeds of certain equity offerings, provided that certain conditions are met. Subject to certain limitations, in the event of a change of control, as defined in the indenture governing the 2012 Senior Notes, Prestige Brands, Inc. will be required to make an offer to purchase the 2012 Senior Notes at a price equal to 101% of the aggregate principal amount of the 2012 Senior Notes repurchased, plus accrued and unpaid interest, if any, to the date of repurchase.

The indentures governing the 2010 Senior Notes and 2012 Senior Notes contain provisions that restrict us from undertaking specified corporate actions, such as asset dispositions, acquisitions, dividend payments, repurchases of common shares outstanding, changes of control, incurrences of indebtedness, issuance of equity, creation of liens, making of loans and transactions with affiliates. Additionally, the credit agreement with respect to the 2012 Term Loan and the 2012 ABL Revolver and the indenture governing the 2012 Senior Notes contain cross-default provisions, whereby a default pursuant to the terms and conditions of certain indebtedness will cause a default on the remaining indebtedness under the credit agreement and the indenture governing the 2012 Senior Notes. At March 31, 2013, we were in compliance with the covenants under our long-term indebtedness.

During the year ended March 31, 2013, we made principal payments of $190.0 million against the outstanding 2012 Term Loan and borrowed a net amount of $33.0 million against the 2012 ABL Revolver. The 2010 Senior Term Loan was repaid in full on January 31, 2012.

Long-term debt consists of the following, as of the dates indicated:



(In thousands, except percentages)	March 31,
	2013			2012
2012 Senior Notes bearing interest at 8.125%, with interest only payable on February 1st and August 1st of each year. The 2012 Senior Notes mature on February 1, 2020.	$250,000			$	250,000
2012 Term Loan bearing interest at the Company's option at either a base rate plus applicable margin with a floor of 2.00% or LIBOR with a floor of 1.00%, due on January 31, 2019.	445,000			635,000
2012 ABL Revolver bearing interest at the Company's option at either a base rate plus applicable margin or LIBOR plus applicable margin. Any unpaid balance is due on January 31, 2017.	33,000			—
2010 Senior Notes bearing interest at 8.25%, with interest only payable on April 1st and October 1st of each year. The 2010 Senior Notes mature on April 1, 2018.	250,000			250,000
	978,000			1,135,000
Current portion of long-term debt	—			—
	978,000			1,135,000
Less: unamortized discount	(7,100		)	(11,092		)
Long-term debt, net of unamortized discount	$	970,900		$	1,123,908

During the year ended March 31, 2013, we made significant payments toward our outstanding indebtedness under our 2012 Term Loan. As such, we accelerated the amortization of a portion of the debt discount related to the 2012 Term Loan in the amount of $2.6 million. Aggregate future principal payments required in accordance with the terms of the 2012 Term Loan, the 2012 ABL Revolver and the indentures governing the 2010 Senior Notes and the 2012 Senior Notes are as follows (in thousands):



Year Ending March 31,	Amount
2014	$	—
2015	—
2016	—
2017	33,000
2018	—
Thereafter	945,000
	$	978,000

Fair Value Measurements	12 Months Ended
Fair Value Measurements	Mar. 31, 2013
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements As we deem appropriate, we may from time to time utilize derivative financial instruments to mitigate the impact of changing interest rates associated with our long-term debt obligations or other derivative financial instruments. While we have utilized derivative financial instruments in the past, we did not have any derivative financial instruments outstanding at March 31, 2013, 2012 or 2011. We have not entered into derivative financial instruments for trading purposes; all of our derivatives were over-the-counter instruments with liquid markets. For certain of our financial instruments, including cash, accounts receivable, accounts payable and other current liabilities, the carrying amounts approximate their respective fair values due to the relatively short maturity of these amounts. The Fair Value Measurements and Disclosures topic of the FASB ASC requires fair value to be determined based on the exchange price that would be received for an asset or paid to transfer a liability in the principal or most advantageous market assuming an orderly transaction between market participants. The Fair Value Measurements and Disclosures topic established market (observable inputs) as the preferred source of fair value to be followed by the Company's assumptions of fair value based on hypothetical transactions (unobservable inputs) in the absence of observable market inputs. Based upon the above, the following fair value hierarchy was created: Level 1 - Quoted market prices for identical instruments in active markets; Level 2 - Quoted prices for similar instruments in active markets, as well as quoted prices for identical or similar instruments in markets that are not considered active; and Level 3 - Unobservable inputs developed by the Company using estimates and assumptions reflective of those that would be utilized by a market participant. The market values have been determined based on market values for similar instruments adjusted for certain factors. As such, the 2012 Term Loan, the 2012 Senior Notes, the 2010 Senior Notes, and the 2012 ABL Revolver are measured in Level 2 of the above hierarchy. At March 31, 2013 and 2012, we did not have any assets or liabilities measured in Level 1 or 3. During 2013, 2012 and 2011, there were no transfers of assets or liabilities between Levels 1, 2 and 3. At March 31, 2013 and March 31, 2012, the carrying value of our 2012 Senior Notes was $250.0 million and $250.0 million, respectively. The market value of our 2012 Senior Notes was $281.9 million and $270.6 million, respectively, at March 31, 2013 and March 31, 2012. At March 31, 2013 and March 31, 2012, the carrying value of the 2012 Term Loan was $445.0 million and $635.0 million, respectively. The market value of the 2012 Term Loan was $451.1 million and $639.0 million at March 31, 2013 and March 31, 2012, respectively. At March 31, 2013 and March 31, 2012, the carrying value of our 2010 Senior Notes was $250.0 million and $250.0 million, respectively. The market value of our 2010 Senior Notes was $271.9 million and $272.5 million at March 31, 2013 and March 31, 2012, respectively. At March 31, 2013, the carrying value of the 2012 ABL Revolver of $33.0 million approximated its market value.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 107

-Paragraph 3, 10, 14, 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 107

-Paragraph 15C, 15D

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 157

-Paragraph 32, 33, 34

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 21

-URI http://asc.fasb.org/extlink&oid=7491637&loc=d3e13537-108611

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 133

-Paragraph 44A, 44B

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=7491637&loc=d3e13433-108611

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7578670&loc=d3e19207-110258

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 30

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14172-108612

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=7491637&loc=d3e13504-108611

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 107

-Paragraph 15B

-Subparagraph a, b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 159

-Paragraph 17-22, 27, 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 107

-Paragraph 15A

-Subparagraph a-d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Stockholders' Equity	12 Months Ended
Stockholders' Equity	Mar. 31, 2013
Stockholders' Equity Note [Abstract]
Stockholders' Equity	Stockholders' Equity We are authorized to issue 250.0 million shares of common stock, $0.01 par value per share, and 5.0 million shares of preferred stock, $0.01 par value per share. The Board of Directors may direct the issuance of the undesignated preferred stock in one or more series and determine preferences, privileges and restrictions thereof. Each share of common stock has the right to one vote on all matters submitted to a vote of stockholders. The holders of common stock are also entitled to receive dividends whenever funds are legally available and when declared by the Board of Directors, subject to prior rights of holders of all classes of stock outstanding having priority rights as to dividends. No dividends have been declared or paid on our common stock through March 31, 2013. Effective February 26, 2012, our Board of Directors adopted a stockholder rights plan (the "Rights Plan"). Pursuant to the Rights Plan, the Board of Directors declared a dividend distribution of one preferred share right (a "Right") for each share of common stock held of record by our stockholders as of March 8, 2012. Each Right entitles the holder to purchase one one-thousandth of a share of Series A Preferred Stock (the "Preferred Shares") at an initial exercise price of $65.00, subject to dilution adjustments for dividends payable in Preferred Shares or other such events. The Rights Plan is intended to ensure that all of our stockholders receive fair and equal treatment in the event of any proposed takeover of the Company and to protect stockholders' interests in the event we are confronted with partial tender offers or other coercive or unfair takeover tactics. The Rights become exercisable after ten days following the acquisition by an acquiring person or group of 10% or more of our outstanding common stock (“Acquisition Event”). If such acquiring person or group acquires 10% or more of the common stock, each Right (other than such acquiring person's or group's Rights, whose Rights become void upon exceeding the 10% threshold) will entitle the holder to purchase, at the exercise price, common stock having a market value equal to twice the exercise price of the Right. The Rights Plan and the Rights will expire on the date of the 2013 Annual Stockholders' Meeting if the Rights Plan is not approved by the Company's stockholders. If approved by the stockholders, the Rights Plan and the Rights will expire on February 26, 2022, unless an Acquisition Event occurs earlier. Subject to the provisions of the Rights Plan, at the Company's option, the Rights may be redeemed by the Company at an initial cash redemption price of $0.01 per Right or may be exchanged in whole or in part for one share of the Company's common stock, or one one-thousandth of a share of Preferred Share. During March 2012, we recorded a charge against retained earnings in the amount of $283,000 related to the fair value of the Rights as of the dividend date. For any right that expires unredeemed, the appropriate charge to retained earnings will be reversed. During 2013, 2012 and 2011, we repurchased zero, 20,999, and 36,032 shares, respectively, of restricted common stock from current and former employees pursuant to the provisions of the various employee stock purchase agreements. The purchases were at an average price of $12.86 per share for 2012 and $9.81 per share for 2011. All of such shares have been recorded as treasury stock.

- Definition

The entire disclosure for shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, if any, including other comprehensive income (as applicable). Including, but not limited to: (1) balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings; (2) accumulated balance for each classification of other comprehensive income and total amount of comprehensive income; (3) amount and nature of changes in separate accounts, including the number of shares authorized and outstanding, number of shares issued upon exercise and conversion, and for other comprehensive income, the adjustments for reclassifications to net income; (4) rights and privileges of each class of stock authorized; (5) basis of treasury stock, if other than cost, and amounts paid and accounting treatment for treasury stock purchased significantly in excess of market; (6) dividends paid or payable per share and in the aggregate for each class of stock for each period presented; (7) dividend restrictions and accumulated preferred dividends in arrears (in aggregate and per share amount); (8) retained earnings appropriations or restrictions, such as dividend restrictions; (9) impact of change in accounting principle, initial adoption of new accounting principle and correction of an error in previously issued financial statements; (10) shares held in trust for Employee Stock Ownership Plan (ESOP); (11) deferred compensation related to issuance of capital stock; (12) note received for issuance of stock; (13) unamortized discount on shares; (14) description, terms, and number of warrants or rights outstanding; (15) shares under subscription and subscription receivables, effective date of new retained earnings after quasi-reorganization and deficit eliminated by quasi-reorganization and, for a period of at least ten years after the effective date, the point in time from which the new retained dates; and (16) retroactive effective of subsequent change in capital structure.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 5

-Paragraph 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Preferred Stock

-URI http://asc.fasb.org/extlink&oid=6521494

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(d),(e))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=6228006&loc=d3e74512-122707

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Article 4

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section C

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 43

-Section B

-Paragraph 7, 11A

-Chapter 1

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 4

-Subparagraph (SAB TOPIC 4.C)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187143-122770

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 129

-Paragraph 2, 3, 4, 5, 6, 7, 8

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 17: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 18: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 19: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Reference 20: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 21: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 22: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 23: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph d

-Article 4

+ Details

Earnings Per Share

12 Months Ended

Mar. 31, 2013

Earnings Per Share [Abstract]

Earnings Per Share

Basic earnings per share is computed based on the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per share is computed based on the weighted-average number of shares of common stock outstanding plus the effect of potentially dilutive common shares outstanding during the period using the treasury stock method, which includes stock options, restricted stock awards, and restricted stock units. The following table sets forth the computation of basic and diluted earnings per share:



(In thousands, except per share data)	Year Ended March 31,
	2013		2012		2011
Numerator
Income from continuing operations	$	65,505	$	37,212	$	29,179
Income from discontinued operations and loss on sale of discontinued operations	—		—		41
Net income	$	65,505	$	37,212	$	29,220

Denominator
Denominator for basic earnings per share- weighted average shares	50,633		50,270		50,081
Dilutive effect of unvested restricted common stock (including restricted stock units) and options issued to employees and directors	807		478		257
Denominator for diluted earnings per share	51,440		50,748		50,338

Earnings per Common Share:
Basic earnings per share from continuing operations	$	1.29	$	0.74	$	0.58
Basic earnings per share from discontinued operations and loss on sale of discontinued operations	—		—		—
Basic net earnings per share	$	1.29	$	0.74	$	0.58

Diluted earnings per share from continuing operations	$	1.27	$	0.73	$	0.58
Diluted earnings per share from discontinued operations and loss on sale of discontinued operations	—		—		—
Diluted net earnings per share	$	1.27	$	0.73	$	0.58

Additionally, for 2013, 2012 and 2011 there were zero, 0.4 million and 0.5 million shares attributable to outstanding stock-based awards that were excluded from the calculation of diluted earnings per share because their inclusion would have been anti-dilutive.

- Definition

The entire disclosure for earnings per share.

+ References+ Details

Share-Based Compensation

12 Months Ended

Mar. 31, 2013

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Share-based Compensation

Share-Based Compensation

In connection with our initial public offering, the Board of Directors adopted the 2005 Long-Term Equity Incentive Plan (the “Plan”) which provides for the grant, up to a maximum of 5.0 million shares of restricted stock, stock options, restricted stock units and other equity-based awards. Directors, officers and other employees of the Company and its subsidiaries, as well as others performing services for the Company, are eligible for grants under the Plan.

During 2013, pre-tax share-based compensation costs charged against income and the related income tax benefit recognized were $3.8 million and $1.2 million, respectively.

During 2012, pre-tax share-based compensation costs charged against income and the related income tax benefit recognized were $3.1 million and $1.2 million, respectively. During 2012 management determined that performance goals associated with the grants of stock to management and employees in May 2008 were met and recorded stock compensation costs, and accordingly shares were issued in accordance with the Plan in May 2011. No prior compensation costs were required to be reversed.

During 2011, pre-tax share-based compensation costs charged against income and the related income tax benefit recognized were $3.6 million and $1.4 million, respectively. During 2011 management determined that performance goals associated with the grants of stock to management and employees in May 2008 were met and recorded stock compensation costs accordingly. No prior compensation costs were required to be reversed.

Restricted Shares

Restricted shares granted to employees under the Plan generally vest in three to five years, primarily upon the attainment of certain time vesting thresholds, and may also be contingent on the attainment of certain performance goals of the Company, including revenue and earnings before income taxes, depreciation and amortization targets. The restricted share awards provide for accelerated vesting if there is a change of control, as defined in the Plan. On January 25, 2012, the Compensation Committee of our Board of Directors granted 95,000 shares of restricted stock units to certain members of executive management. The restricted stock units will vest in equal annual installments over a three year period on the anniversary date of the grants. The grant-date fair value of restricted shares is determined using the closing price of our common stock on the day of grant. On May 9, 2012, the Compensation Committee of our Board of Directors granted 111,152 shares of restricted common stock units to certain executive officers and employees under the Plan. On June 29, 2012, the Compensation Committee of our Board of Directors granted 12,652 shares of restricted common stock units to the independent members of the Board of Directors under the Plan. On August 6, 2012, the Compensation Committee of the Board of Directors granted 5,109 shares of restricted common stock units to Matthew M. Mannelly, our President and CEO, under the Plan..

The restricted common stock units granted to directors will vest in their entirety one year after the date of grant so long as the membership on the Board of Directors continues through the vesting date, with the settlement in common stock to occur on the earliest of the director's death, disability or six-month anniversary of the date on which the director's Board membership ceases for reasons other than death or disability. The restricted stock units granted to employees generally vest in their entirety on the three-year anniversary of the date of the grant. Upon vesting, the units will be settled in shares of our common stock. The fair value of the restricted stock units is determined using the closing price of our common stock on the day of grant. The weighted-average grant-date fair value during 2013, 2012 and 2011 was $13.59, $11.81 and $8.99, respectively.

A summary of the Company’s restricted shares granted under the Plan is presented below:



Nonvested Shares	Shares (in thousands)		Weighted-Average Grant-Date Fair Value

Nonvested at March 31, 2010	287.1		$	8.86

Granted	125.0		8.99
Vested and issued	(88.2	)	9.63
Forfeited	(48.5	)	10.10
Vested and nonvested at March 31, 2011	275.4		8.46
Vested at March 31, 2011	29.2		6.84

Granted	217.5		11.81
Vested and issued	(103.4	)	9.93
Forfeited	(26.1	)	10.17
Vested and nonvested at March 31, 2012	363.4		9.92
Vested at March 31, 2012	54.0		7.40

Granted	128.9		13.59
Vested and issued	(58.7	)	9.99
Forfeited	(12.3	)	10.69
Vested and nonvested at March 31, 2013	421.3		11.01
Vested at March 31, 2013	70.4		8.52

Options

The Plan provides that the exercise price of options granted shall be no less than the fair market value of the Company's common stock on the date the options are granted. Options granted have a term of no greater than ten years from the date of grant and vest in accordance with a schedule determined at the time the option is granted, generally three to five years. The option awards provide for accelerated vesting in the event of a change in control, as defined in the Plan.

The fair value of each option award is estimated on the date of grant using the Black-Scholes Option Pricing Model that uses the assumptions noted in the table below. Expected volatilities are based on the historical volatility of our common stock and other factors, including the historical volatilities of comparable companies. We use appropriate historical data, as well as current data, to estimate option exercise and employee termination behaviors. Employees that are expected to exhibit similar exercise or termination behaviors are grouped together for the purposes of valuation. The expected terms of the options granted are derived from our historical experience, management’s estimates, and consideration of information derived from the public filings of companies similar to us, and represent the period of time that options granted are expected to be outstanding. The risk-free rate represents the yield on U.S. Treasury bonds with a maturity equal to the expected term of the granted option. On May 9, 2012, the Compensation Committee of our Board of Directors granted stock options to acquire 422,962 shares of our common stock to certain executive officers and employees under the Plan. These stock options were granted at an exercise price of $13.24 per share, which is equal to the closing price for our common stock on the day of the grant. On August 6, 2012, the Compensation Committee of the Board of Directors granted stock options to acquire 21,978 shares of our common stock to Matthew M. Mannelly. These stock options were granted at an exercise price of $15.66 per share, which is equal to the closing price for our common stock on the date of grant. The stock options will vest 33.3% per year over three years and are exercisable for up to ten years from the date of grant.

The weighted-average grant-date fair value of the options granted during 2013, 2012 and 2011 were $6.03, $5.83 and $4.91, respectively.



	Year Ended March 31,
	2013		2012
Expected volatility	44.0	%	53.0	%
Expected dividends	—		—
Expected term in years	6.5		6.5
Risk-free rate	1.2	%	2.4	%

A summary of option activity under the Plan is as follows:



Options	Shares (in thousands)		Weighted-Average Exercise Price		Weighted- Average Remaining Contractual Term	Aggregate Intrinsic Value (in thousands)

Outstanding at March 31, 2010	1,584.2		$	8.50

Granted	418.6		9.26
Exercised	(33.8	)	9.79
Forfeited or expired	(347.5	)	10.74
Outstanding at March 31, 2011	1,621.5		8.19

Granted	308.2		11.27
Exercised	(86.9	)	10.24
Forfeited or expired	(97.4	)	11.57
Outstanding at March 31, 2012	1,745.4		8.44

Granted	444.9		13.36
Exercised	(786.5	)	7.67
Forfeited or expired	(17.4	)	11.21
Outstanding at March 31, 2013	1,386.4		10.43		7.6	$	10,468
Exercisable at March 31, 2013	254.4		10.81		6.6	1,666

The aggregate intrinsic value of options exercised during 2013 was $3.8 million. The aggregate intrinsic value at March 31, 2013 for options granted during 2013 was $5.5 million. The weighted-average fair value per option at the grant date was $6.03 for 2013.

At March 31, 2013, there were $3.0 million of unrecognized compensation costs related to nonvested share-based compensation arrangements under the Plan, based on management’s estimate of the shares that will ultimately vest. We expect to recognize such costs over a weighted-average period of 0.9 years. The total fair value of options and restricted shares vested during 2013, 2012 and 2011, was $2.5 million, $2.9 million and $2.3 million, respectively. Cash received from the exercise of stock options was $6.0 million during 2013, and we realized $11.3 million in tax benefits for the tax deductions resulting from option exercises. Cash received from the exercise of stock options was $0.6 million during 2012, and we realized $0.3 million in tax benefits for the tax deductions resulting from option exercises. Cash received from the exercise of stock options was $0.3 million during 2011, and we realized $0.2 million in tax benefits for the tax deductions from option exercises. At March 31, 2013, there were 1.9 million shares available for issuance under the Plan.

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 50

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 123R

-Paragraph 64, 65, A240

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 40

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 14

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Statement of Position (SOP)

-Number 93-6

-Paragraph 53

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Income Taxes

12 Months Ended

Mar. 31, 2013

Income Tax Disclosure [Abstract]

Income Taxes

The provision for income taxes from continuing operations consists of the following:



(In thousands)	Year Ended March 31,
	2013		2012		2011
Current
Federal	$	12,520	$	8,127	$	8,793
State	1,972		1,396		1,496
Foreign	532		630		522
Deferred
Federal	23,845		13,100		7,211
State	1,660		692		1,327
Total provision for income taxes from continuing operations	$	40,529	$	23,945	$	19,349

The principal components of our deferred tax balances are as follows:



(In thousands)	March 31,
	2013			2012
Deferred Tax Assets
Allowance for doubtful accounts and sales returns	$	2,807		$	1,931
Inventory capitalization	1,370			1,184
Inventory reserves	525			635
Net operating loss carryforwards	411			495
State income taxes	7,364			7,103
Accrued liabilities	1,896			1,762
Stock compensation	2,367			2,536
Other	496			1
Total deferred tax assets	17,236			15,647

Deferred Tax Liabilities
Property and equipment	(1,504		)	(155		)
Intangible assets	(203,671		)	(177,926		)
Total deferred tax liabilities	(205,175		)	(178,081		)

Net deferred tax liability	$	(187,939	)	$	(162,434	)

At March 31, 2013, a 100% owned subsidiary had a net operating loss carryforward of approximately $1.2 million, which may be used to offset future taxable income of the consolidated group and begins to expire in 2020. The net operating loss carryforward is subject to an annual limitation as to usage under Internal Revenue Code Section 382 of approximately $0.2 million.

A reconciliation of the effective tax rate compared to the statutory U.S. Federal tax rate is as follows:



	Year Ended March 31,
(In thousands)	2013					2012					2011
				%					%					%
Income tax provision at statutory rate	$	37,112		35.0		$	21,405		35.0		$	17,008		35.0
Foreign tax (benefit) provision	—			—		191			0.3		(42		)	(0.1	)
State income taxes, net of federal income tax benefit	3,413			3.2		2,073			3.4		1,615			3.3
(Decrease) increase in net deferred tax liability resulting from a change in the effective state tax rate	(1,741		)	(1.6	)	(1,177		)	(1.9	)	302			0.6
Nondeductible compensation	1,684			1.6		1,305			2.1		—			—
Transaction costs	—			—		—			—		367			0.8
Other	61			—		148			0.3		124			0.3
Total provision for income taxes	40,529			38.2		23,945			39.2		19,374			39.9
Amount included in discontinued operations	—			—		—			—		25			38.2
Provision for income taxes from continuing operations	$	40,529		38.2		$	23,945		39.2		$	19,349		39.9

Uncertain tax liability activity is as follows:



	2013			2012
(In thousands)
Balance – beginning of year	$	292		456
Additions based on tax positions related to the current year	831			45
Reductions based on lapse of statute of limitations	(107		)	(209		)
Balance – end of year	$	1,016		$	292

We recognize interest and penalties related to uncertain tax positions as a component of income tax expense. All of our uncertain tax liabilities, if recognized, would reduce our effective tax rate. We did not incur any material interest or penalties related to income taxes in any of the periods presented. We do not anticipate any events or circumstances that would cause a material change to these uncertainties during the ensuing year. We are subject to taxation in the United States and various state and foreign jurisdictions, and we are generally open to examination from the year ended March 31, 2010 forward.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32718-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph h

-Article 4

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32559-109319

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 136, 172

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 43, 44, 45, 46, 47, 48, 49

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Commitments and Contingencies

12 Months Ended

Mar. 31, 2013

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

We are involved from time to time in routine legal matters and other claims incidental to our business. We review outstanding claims and proceedings internally and with external counsel as necessary to assess probability and amount of potential loss. These assessments are re-evaluated at each reporting period and as new information becomes available to determine whether a reserve should be established or if any existing reserve should be adjusted. The actual cost of resolving a claim or proceeding ultimately may be substantially different than the amount of the recorded reserve. In addition, because it is not permissible under GAAP to establish a litigation reserve until the loss is both probable and estimable, in some cases there may be insufficient time to establish a reserve prior to the actual incurrence of the loss (upon verdict and judgment at trial, for example, or in the case of a quickly negotiated settlement). We believe the resolution of routine legal matters and other claims incidental to our business, taking our reserves into account, will not have a material adverse effect on our business, financial condition, or results from operations.

Lease Commitments

We have operating leases for office facilities and equipment in New York and Wyoming, which expire at various dates through 2018. Due to the recent acquisition of the GSK Brands, we required additional office space and entered into a 5.5 year lease for a new office facility in New York, which began in the third quarter of fiscal 2013. In May 2012, we also entered into a three year office lease in Rogers, Arkansas. These amounts have been included in the schedule below.

The following summarizes future minimum lease payments for our operating leases:



(In thousands)	Facilities		Equipment		Total
Year Ending March 31,
2014	$	1,764	$	141	$	1,905
2015	1,049		136		1,185
2016	994		135		1,129
2017	1,023		68		1,091
2018	1,044		—		1,044
	$	5,874	$	480	$	6,354

Rent expense was $1.2 million, $0.9 million, and $0.8 million for 2013, 2012, and 2011, respectively.

Purchase Commitments

Effective November 1, 2009, we entered into a ten year supply agreement for the exclusive manufacture of a portion of one of our Household Cleaning products. Although we are committed under the supply agreement to pay the minimum amounts set forth in the table below, the total commitment is less than 10% of the estimated purchases that we expect to make during the course of the agreement.



(In thousands)
Year Ending March 31,
2014	1,136
2015	1,105
2016	1,074
2017	1,044
2018	1,013
Thereafter	1,542
	$	6,914

- Definition

The entire disclosure for commitments and contingencies.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name FASB Interpretation (FIN)

-Number 14

-Paragraph 3

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.25)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 460

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6398077&loc=d3e12565-110249

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6952336&loc=d3e14435-108349

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 440

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 5

-Paragraph 9, 10, 11, 12

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Concentrations of Risk	12 Months Ended
Concentrations of Risk	Mar. 31, 2013
Risks and Uncertainties [Abstract]
Concentrations of Risk	Concentrations of Risk Our sales are concentrated in the areas of OTC Healthcare and Household Cleaning products. We sell our products to mass merchandisers, food and drug stores, and dollar and club stores. During 2013, 2012 and 2011, approximately 40.5%, 51.3% and 63.3%, respectively, of our total sales were derived from our five top selling brands. One customer, Walmart, accounted for more than 10% of our gross revenues for each of the periods presented. During 2013, 2012 and 2011, Walmart accounted for approximately 15.9%, 18.9% and 20.3%, respectively, of our gross revenues. At March 31, 2013, approximately 24.5% of accounts receivable were owed by the same customer. We manage product distribution in the continental United States through a third-party distribution center in St. Louis, Missouri. A serious disruption, such as a flood or fire, to the main distribution center could damage our inventories and could materially impair our ability to distribute our products to customers in a timely manner or at a reasonable cost. We could incur significantly higher costs and experience longer lead times associated with the distribution of our products to our customers during the time that it takes us to reopen or replace our distribution center. As a result, any such disruption could have a material adverse effect on our business, sales and profitability. At March 31, 2013, we had relationships with 66 third-party manufacturers. Of those, we had long-term contracts with 22 manufacturers that produced items that accounted for approximately 75.3% of our gross sales for 2013, compared to 20 manufactures with long-term contracts that accounted for approximately 70.6% of gross sales in 2012. The fact that we do not have long-term contracts with certain manufacturers means that they could cease manufacturing our products at any time and for any reason or initiate arbitrary and costly price increases which could have a material adverse effect on our business, financial condition, and results from operations.

- Definition

The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 107

-Paragraph 15A

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6404-108592

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6327-108592

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Statement of Position (SOP)

-Number 94-6

-Paragraph 21, 22, 24

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=7491637&loc=d3e13531-108611

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 18

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6351-108592

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 21

-URI http://asc.fasb.org/extlink&oid=7491637&loc=d3e13537-108611

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 21

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6442-108592

+ Details

Business Segments

12 Months Ended

Mar. 31, 2013

Segment Reporting [Abstract]

Business Segments

Segment information has been prepared in accordance with Segment Reporting topic of the FASB ASC and includes certain information that our chief operating decision maker, the Company's Chief Executive Officer, reviews, including contribution margin, which is a non-GAAP financial measure. Contribution margin is defined as gross profit less advertising and promotional expenses. Our general and administrative expenses and other corporate-level activity is not allocated to our segments, including costs of: employee-related costs; legal; finance; information technology; corporate development; legal settlements; depreciation and amortization; and facility and insurance costs. As described in Note 2, on September 1, 2010, we sold certain assets related to the Cutex nail polish remover brand included in our previously reported Personal Care segment to an unrelated third party. The assets sold comprised a substantial majority of the assets in our previously reported Personal Care segment. The remaining assets and revenues generated do not constitute a reportable segment under the Segment Reporting topic of the FASB ASC. Therefore, we reclassified the remaining assets and results of the Personal Care segment to the OTC Healthcare segment for all periods presented. Our current operating and reportable segments now consist of (i) OTC Healthcare and (ii) Household Cleaning.

There were no inter-segment sales or transfers during any of the periods presented. We evaluate the performance of our operating segments and allocate resources to them based primarily on contribution margin.

The table below summarizes information about our operating and reportable segments.



	Year Ended March 31, 2013
	OTC Healthcare		Household Cleaning		Consolidated
(In thousands)
Net sales	$	536,247	$	84,147	$	620,394
Other revenues	684		2,519		3,203
Total revenues	536,931		86,666		623,597
Cost of sales	211,654		64,727		276,381
Gross profit	325,277		21,939		347,216
Advertising and promotion	84,537		6,093		90,630
Contribution margin	$	240,740	$	15,846	256,586
Other operating expenses					64,702
Operating income					191,884
Other expenses					85,850
Provision for income taxes					40,529
Income from continuing operations					65,505
Income from discontinued operations, net of income tax					—
Loss on sale of discontinued operations, net of income tax benefit					—
Net income					$	65,505



	Year Ended March 31, 2012
	OTC Healthcare		Household Cleaning		Consolidated
(In thousands)
Net sales	$	344,282	$	93,556	$	437,838
Other revenues	719		2,528		3,247
Total revenues	345,001		96,084		441,085
Cost of sales	143,151		70,550		213,701
Gross profit	201,850		25,534		227,384
Advertising and promotion	51,895		5,232		57,127
Contribution margin	$	149,955	$	20,302	170,257
Other operating expenses					67,434
Operating income					102,823
Other expenses					41,666
Provision for income taxes					23,945
Income from continuing operations					37,212
Income from discontinued operations, net of income tax					—
Loss on sale of discontinued operations, net of income tax					—
Net income					$	37,212



	Year Ended March 31, 2011
	OTC Healthcare		Household Cleaning		Consolidated
(In thousands)
Net sales	$	234,042	$	99,673	$	333,715
Other revenues	543		2,252		2,795
Total revenues	234,585		101,925		336,510
Cost of sales	97,710		67,922		165,632
Gross profit	136,875		34,003		170,878
Advertising and promotion	36,752		6,145		42,897
Contribution margin	$	100,123	$	27,858	127,981
Other operating expenses					51,836
Operating income					76,145
Other expenses					27,617
Provision for income taxes					19,349
Income from continuing operations					29,179
Income from discontinued operations, net of income tax					591
Loss on sale of discontinued operations, net of income tax					(550		)
Net income					$	29,220



	Year Ended March 31,
(In thousands)	2013		2012		2011
Analgesics	$	108,144	$	18,930	$	3,063
Cough & Cold	126,974		116,669		75,013
Gastrointestinal	97,940		29,489		4,067
Eye & Ear Care	86,380		74,363		70,724
Dermatologicals	52,401		52,592		51,398
Oral Care	49,617		46,551		26,518
Other OTC	15,475		6,407		3,802
Total OTC Healthcare Segment	536,931		345,001		234,585
Household Cleaning Segment	86,666		96,084		101,925
Consolidated Net Revenues	$	623,597	$	441,085	$	336,510

During 2013, 2012 and 2011, approximately 89.9%, 90.2%, and 89.3%, respectively of our sales were made to customers in the United States. Other than the United States, no individual geographical area accounted for more than 10% of net sales in any of the periods presented. Sales to Canada accounted for 7.4%, 6.3%, and 6.5% of our total revenues for 2013, 2012, and 2011, respectively. At March 31, 2013, substantially all of our long-term assets were located in the United States of America and have been allocated to the operating segments as follows:



(In thousands)	OTC Healthcare		Household Cleaning		Consolidated
Goodwill	$	160,157	$	7,389	$	167,546

Intangible assets
Indefinite-lived	1,123,898		119,820		1,243,718
Finite-lived	101,611		27,911		129,522
	1,225,509		147,731		1,373,240

	$	1,385,666	$	155,120	$	1,540,786

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 29

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 131

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 32

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 34

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 35

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 42

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 40

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 31

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 41

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 30

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 33

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599

+ Details

Gain on Settlement	12 Months Ended
Gain on Settlement	Mar. 31, 2013
Commitments and Contingencies Disclosure [Abstract]
Gain on Settlement	Gain on Settlement On June 15, 2011, we received a settlement payment of $8.0 million in the resolution of pending litigation, which Prestige Brands, Inc. had initiated for legal malpractice, breach of contract and breach of fiduciary duty against a law firm and two individual lawyers who had previously provided legal representation to Prestige Brands, Inc. Because the result of the litigation could only have resulted in a potential gain and the amount could not be determined prior to the settlement, the settlement payment was not disclosed prior to the actual receipt of the settlement. Additionally, the costs netted against the gain during the period ended June 30, 2011 were legal fees paid solely on a contingent basis and other immaterial legal fees incurred in the period ended June 30, 2011. All other costs and legal fees that were incurred prior to the period ended June 30, 2011 were immaterial and expensed as incurred. We incurred costs of $2.9 million in pursuing this matter. Therefore, we recorded a pre-tax gain on settlement of $5.1 million, net of costs incurred, and $3.2 million after income tax effects for the fiscal year ended March 31, 2012. The $5.1 million pre-tax gain is included in other (income) expense, as this gain did not relate to our ongoing operations.

Unaudited Quarterly Financial Information

12 Months Ended

Mar. 31, 2013

Quarterly Financial Information Disclosure [Abstract]

Unaudited Quarterly Financial Information

Unaudited quarterly financial information for 2013 and 2012 is as follows:

Year Ended March 31, 2013



	Quarterly Period Ended
(In thousands, except for per share data)	June 30, 2012			September 30, 2012		December 31, 2012			March 31, 2013
Total revenues	$	146,997		$	161,855	$	160,232		$	154,513
Cost of sales (exclusive of depreciation shown below)	63,393			71,310		75,235			66,443
Gross profit	83,604			90,545		84,997			88,070

Operating expenses
Advertising and promotion	20,325			23,508		23,538			23,259
General and administrative	16,151			12,585		11,378			11,353
Depreciation and amortization	3,295			3,296		3,359			3,285
	39,771			39,389		38,275			37,897
Operating income	43,833			51,156		46,722			50,173
Net interest expense	19,848			19,660		26,661			18,238
Gain on settlement	—			—		—			—
Loss on extinguishment of debt	—			—		—			1,443
Income before income taxes	23,985			31,496		20,061			30,492
Provision for income taxes	9,330			12,252		7,804			11,143
Net income	14,655			19,244		12,257			19,349


Earnings per share:
Basic	$	0.29		$	0.38	$	0.24		$	0.38
Diluted	$	0.29		$	0.38	$	0.24		$	0.37

Weighted average shares outstanding:
Basic	50,342			50,364		50,686			51,147
Diluted	51,106			51,225		51,523			51,913

Comprehensive income, net of tax:
Currency translation adjustments	(42		)	66		(1		)	(114		)
Total other comprehensive income (loss)	(42		)	66		(1		)	(114		)
Comprehensive income	14,613			19,310		12,256			19,235

Year Ended March 31, 2012



	Quarterly Period Ended
(In thousands, except for per share data)	June 30, 2011			September 30, 2011			December 31, 2011			March 31, 2012
Total revenues	$	95,295		$	105,544		$	106,250		$	133,996
Cost of sales (exclusive of depreciation shown below)	45,427			51,638			51,128			65,508
Gross profit	49,868			53,906			55,122			68,488

Operating expenses
Advertising and promotion	10,233			13,073			15,274			18,547
General and administrative	9,850			8,861			13,655			24,334
Depreciation and amortization	2,550			2,570			2,563			3,051
	22,633			24,504			31,492			45,932
Operating income	27,235			29,402			23,630			22,556
Net interest expense	8,578			8,279			8,116			16,347
Gain on settlement	(5,063		)	—			—			—
Loss on extinguishment of debt	—			—			—			5,409
Income before income taxes	23,720			21,123			15,514			800
Provision for income taxes	8,952			8,174			6,004			815
Net income (loss)	14,768			12,949			9,510			(15		)

Earnings per share:
Basic	$	0.29		$	0.26		$	0.19		$	—
Diluted	$	0.29		$	0.26		$	0.19		$	—

Weighted average shares outstanding:
Basic	50,183			50,278			50,307			50,314
Diluted	50,646			50,671			50,684			50,992

Comprehensive income, net of tax:
Currency translation adjustments	(10		)	(42		)	(18		)	57
Total other comprehensive income (loss)	(10		)	(42		)	(18		)	57
Comprehensive income	14,758			12,907			9,492			42

- Definition

The entire disclosure for the quarterly financial data in the annual financial statements. The disclosure may include a tabular presentation of financial information for each fiscal quarter for the current and previous year, including revenues, gross profit, income or loss before extraordinary items and earnings per share data. It also includes an indication if the information in the note is unaudited, comments on the aggregate effect of year-end adjustments, and an explanation of matters or transactions that affect comparability or are pertinent to an understanding of the information furnished.

+ References+ Details

Condensed Consolidating Financial Statements

12 Months Ended

Mar. 31, 2013

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Condensed Consolidating Financial Statements

As described in Note 11, Prestige Brands Holdings, Inc., ("Holdings") together with certain of our 100% owned subsidiaries, have fully and unconditionally guaranteed, on a joint and several basis, the obligations of Prestige Brands, Inc. (a 100% owned subsidiary of the Company) set forth in the indenture governing the 2012 Senior Notes , including, without limitation, the obligation to pay principal and interest with respect to the indenture governing the 2012 Senior Notes. The 100% owned subsidiaries of the Company that have guaranteed the 2012 Senior Notes are as follows: Prestige Services Corp., Prestige Brands Holdings, Inc. (a Virginia corporation), Prestige Brands International, Inc., Medtech Holdings, Inc., Medtech Products Inc., The Cutex Company, The Spic and Span Company and Blacksmith Brands, Inc. (collectively, the "Subsidiary Guarantors"). A significant portion of our operating income and cash flow is generated by our subsidiaries. As a result, funds necessary to meet Prestige Brands, Inc.'s debt service obligations are provided in part by distributions or advances from our subsidiaries. Under certain circumstances, contractual and legal restrictions, as well as the financial condition and operating requirements of our subsidiaries, could limit Prestige Brands, Inc.'s ability to obtain cash from our subsidiaries for the purpose of meeting our debt service obligations, including the payment of principal and interest on the 2012 Senior Notes and the 2010 Senior Notes. Although holders of the 2012 Senior Notes and the 2010 Senior Notes will be direct creditors of the guarantors of the 2012 Senior Notes and the 2010 Senior Notes by virtue of the guarantees, we have indirect subsidiaries located primarily in the United Kingdom and in the Netherlands (collectively, the "Non-Guarantor Subsidiaries") that have not guaranteed the 2012 and the 2010 Senior Notes, and such subsidiaries will not be obligated with respect to the 2012 Senior Notes and the 2010 Senior Notes. As a result, the claims of creditors of the Non-Guarantor Subsidiaries will effectively have priority with respect to the assets and earnings of such companies over the claims of the holders of the 2012 Senior Notes and the 2010 Senior Notes.

In February 2013, we merged Prestige Personal Care Holdings, Inc., Prestige Personal Care, Inc. and The Denorex Company into Holdings. The net assets of these entities was transferred to Holdings as a carryover of approximately $17.7 million in outstanding intercompany payables and was treated as a deemed contribution.

Presented below are supplemental Condensed Consolidating Balance Sheets as of March 31, 2013 and 2012 and Condensed Consolidating Income and Comprehensive Income Statements and Condensed Consolidating Statements of Cash Flows for each year in the three year period ended March 31, 2013. Such consolidating information includes separate columns for:

a) Prestige Brands Holdings, Inc., the parent,

b) Prestige Brands, Inc., the issuer,

c) Combined Subsidiary Guarantors,

d) Combined Non-Guarantor Subsidiaries,

e) Elimination entries necessary to consolidate the Company and all of its subsidiaries.

The Condensed Consolidating Financial Statements are presented using the equity method of accounting for investments in 100% owned subsidiaries. Under the equity method, the investments in subsidiaries are recorded at cost and adjusted for our share of the subsidiaries' cumulative results of operations, capital contributions, distributions and other equity changes. The elimination entries principally eliminate investments in subsidiaries and intercompany balances and transactions. The financial information in this footnote should be read in conjunction with the Consolidated Financial Statements presented and other notes related thereto contained in this Annual Report on Form 10-K for the fiscal year ended March 31, 2013.

Condensed Consolidating Statement of Income and Comprehensive Income

Year Ended March 31, 2013



(In thousands)	Prestige Brands Holdings, Inc.			Prestige Brands, Inc., the issuer			Combined Subsidiary Guarantors			Combined Non- guarantor Subsidiaries			Eliminations			Consolidated
Revenues
Net sales	$	—		$	102,706		$	513,017		$	4,671		$	—		$	620,394
Other revenues	—			278			3,158			1,517			(1,750		)	3,203
Total Revenues	—			102,984			516,175			6,188			(1,750		)	623,597

Cost of Sales
Cost of sales (exclusive of depreciation shown below)	—			39,333			236,795			2,003			(1,750		)	276,381
Gross profit	—			63,651			279,380			4,185			—			347,216

Advertising and promotion	—			12,605			76,599			1,426			—			90,630
General and administrative	5,127			6,917			38,713			710			—			51,467
Depreciation and amortization	1,346			569			11,261			59			—			13,235
Total operating expenses	6,473			20,091			126,573			2,195			—			155,332

Operating income (loss)	(6,473		)	43,560			152,807			1,990			—			191,884

Other (income) expense
Interest income	(30,561		)	(57,496		)	—			(1		)	88,045			(13		)
Interest expense	34,671			84,420			53,374			—			(88,045		)	84,420
Loss on extinguishment of debt	—			1,443			—			—			—			1,443
Equity in income of subsidiaries	(72,295		)	(65,784		)	(1,482		)	—			139,561			—
Total other (income) expense	(68,185		)	(37,417		)	51,892			(1		)	139,561			85,850

Income (loss) before income taxes	61,712			80,977			100,915			1,991			(139,561		)	106,034

Provision (benefit) for income taxes	(3,793		)	5,807			38,006			509			—			40,529
Net income (loss)	65,505			75,170			62,909			1,482			(139,561		)	65,505

Comprehensive income, net of tax:
Currency translation adjustments	(91		)	—			—			(91		)	91			(91		)
Total other comprehensive income (loss)	(91		)	—			—			(91		)	91			(91		)
Comprehensive income (loss)	$	65,414		$	75,170		$	62,909		$	1,391		$	(139,470	)	$	65,414

Condensed Consolidating Statement of Income and Comprehensive Income

Year Ended March 31, 2012



(In thousands)	Prestige Brands Holdings, Inc.			Prestige Brands, Inc., the issuer			Combined Subsidiary Guarantors			Combined Non- guarantor Subsidiaries			Eliminations			Consolidated
Revenues
Net sales	$	—		$	100,542		$	333,407		$	3,889		$	—		$	437,838
Other revenues	—			229			3,212			1,475			(1,669		)	3,247
Total Revenues	—			100,771			336,619			5,364			(1,669		)	441,085

Cost of Sales
Cost of sales (exclusive of depreciation)	—			36,658			177,112			1,600			(1,669		)	213,701
Gross profit	—			64,113			159,507			3,764			—			227,384

Advertising and promotion	—			11,918			43,906			1,303			—			57,127
General and administrative	17,181			10,059			28,698			762			—			56,700
Depreciation and amortization	538			570			9,556			70			—			10,734
Total operating expenses (income)	17,719			22,547			82,160			2,135			—			124,561

Operating (loss) income	(17,719		)	41,566			77,347			1,629			—			102,823

Other (income) expense
Interest income	(50,357		)	(44,269		)	—			(221		)	94,829			(18		)
Interest expense	35,004			76,341			24,822			—			(94,829		)	41,338
Gain on settlement	(5,063		)	—			—			—			—			(5,063		)
Loss on extinguishment of debt	—			5,409			—			—			—			5,409
Equity in income of subsidiaries	(35,571		)	(37,192		)	(1,313		)	—			74,076			—
Total other (income) expense	(55,987		)	289			23,509			(221		)	74,076			41,666

Income (loss) from continuing operations before income taxes	38,268			41,277			53,838			1,850			(74,076		)	61,157

Provision (benefit) for income taxes	1,056			1,599			20,565			725			—			23,945
Net income (loss)	37,212			39,678			33,273			1,125			(74,076		)	37,212

Comprehensive income, net of tax:
Currency translation adjustments	(13		)	—			—			13			(13		)	(13		)
Total other comprehensive income (loss)	(13		)	—			—			13			(13		)	(13		)
Comprehensive income (loss)	$	37,199		$	39,678		$	33,273		$	1,138		$	(74,089	)	$	37,199

Condensed Consolidating Statement of Income and Comprehensive Income

Year Ended March 31, 2011



(In thousands)	Prestige Brands Holdings, Inc.			Prestige Brands, Inc., the issuer			Combined Subsidiary Guarantors			Combined Non- guarantor Subsidiaries			Eliminations			Consolidated
Revenues
Net sales	$	—		$	98,988		$	230,986		$	3,741		$	—		$	333,715
Other revenues	—			207			2,775			1,479			(1,666		)	2,795
Total Revenues	—			99,195			233,761			5,220			(1,666		)	336,510

Cost of Sales
Cost of sales (exclusive of depreciation)	—			37,268			128,527			1,503			(1,666		)	165,632
Gross profit	—			61,927			105,234			3,717			—			170,878

Advertising and promotion	—			11,642			29,762			1,493			—			42,897
General and administrative	4,003			10,883			27,190			(116		)	—			41,960
Depreciation and amortization	486			577			8,745			68			—			9,876
Total operating expenses	4,489			23,102			65,697			1,445			—			94,733

Operating (loss) income	(4,489		)	38,825			39,537			2,272			—			76,145

Other (income) expense
Interest income	(51,909		)	(44,453		)	—			(189		)	96,550			(1		)
Interest expense	35,149			62,467			26,248			4			(96,550		)	27,318
Loss on extinguishment of debt	—			300			—			—			—			300
Equity in income of subsidiaries	(21,842		)	(8,912		)	(1,928		)	—			32,682			—
Total other (income) expense	(38,602		)	9,402			24,320			(185		)	32,682			27,617

Income (loss) from continuing operations before income taxes	34,113			29,423			15,217			2,457			(32,682		)	48,528

Provision (benefit) for income taxes	4,893			8,177			5,299			980			—			19,349
Income (loss) from continuing operations	29,220			21,246			9,918			1,477			(32,682		)	29,179

Discontinued operations
Income (loss) from discontinued operations, net of income tax/(benefit)	—			—			591			—			—			591
Gain/(loss) on sale of discontinued operations, net of income tax/(benefit)	—			—			(550		)	—			—			(550		)
Net income (loss)	$	29,220		$	21,246		$	9,959		$	1,477		$	(32,682	)	$	29,220

Comprehensive income, net of tax:
Currency translation adjustments	—			—			—			—			—			—
Total other comprehensive income (loss)	—			—			—			—			—			—
Comprehensive income	$	29,220		$	21,246		$	9,959		$	1,477		$	(32,682	)	$	29,220

Condensed Consolidating Balance Sheet

March 31, 2013



(In thousands)	Prestige Brands Holdings, Inc.			Prestige Brands, Inc., the issuer			Combined Subsidiary Guarantors		Combined Non- guarantor Subsidiaries			Eliminations			Consolidated
Assets
Current assets
Cash and cash equivalents	$	14,720		$	—		$	—	$	950		$	—		$	15,670
Accounts receivable, net	21			13,875			58,345		812			—			73,053
Inventories	—			11,164			48,474		563			—			60,201
Deferred income tax assets	218			855			5,276		—			—			6,349
Prepaid expenses and other current assets	4,942			93			3,609		256			—			8,900
Total current assets	19,901			25,987			115,704		2,581			—			164,173

Property and equipment, net	9,609			34			253		—			—			9,896
Goodwill	—			66,007			101,539		—			—			167,546
Intangible assets, net	—			193,396			1,179,524		320			—			1,373,240
Other long-term assets	—			24,944			—		—			—			24,944
Intercompany receivable	653,049			1,911,573			415,587		7,316			(2,987,525		)	—
Investment in subsidiary	1,429,775			638,611			7,067		—			(2,075,453		)	—
Total Assets	$	2,112,334		$	2,860,552		$	1,819,674	$	10,217		$	(5,062,978	)	$	1,739,799

Liabilities and Stockholders' Equity
Current liabilities
Accounts payable	$	2,601		$	10,600		$	37,695	$	480		$	—		$	51,376
Accrued interest payable	—			13,894			—		—			—			13,894
Other accrued liabilities	12,694			1,684			16,107		913			—			31,398
Total current liabilities	15,295			26,178			53,802		1,393			—			96,668

Long-term debt
Principal amount	—			978,000			—		—			—			978,000
Less unamortized discount	—			(7,100		)	—		—			—			(7,100		)
Long-term debt, net of unamortized discount	—			970,900			—		—			—			970,900

Deferred income tax liabilities	—			55,291			138,924		73			—			194,288
Intercompany payable	1,619,096			447,419			920,865		145			(2,987,525		)	—
Total Liabilities	1,634,391			1,499,788			1,113,591		1,611			(2,987,525		)	1,261,856

Stockholders' Equity
Preferred share rights	283			—			—		—			—			283
Common Stock	513			—			—		—			—			513
Additional paid-in capital	401,691			1,280,945			624,742		1,111			(1,906,798		)	401,691
Treasury stock, at cost - 181 shares	(687		)	—			—		—			—			(687		)
Accumulated other comprehensive loss, net of tax	(104		)	—			—		(104		)	104			(104		)
Retained earnings (accumulated deficit)	76,247			79,819			81,341		7,599			(168,759		)	76,247
Total Stockholders' Equity	477,943			1,360,764			706,083		8,606			(2,075,453		)	477,943

Total Liabilities and Stockholders' Equity	$	2,112,334		$	2,860,552		$	1,819,674	$	10,217		$	(5,062,978	)	$	1,739,799

Condensed Consolidating Balance Sheet

March 31, 2012



(In thousands)	Prestige Brands Holdings, Inc.			Prestige Brands, Inc., the issuer			Combined Subsidiary Guarantors		Combined Non- guarantor Subsidiaries			Eliminations			Consolidated
Assets
Current assets
Cash and cash equivalents	$	18,221		$	—		$	—	$	794		$	—		$	19,015
Accounts receivable, net	25			13,502			45,954		747			—			60,228
Inventories	—			8,098			42,334		681			—			51,113
Deferred income tax assets	356			849			4,078		—			—			5,283
Prepaid expenses and other current assets	8,102			56			2,874		364			—			11,396
Total current assets	26,704			22,505			95,240		2,586			—			147,035

Property and equipment, net	934			22			346		2			—			1,304
Goodwill	—			66,007			107,695		—			—			173,702
Intangible assets, net	—			193,932			1,206,213		377			—			1,400,522
Other long-term assets	—			35,713			—		—			—			35,713
Intercompany receivable	683,358			1,449,005			312,581		5,935			(2,450,879		)	—
Investment in subsidiary	1,354,829			1,172,601			5,583		—			(2,533,013		)	—
Total Assets	$	2,065,825		$	2,939,785		$	1,727,658	$	8,900		$	(4,983,892	)	$	1,758,276

Liabilities and Stockholders' Equity
Current liabilities
Accounts payable	$	4,531		$	4,816		$	17,008	$	371		$	—		$	26,726
Accrued interest payable	—			13,889			—		—			—			13,889
Other accrued liabilities	11,758			1,687			8,944		919			—			23,308
Total current liabilities	16,289			20,392			25,952		1,290			—			63,923

Long-term debt
Principal amount	—			1,135,000			—		—			—			1,135,000
Less unamortized discount	—			(11,092		)	—		—			—			(11,092		)
Long-term debt, net of unamortized discount	—			1,123,908			—		—			—			1,123,908

Deferred income tax liabilities	—			50,944			116,690		83			—			167,717
Intercompany payable	1,646,808			458,993			344,766		312			(2,450,879		)	—
Total Liabilities	1,663,097			1,654,237			487,408		1,685			(2,450,879		)	1,355,548

Stockholders' Equity
Preferred share rights	283			—			—		—			—			283
Common Stock	505			—			—		—			—			505
Additional paid-in capital	391,898			1,280,719			1,239,497		1,111			(2,521,327		)	391,898
Treasury stock, at cost - 181 shares	(687		)	—			—		—			—			(687		)
Accumulated other comprehensive loss, net of tax	(13		)	—			—		(13		)	13			(13		)
Retained earnings (accumulated deficit)	10,742			4,829			753		6,117			(11,699		)	10,742
Total Stockholders' Equity	402,728			1,285,548			1,240,250		7,215			(2,533,013		)	402,728
Total Liabilities and Stockholders’ Equity	$	2,065,825		$	2,939,785		$	1,727,658	$	8,900		$	(4,983,892	)	$	1,758,276

Condensed Consolidating Statement of Cash Flows

Year Ended March 31, 2013



(In thousands)	Prestige Brands Holdings, Inc.			Prestige Brands, Inc., the issuer			Combined Subsidiary Guarantors			Combined Non- guarantor Subsidiaries			Eliminations			Consolidated
Operating Activities
Net income (loss)	$	65,505		$	75,170		$	62,909		$	1,482		$	(139,561	)	$	65,505
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	1,346			569			11,261			59			—			13,235
Deferred income taxes	138			4,341			21,036			(10		)	—			25,505
Amortization of deferred financing costs	—			9,832			—			—			—			9,832
Stock-based compensation costs	3,772			—			—			—			—			3,772
Loss on extinguishment of debt	—			1,443			—			—			—			1,443
Amortization of debt discount	—			4,632			—			—			—			4,632
Lease termination costs	975			—			—			—			—			975
Loss on disposal of equipment	82			—			21			—			—			103
Equity in income of subsidiaries	(72,295		)	(65,784		)	(1,482		)	—			139,561			—
Changes in operating assets and liabilities
Accounts receivable	4			(373		)	(12,391		)	(122		)	—			(12,882		)
Inventories	—			(3,066		)	(6,360		)	84			—			(9,342		)
Prepaid expenses and other current assets	3,160			(37		)	(135		)	108			—			3,096
Accounts payable	(1,930		)	5,784			20,687			136			—			24,677
Accrued liabilities	(39		)	2			7,069			22			—			7,054
Net cash provided by (used in) operating activities	718			32,513			102,615			1,759			—			137,605

Investing Activities
Purchases of property and equipment	(10,268		)	—			—			—			—			(10,268		)
Proceeds from the sale of property and equipment	—			—			15			—			—			15
Proceeds from the sale of the Phazyme brand	—			—			21,700			—			—			21,700
Acquisition of brands from GSK purchase price adjustments	—			—			(226		)	—			—			(226		)
Intercompany activity, net	(226		)	—			226			—			—			—
Net cash provided by (used in) investing activities	(10,494		)	—			21,715			—			—			11,221

Financing Activities
Repayments of long-term debt	—			(190,000		)	—			—			—			(190,000		)
Repayments under revolving credit agreement	—			(15,000		)	—			—			—			(15,000		)
Borrowings under revolving credit agreement	—			48,000			—			—			—			48,000
Payment of deferred financing costs	—			(1,146		)	—			—			—			(1,146		)
Proceeds from exercise of stock options	6,029			—			—			—			—			6,029
Intercompany activity, net	246			125,633			(124,330		)	(1,549		)	—			—
Net cash (used in) provided by financing activities	6,275			(32,513		)	(124,330		)	(1,549		)	—			(152,117		)

Effects of exchange rate changes on cash and cash equivalents	—			—			—			(54		)	—			(54		)
Increase (decrease) in cash and cash equivalents	(3,501		)	—			—			156			—			(3,345		)
Cash - beginning of period	18,221			—			—			794			—			19,015

Cash - end of period	$	14,720		$	—		$	—		$	950		$	—		$	15,670

Condensed Consolidating Statement of Cash Flows

Year Ended March 31, 2012



(In thousands)	Prestige Brands Holdings, Inc.			Prestige Brands, Inc., the issuer			Combined Subsidiary Guarantors			Combined Non- guarantor Subsidiaries			Eliminations			Consolidated
Operating Activities
Net income (loss)	$	37,212		$	39,678		$	33,273		$	1,125		$	(74,076	)	$	37,212
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	538			570			9,556			70			—			10,734
Deferred income taxes	290			3,514			10,000			(11		)	—			13,793
Amortization of deferred financing costs	—			1,630			—			—			—			1,630
Stock-based compensation costs	3,078			—			—			—			—			3,078
Loss on extinguishment of debt	—			5,409			—			—			—			5,409
Amortization of debt discount	—			1,030			—			—			—			1,030
Equity in income of subsidiaries	(35,571		)	(37,192		)	(1,313		)	—			74,076			—
Changes in operating assets and liabilities
Accounts receivable	(12		)	(3,412		)	(12,367		)	(63		)	—			(15,854		)
Inventories	—			1,459			2,252			(1		)	—			3,710
Prepaid expenses and other current assets	(3,598		)	(20		)	968			(359		)	—			(3,009		)
Accounts payable	2,611			(1,598		)	4,139			(25		)	—			5,127
Accrued liabilities	417			2,984			856			335			—			4,592
Intercompany activity, net	—			—			—			—			—			—
Net cash provided by operating activities	4,965			14,052			47,364			1,071			—			67,452

Investing Activities
Purchases of equipment	(367		)	—			(239		)	—			—			(606		)
Proceeds from escrow of Blacksmith acquisition	—			—			1,200			—			—			1,200
Acquisition of GSK Brands	—			—			(662,800		)	—			—			(662,800		)
Intercompany activity, net	1,200			(662,800		)	661,600			—			—			—
Net cash used in investing activities	833			(662,800		)	(239		)	—			—			(662,206		)

Financing Activities
Proceeds from issuance of 2012 Senior notes	—			250,000			—			—			—			250,000
Repayment of 2010 Senior Term Loan	—			(242,000		)	—			—			—			(242,000		)
Proceeds from issuance of 2012 Term Loan and 2010 Term Loan	—			650,100			—			—			—			650,100
Payment of deferred financing costs	—			(33,284		)	—			—			—			(33,284		)
Repayment of 2012 Term Loan	—			(25,000		)	—			—			—			(25,000		)
Proceeds from exercise of stock options	889			—			—			—			—			889
Shares surrendered as payment of tax withholding	(271		)	—			—			—			—			(271		)
Intercompany activity, net	(893		)	48,932			(47,125		)	(914		)	—			—
Net cash (used in) provided by financing activities	(275		)	648,748			(47,125		)	(914		)	—			600,434

Effect of exchange rate changes on cash and cash equivalents	—			—			—			1			—			1
Increase (decrease) in cash and cash equivalents	5,523			—			—			158			—			5,681
Cash - beginning of period	12,698			—			—			636			—			13,334

Cash - end of period	$	18,221		$	—		$	—		$	794		$	—		$	19,015

Condensed Consolidating Statement of Cash Flows

Year Ended March 31, 2011



(In thousands)	Prestige Brands Holdings, Inc.			Prestige Brands, Inc., the issuer			Combined Subsidiary Guarantors			Combined Non- guarantor Subsidiaries			Eliminations			Consolidated
Operating Activities
Net income (loss)	$	29,220		$	21,246		$	9,959		$	1,477		$	(32,682	)	$	29,220
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	486			577			8,973			72			—			10,108
Loss on sale of discontinued operations	—			—			890			—			—			890
Deferred income taxes	1,668			1,851			5,806			(1		)	—			9,324
Amortization of deferred financing costs	—			1,043			—			—			—			1,043
Stock-based compensation costs	3,575			—			—			—			—			3,575
Loss on extinguishment of debt	—			300			—			—			—			300
Amortization of debt discount	—			702			—			—			—			702
Loss on disposal of equipment	27			—			126			—			—			153
Equity in income of subsidiaries	(21,842		)	(8,912		)	(1,928		)	—			32,682			—
Changes in operating assets and liabilities
Accounts receivable	1,041			(1,949		)	5,852			(26		)	—			4,918
Inventories	—			1,852			10,648			(57		)	—			12,443
Prepaid expenses and other current assets	(63		)	92			97			28			—			154
Accounts payable	(605		)	2,538			(212		)	63			—			1,784
Accrued liabilities	4,113			9,776			(2,117		)	284			—			12,056
Net cash provided by operating activities	17,620			29,116			38,094			1,840			—			86,670

Investing Activities
Purchases of equipment	(595		)	—			(56		)	(4		)	—			(655		)
Proceeds from sale of property and equipment	12			—			—			—			—			12
Proceeds from sale of discontinued operations	—			—			4,122			—			—			4,122
Acquisition of Blacksmith, net of cash acquired	—			—			(202,044		)	—			—			(202,044		)
Acquisition of Dramamine	—			—			(77,115		)	—			—			(77,115		)
Intercompany activity, net	—			(202,044		)	202,044			—			—			—
Net cash (used in) provided by investing activities	(583		)	(202,044		)	(73,049		)	(4		)	—			(275,680		)

Financing Activities
Proceed from issuance of debt	—			100,250			—			—			—			100,250
Proceeds from issuance of senior term loan	—			112,936			—			—			—			112,936
Payment of deferred financing costs	—			(830		)	—			—			—			(830		)
Repayment of long-term debt	—			(51,087		)	—			—			—			(51,087		)
Proceeds from exercise of stock options	331			—			—			—			—			331
Purchase of treasury stock	(353		)	—			—			—			—			(353		)
Intercompany activity, net	(44,961		)	11,659			34,955			(1,653		)	—			—
Net cash (used in) provided by financing activities	(44,983		)	172,928			34,955			(1,653		)	—			161,247

Increase (decrease) in cash	(27,946		)	—			—			183			—			(27,763		)
Cash - beginning of period	40,644			—			—			453			—			41,097

Cash - end of period	$	12,698		$	—		$	—		$	636		$	—		$	13,334

In the first quarter of fiscal 2013, the Company determined that in prior periods it had incorrectly recorded intercompany transactions between Prestige Brands Holdings, Inc. ("the Parent") and Prestige Brands, Inc. ("the Issuer") as a component of interest expense, resulting in (i) the misclassification of amounts between interest expense, equity in income of subsidiaries, and taxes of the Parent, and (ii) a corresponding understatement of interest income, taxes and net income of the Issuer. It was further determined that certain subsidiaries of the Issuer had been fully consolidated by the Issuer in error, resulting in (i) a gross-up of the Issuer's balance sheet, statement of income and comprehensive income and statement of cash flows, and (ii) the need to revise the presentation to reflect the Issuer's interests in those subsidiaries under the equity method. Those entities had previously been incorrectly included in the Issuer column and omitted from the Guarantor column, and accordingly, this resulted in a need to revise the presentation to include the balance sheet, results of operations, and cash flows of those Issuer subsidiary entities in the Combined Subsidiary Guarantors column of the revised Condensed Consolidating Financial Statements. In addition, the Company reclassified portions of its intercompany activity between operating and financing in the statement of cash flows. The Company also determined that it had incorrectly presented certain intercompany balances between the Parent, the Issuer, the Combined Subsidiary Guarantors and Non-Guarantors resulting in revisions impacting other accrued liabilities, deferred income taxes, provision (benefit) for income taxes, intercompany receivables, intercompany payables, investment in subsidiaries and total equity balances. Additionally, certain revisions have been made to the Company's Condensed Consolidating Statement of Income and Comprehensive Income for the three months ended June 30, 2012. For the three months ended June 30, 2012, the provision for income taxes was increased approximately $4.3 million to $0.6 million for the Parent, and the benefit for income taxes was increased approximately $4.4 million to $3.0 million for the Issuer.

The Company has revised its Condensed Consolidating Financial Statements to correct the presentation of these items. There were no changes to any of the Company's Condensed Consolidated Financial Statements. The Company assessed the materiality of these items on previously issued annual and interim financial statements in accordance with SEC Staff Accounting Bulletin No. 99 and No. 108 and concluded that the revisions were not material to the consolidated financial statements. The Company has disclosed the impact of the revisions on previously reported annual period amounts and accordingly has revised the Condensed Consolidated Financial Statements for comparative periods. The impact of these revisions as of March 31, 2012 and for each of the periods ended March 31, 2012 and 2011 are shown in the following tables:

Condensed Consolidating Statement of Income and Comprehensive Income for the year ended March 31, 2012;



(In thousands)	Prestige Brands Holdings, Inc.				Prestige Brands, Inc., the issuer				Combined Subsidiary Guarantors					Combined Non-Guarantor Subsidiaries				Eliminations
	Reported		Revised		Reported		Revised		Reported			Revised		Reported		Revised		Reported			Revised
Revenue	$	—	$	—	$	341,307	$	100,771	$	96,082		$	336,619	$	5,365	$	5,364	$	(1,669	)	$	(1,669	)
Income before income taxes	38,995		38,268		76,595		41,277		(4,905		)	53,838		1,656		1,850		(51,184		)	(74,076		)
Provision (benefit) for income taxes	1,783		1,056		23,643		1,599		(2,018		)	20,565		537		725		—			—
Net income	37,212		37,212		52,952		39,678		(2,887		)	33,273		1,119		1,125		(51,184		)	(74,076		)

Condensed Consolidating Statement of Income and Comprehensive Income for the year ended March 31, 2011;



(In thousands)	Prestige Brands Holdings, Inc.				Prestige Brands, Inc., the issuer					Combined Subsidiary Guarantors				Combined Non-Guarantor Subsidiaries				Eliminations
	Reported		Revised		Reported			Revised		Reported		Revised		Reported		Revised		Reported			Revised
Revenue	$	—	$	—	$	230,844		$	99,195	$	101,925	$	233,761	$	5,407	$	5,220	$	(1,666	)	$	(1,666	)
Income before income taxes	49,846		34,113		(6,252		)	29,423		602		15,217		2,457		2,457		1,875			(32,682		)
Provision (benefit) for income taxes	20,626		4,893		(2,081		)	8,177		274		5,299		530		980		—			—
Net income from continuing operations	29,220		29,220		(4,143		)	21,246		341		9,918		1,927		1,477		1,875			(32,682		)

Condensed Consolidating Balance sheet as of March 31, 2012;



(In thousands)	Prestige Brands Holdings, Inc.				Prestige Brands, Inc., the issuer				Combined Subsidiary Guarantors					Combined Non-Guarantor Subsidiaries				Eliminations
	Reported		Revised		Reported		Revised		Reported			Revised		Reported		Revised		Reported			Revised
Total current assets	$	26,704	$	26,704	$	98,887	$	22,505	$	19,222		$	95,240	$	2,222	$	2,586	$	—		$	—
Total assets	2,200,652		2,065,825		3,236,598		2,939,785		267,407			1,727,658		10,402		8,900		(3,956,783		)	(4,983,892		)
Total current liabilities	16,779		16,289		49,246		20,392		(3,446		)	25,952		1,344		1,290		—			—
Total liabilities	1,797,927		1,663,097		2,982,492		1,654,237		196,430			487,408		2,116		1,685		(3,623,417		)	(2,450,879		)
Total stockholder's equity	402,725		402,728		254,106		1,285,548		70,977			1,240,250		8,286		7,215		(333,366		)	(2,533,013		)

Condensed Consolidating Statement of Cash Flows for the Year Ended March 31, 2012;



(In thousands)	Prestige Brands Holdings, Inc.						Prestige Brands, Inc., the issuer						Combined Subsidiary Guarantors						Combined Non-Guarantor Subsidiaries						Eliminations
	Reported			Revised			Reported			Revised			Reported			Revised			Reported			Revised			Reported			Revised
Net cash provided by (used in) operating activities	$	60,323		$	4,965		$	51,023		$	14,052		$	(2,125	)	$	47,364		$	(230	)	$	1,071		$	(41,539	)	$	—
Net cash provided by (used in) investing activities	833			833			(239		)	(662,800		)	—			(239		)	—			—			(662,800		)	—
Net cash provided by (used in) financing activities	(55,633		)	(275		)	(50,784		)	648,748			2,125			(47,125		)	387			(914		)	704,339			—

Condensed Consolidating Statement of Cash Flows for the Year Ended March 31, 2011;



(In thousands)	Prestige Brands Holdings, Inc.						Prestige Brands, Inc., the issuer						Combined Subsidiary Guarantors						Combined Non-Guarantor Subsidiaries						Eliminations
	Reported			Revised			Reported			Revised			Reported			Revised			Reported			Revised			Reported			Revised
Net cash provided by (used in) operating activities	$	36,726		$	17,620		$	42,853		$	29,116		$	3,190		$	38,094		$	2,026		$	1,840		$	1,875		$	—
Net cash provided by (used in) investing activities	(803		)	(583		)	(274,873		)	(202,044		)	—			(73,049		)	(4		)	(4		)	—			—
Net cash provided by (used in) financing activities	(63,869		)	(44,983		)	232,020			172,928			(3,190		)	34,955			(1,839		)	(1,653		)	(1,875		)	—

Subsequent Events	12 Months Ended
Subsequent Events	Mar. 31, 2013
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events On May 14, 2013, the Compensation Committee of our Board of Directors granted 113,637 shares of restricted common stock units and stock options to acquire 227,672 shares of our common stock to certain executive officers and employees under the Plan. 55,637 shares of restricted common stock units vest in their entirety on the three-year anniversary of the date of grant. 58,000 shares of restricted common stock units vest 33.3% per year over three years. Upon vesting, the units will be settled in shares of our common stock. The stock options will vest 33.3% per year over three years and are exercisable for up to ten years from the date of grant. These stock options were granted at an exercise price of $29.94 per share, which is equal to the closing price for our common stock on the day of the grant. Termination of employment prior to vesting will result in forfeiture of the restricted common stock units and the unvested stock options. Vested stock options will remain exercisable by the employee after termination, subject to the terms of the Plan.

Schedule II Valuation and Qualifying Accounts

12 Months Ended

Mar. 31, 2013

Valuation and Qualifying Accounts [Abstract]

Schedule II Valuation and Qualifying Accounts

VALUATION AND QUALIFYING ACCOUNTS



(In thousands)	Balance at Beginning of Year		Amounts Charged to Expense				Deductions			Other				Balance at End of Year
Year Ended March 31, 2013
Reserves for sales returns and allowance	$	4,257	$	33,165			$	(30,976	)	$	—			$	6,446
Reserves for trade promotions	5,506		41,041				(38,024		)	—				8,523
Reserves for consumer coupon redemptions	3,509		8,282				(7,542		)	—				4,249
Allowance for doubtful accounts	604		265				(6		)	—				863

Year Ended March 31, 2012
Reserves for sales returns and allowance	6,208		23,457				(25,408		)	—				4,257
Reserves for trade promotions	4,853		32,185				(31,532		)	—				5,506
Reserves for consumer coupon redemptions	2,723		7,180				(6,394		)	—				3,509
Allowance for doubtful accounts	444		200				(40		)	—				604

Year Ended March 31, 2011
Reserves for sales returns and allowance	6,221		17,316				(17,746		)	417		(2	)	6,208
Reserves for trade promotions	2,051		23,906		(1	)	(23,350		)	2,246		(2	)	4,853
Reserves for consumer coupon redemptions	263		3,932		(1	)	(3,090		)	1,618		(2	)	2,723
Allowance for doubtful accounts	273		180				(16		)	7		(2	)	444


(1)	We increased our reserves for Trade Promotion and Consumer Coupon Redemption by $3.0 million and $2.0 million, respectively, in an effort to gain market share for the PediaCare brand.


(2)	Reflect the applicable amounts acquired from the purchase of Blacksmith on November 1, 2010.

Business and Basis of Presentation (Policies)

12 Months Ended

Mar. 31, 2013

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation

Use of Estimates

Cash and Cash Equivalents

Accounts Receivable

Inventories

Property and Equipment

Property and equipment are stated at cost and are depreciated using the straight-line method based on the following estimated useful lives:



	Years
Machinery	5
Computer equipment	3
Furniture and fixtures	7
Leasehold improvements	*

*Leasehold improvements are amortized over the lesser of the lease-term or the estimated useful life of the related asset.

Goodwill

Intangible Assets

Deferred Financing Costs

Revenue Recognition

Cost of Sales

Cost of sales includes product costs, warehousing costs, inbound and outbound shipping costs, and handling and storage costs.

Advertising and Promotion Costs

Stock-based Compensation

Income Taxes

We are subject to taxation in the United States and various state and foreign jurisdictions.

We classify penalties and interest related to unrecognized tax benefits as income tax expense in the Consolidated Statements of Income and Comprehensive Income.

Earnings Per Share

Recently Issued Accounting Standards

Business and Basis of Presentation (Tables)

12 Months Ended

Mar. 31, 2013

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Property and Equipment

Property and equipment are stated at cost and are depreciated using the straight-line method based on the following estimated useful lives:



	Years
Machinery	5
Computer equipment	3
Furniture and fixtures	7
Leasehold improvements	*

- Definition

Tabular disclosure of the useful life and salvage value of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.

+ References+ Details

Discontinued Operations and Sale of Certain Assets (Tables)

12 Months Ended

Mar. 31, 2013

Discontinued Operations and Disposal Groups [Abstract]

Results of Discontinued Operations

The following table summarizes the results of discontinued operations:



(In thousands)	Year Ended March 31,
	2013		2012		2011
Components of Income
Revenues	$	—	$	—	$	4,027
Income (loss) from discontinued operations, net of income tax	—		—		591

The following table presents the assets sold at October 31, 2012 related to the Phazyme brand:



(In thousands)	October 31, 2012
Components of assets sold:
Inventory	$	220
Prepaid expenses	100
Trade names	15,604
Goodwill	6,382

- Definition

Tabular disclosure of disposal groups, which may include the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss), amounts of revenues and pretax profit or loss reported in discontinued operations, the classification and carrying value of the assets and liabilities comprising the disposal group, and the segment in which the disposal group was reported. Also may include the amount of adjustments to amounts previously reported in discontinued operations such as resolution of contingencies arising from the disposal transaction or the operations of the component prior to disposal.

+ References+ Details

Acquisitions (Tables)

12 Months Ended

Mar. 31, 2013

Business Acquisition [Line Items]

Unaudited Pro Forma Information



	Year Ended March 31,
(In thousands, except per share data)	2012		2011
	(Unaudited)
Revenues	$	616,849	$	599,543
Income from continuing operations	69,989		34,913

Basic earnings per share:
Income from continuing operations	$	1.39	$	0.70

Diluted earnings per share:
Income from continuing operations	$	1.38	$	0.69

GSK Brands

Business Acquisition [Line Items]

Purchase Price Allocation

The following table summarizes our allocation of the $663.0 million purchase price to the assets we acquired on the GSK Brands acquisition dates:



(In thousands)	GSK Brands I (January 31, 2012)		GSK Brands II (March 30, 2012)		Total
Inventory	$	14,820	$	250	$	15,070
Prepaid expenses	3,575		—		3,575
Trade names	542,892		81,257		624,149
Goodwill	17,401		2,831		20,232
Total purchase price	$	578,688	$	84,338	$	663,026

Blacksmith

Business Acquisition [Line Items]

Purchase Price Allocation

The following table summarizes our final allocation of the $203.4 million purchase price to the assets we acquired and liabilities assumed on the Blacksmith acquisition date:



(In thousands)	November 1, 2010
Cash acquired	$	2,507
Accounts receivable, net	17,473
Other receivables	1,198
Income taxes receivable	5
Inventories	22,155
Prepaids and other current assets	44
Property, plant and equipment, net	226
Goodwill	42,207
Trademarks	165,346
Other long-term assets	19
Total assets acquired	251,180

Accounts payable	7,060
Accrued expenses	5,212
Income taxes payable	2,031
Deferred income taxes	33,526
Total liabilities assumed	47,829

Total purchase price	$	203,351

Dramamine

Business Acquisition [Line Items]

Purchase Price Allocation

The following table summarizes our allocation of the $77.1 million purchase price to the assets we acquired comprising the Dramamine brand:



(In thousands)	January 6, 2011
Inventories	$	1,249
Trademark	75,866
Total purchase price	$	77,115

- Definition

Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.

+ References+ Details

Divestitures (Tables)

12 Months Ended

Mar. 31, 2013

Discontinued Operations and Disposal Groups [Abstract]

Assets Sold

The following table summarizes the results of discontinued operations:



(In thousands)	Year Ended March 31,
	2013		2012		2011
Components of Income
Revenues	$	—	$	—	$	4,027
Income (loss) from discontinued operations, net of income tax	—		—		591

The following table presents the assets sold at October 31, 2012 related to the Phazyme brand:



(In thousands)	October 31, 2012
Components of assets sold:
Inventory	$	220
Prepaid expenses	100
Trade names	15,604
Goodwill	6,382

- Definition

+ References+ Details

Goodwill (Tables)

12 Months Ended

Mar. 31, 2013

Goodwill [Abstract]

Summary of Changes in Goodwill

The following table summarizes the changes in the carrying value of goodwill by operating segment for each of 2011, 2012 and 2013:



(In thousands)	OTC Healthcare			Household Cleaning			Consolidated
Balance – March 31, 2010
Goodwill	$	234,270		$72,549			$306,819
Accumulated impairment losses	(130,170		)	(65,160		)	(195,330		)
Balance – March 31, 2010	104,100			7,389			111,489

2011 additions	43,407			—			43,407

Balance – March 31, 2011
Goodwill	277,677			72,549			350,226
Accumulated impairment losses	(130,170		)	(65,160		)	(195,330		)
Balance – March 31, 2011	147,507			7,389			154,896

2012 additions	20,006			—			20,006

Balance – March 31, 2012
Goodwill	296,483			72,549			369,032
Accumulated impairment losses	(130,170		)	(65,160		)	(195,330		)
	166,313			7,389			173,702

2013 additions	226			—			226
2013 reductions	(6,382		)	—			(6,382		)

Balance – March 31, 2013
Goodwill	290,327			72,549			362,876
Accumulated impairment losses	(130,170		)	(65,160		)	(195,330		)
	$	160,157		$	7,389		$	167,546

- Definition

Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.

+ References+ Details

Intangible Assets (Tables)

12 Months Ended

Mar. 31, 2013

Intangible Assets [Abstract]

Reconciliation of the Activity Affecting Intangible Assets

A reconciliation of the activity affecting intangible assets for each of 2011, 2012 and 2013 is as follows:



(In thousands)	Year Ended March 31, 2011
	Indefinite Lived Trademarks		Finite Lived Trademarks			Non Compete Agreement		Totals
Gross Amount
Balance – March 31, 2010 (including discontinued operations)	$	454,571	$	151,264		$	158	$	605,993
Additions	233,913		7,299			—		241,212
Disposals	—		(8,270		)	—		(8,270		)
Balance – March 31, 2011	$	688,484	$	150,293		$	158	$	838,935

Accumulated Amortization
Balance – March 31, 2010	$	—	$	46,606		$	158	$	46,764
Additions	—		9,210			—		9,210
Disposals	—		(3,400		)	—		(3,400		)
Balance – March 31, 2011	$	—	$	52,416		$	158	$	52,574

Intangibles, net – March 31, 2011	$	688,484	$	97,877		$	—	$	786,361



(In thousands)	Year Ended March 31, 2012
	Indefinite Lived Trademarks		Finite Lived Trademarks		Non Compete Agreement		Totals
Gross Amount
Balance – March 31, 2011	$	688,484	$	150,293	$	158	$	838,935
Additions	556,930		67,219		—		624,149
Balance – March 31, 2012	$	1,245,414	$	217,512	$	158	$	1,463,084

Accumulated Amortization
Balance – March 31, 2011	$	—	$	52,416	$	158	$	52,574
Additions	—		9,988		—		9,988
Balance – March 31, 2012	$	—	$	62,404	$	158	$	62,562

Intangibles, net – March 31, 2012	$	1,245,414	$	155,108	$	—	$	1,400,522



(In thousands)	Year Ended March 31, 2013
	Indefinite Lived Trademarks			Finite Lived Trademarks			Non Compete Agreement		Totals
Gross Amount
Balance – March 31, 2012	$	1,245,414		$	217,512		$	158	$	1,463,084
Reclassifications	(1,696		)	1,696			—		—
Reductions	—			(16,142		)	—		(16,142		)
Balance – March 31, 2013	$	1,243,718		$	203,066		$	158	$	1,446,942

Accumulated Amortization
Balance – March 31, 2012	$	—		$	62,404		$	158	$	62,562
Additions	—			11,678			—		11,678
Reductions	—			(538		)	—		(538		)
Balance – March 31, 2013	$	—		$	73,544		$	158	$	73,702

Intangibles, net – March 31, 2013	$	1,243,718		$	129,522		—		$	1,373,240

Schedule of Expected Amortization Expense

At March 31, 2013, finite-lived intangible assets are expected to be amortized over their estimated useful life, which ranges from a period of 3 to 30 years , and the estimated amortization expense for each of the five succeeding years and periods thereafter is as follows (in thousands):



Year Ending March 31,
2014	$	10,210
2015	8,834
2016	8,834
2017	8,834
2018	8,834
Thereafter	83,976
	$	129,522

Long-Term Debt (Tables)

12 Months Ended

Mar. 31, 2013

Debt Disclosure [Abstract]

Schedule of Long-term Debt

Long-term debt consists of the following, as of the dates indicated:



(In thousands, except percentages)	March 31,
	2013			2012
2012 Senior Notes bearing interest at 8.125%, with interest only payable on February 1st and August 1st of each year. The 2012 Senior Notes mature on February 1, 2020.	$250,000			$	250,000
2012 Term Loan bearing interest at the Company's option at either a base rate plus applicable margin with a floor of 2.00% or LIBOR with a floor of 1.00%, due on January 31, 2019.	445,000			635,000
2012 ABL Revolver bearing interest at the Company's option at either a base rate plus applicable margin or LIBOR plus applicable margin. Any unpaid balance is due on January 31, 2017.	33,000			—
2010 Senior Notes bearing interest at 8.25%, with interest only payable on April 1st and October 1st of each year. The 2010 Senior Notes mature on April 1, 2018.	250,000			250,000
	978,000			1,135,000
Current portion of long-term debt	—			—
	978,000			1,135,000
Less: unamortized discount	(7,100		)	(11,092		)
Long-term debt, net of unamortized discount	$	970,900		$	1,123,908

Aggregate Future Principal Payments

Aggregate future principal payments required in accordance with the terms of the 2012 Term Loan, the 2012 ABL Revolver and the indentures governing the 2010 Senior Notes and the 2012 Senior Notes are as follows (in thousands):



Year Ending March 31,	Amount
2014	$	—
2015	—
2016	—
2017	33,000
2018	—
Thereafter	945,000
	$	978,000

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 55

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6584090&loc=d3e28878-108400

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 22

-Article 5

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21521-112644

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21538-112644

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 470

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6479336&loc=d3e64711-112823

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(e),(f))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

+ Details

Earnings Per Share (Tables)

12 Months Ended

Mar. 31, 2013

Earnings Per Share [Abstract]

Computation of Basic and Diluted Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share:



(In thousands, except per share data)	Year Ended March 31,
	2013		2012		2011
Numerator
Income from continuing operations	$	65,505	$	37,212	$	29,179
Income from discontinued operations and loss on sale of discontinued operations	—		—		41
Net income	$	65,505	$	37,212	$	29,220

Denominator
Denominator for basic earnings per share- weighted average shares	50,633		50,270		50,081
Dilutive effect of unvested restricted common stock (including restricted stock units) and options issued to employees and directors	807		478		257
Denominator for diluted earnings per share	51,440		50,748		50,338

Earnings per Common Share:
Basic earnings per share from continuing operations	$	1.29	$	0.74	$	0.58
Basic earnings per share from discontinued operations and loss on sale of discontinued operations	—		—		—
Basic net earnings per share	$	1.29	$	0.74	$	0.58

Diluted earnings per share from continuing operations	$	1.27	$	0.73	$	0.58
Diluted earnings per share from discontinued operations and loss on sale of discontinued operations	—		—		—
Diluted net earnings per share	$	1.27	$	0.73	$	0.58

Share-Based Compensation (Tables)

12 Months Ended

Mar. 31, 2013

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Summary of Restricted Shares

A summary of the Company’s restricted shares granted under the Plan is presented below:



Nonvested Shares	Shares (in thousands)		Weighted-Average Grant-Date Fair Value

Nonvested at March 31, 2010	287.1		$	8.86

Granted	125.0		8.99
Vested and issued	(88.2	)	9.63
Forfeited	(48.5	)	10.10
Vested and nonvested at March 31, 2011	275.4		8.46
Vested at March 31, 2011	29.2		6.84

Granted	217.5		11.81
Vested and issued	(103.4	)	9.93
Forfeited	(26.1	)	10.17
Vested and nonvested at March 31, 2012	363.4		9.92
Vested at March 31, 2012	54.0		7.40

Granted	128.9		13.59
Vested and issued	(58.7	)	9.99
Forfeited	(12.3	)	10.69
Vested and nonvested at March 31, 2013	421.3		11.01
Vested at March 31, 2013	70.4		8.52

Stock Options, Valuation Assumptions



	Year Ended March 31,
	2013		2012
Expected volatility	44.0	%	53.0	%
Expected dividends	—		—
Expected term in years	6.5		6.5
Risk-free rate	1.2	%	2.4	%

Stock Option Activity

A summary of option activity under the Plan is as follows:



Options	Shares (in thousands)		Weighted-Average Exercise Price		Weighted- Average Remaining Contractual Term	Aggregate Intrinsic Value (in thousands)

Outstanding at March 31, 2010	1,584.2		$	8.50

Granted	418.6		9.26
Exercised	(33.8	)	9.79
Forfeited or expired	(347.5	)	10.74
Outstanding at March 31, 2011	1,621.5		8.19

Granted	308.2		11.27
Exercised	(86.9	)	10.24
Forfeited or expired	(97.4	)	11.57
Outstanding at March 31, 2012	1,745.4		8.44

Granted	444.9		13.36
Exercised	(786.5	)	7.67
Forfeited or expired	(17.4	)	11.21
Outstanding at March 31, 2013	1,386.4		10.43		7.6	$	10,468
Exercisable at March 31, 2013	254.4		10.81		6.6	1,666

Income Taxes Income Taxes (Tables)

12 Months Ended

Mar. 31, 2013

Income Tax Disclosure [Abstract]

Components of Provision for Income Taxes

The provision for income taxes from continuing operations consists of the following:



(In thousands)	Year Ended March 31,
	2013		2012		2011
Current
Federal	$	12,520	$	8,127	$	8,793
State	1,972		1,396		1,496
Foreign	532		630		522
Deferred
Federal	23,845		13,100		7,211
State	1,660		692		1,327
Total provision for income taxes from continuing operations	$	40,529	$	23,945	$	19,349

Components of Deferred Tax Balances

The principal components of our deferred tax balances are as follows:



(In thousands)	March 31,
	2013			2012
Deferred Tax Assets
Allowance for doubtful accounts and sales returns	$	2,807		$	1,931
Inventory capitalization	1,370			1,184
Inventory reserves	525			635
Net operating loss carryforwards	411			495
State income taxes	7,364			7,103
Accrued liabilities	1,896			1,762
Stock compensation	2,367			2,536
Other	496			1
Total deferred tax assets	17,236			15,647

Deferred Tax Liabilities
Property and equipment	(1,504		)	(155		)
Intangible assets	(203,671		)	(177,926		)
Total deferred tax liabilities	(205,175		)	(178,081		)

Net deferred tax liability	$	(187,939	)	$	(162,434	)

Reconciliation of Effective Tax Rate

A reconciliation of the effective tax rate compared to the statutory U.S. Federal tax rate is as follows:



	Year Ended March 31,
(In thousands)	2013					2012					2011
				%					%					%
Income tax provision at statutory rate	$	37,112		35.0		$	21,405		35.0		$	17,008		35.0
Foreign tax (benefit) provision	—			—		191			0.3		(42		)	(0.1	)
State income taxes, net of federal income tax benefit	3,413			3.2		2,073			3.4		1,615			3.3
(Decrease) increase in net deferred tax liability resulting from a change in the effective state tax rate	(1,741		)	(1.6	)	(1,177		)	(1.9	)	302			0.6
Nondeductible compensation	1,684			1.6		1,305			2.1		—			—
Transaction costs	—			—		—			—		367			0.8
Other	61			—		148			0.3		124			0.3
Total provision for income taxes	40,529			38.2		23,945			39.2		19,374			39.9
Amount included in discontinued operations	—			—		—			—		25			38.2
Provision for income taxes from continuing operations	$	40,529		38.2		$	23,945		39.2		$	19,349		39.9

Uncertain Tax Liability Activity

Uncertain tax liability activity is as follows:



	2013			2012
(In thousands)
Balance – beginning of year	$	292		456
Additions based on tax positions related to the current year	831			45
Reductions based on lapse of statute of limitations	(107		)	(209		)
Balance – end of year	$	1,016		$	292

- Definition

Tabular disclosure of tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities (i.e., uncertain tax positions) and other types of income tax contingencies, including: (1) the policy on classification of interest and penalties; (2) a tabular reconciliation of the total amounts of unrecognized tax benefits at the beginning and end of the period; the total amount(s) of: (3) unrecognized tax benefits that, if recognized, would affect the effective tax rate, and (4) interest and penalties recognized in each of the income statement and balance sheet; (5) for positions for which it is reasonably possible that the total amounts unrecognized will significantly change within 12 months of the reporting date the: (i) nature of the uncertainty, (ii) nature of the event that could occur that would cause the change, and (iii) an estimate of the range of the reasonably possible change or a statement that an estimate of the range cannot be made; and (6) a description of tax years that remain subject to examination by major tax jurisdictions.

+ References+ Details

Commitments and Contingencies (Tables)

12 Months Ended

Mar. 31, 2013

Commitments and Contingencies Disclosure [Abstract]

Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]

The following summarizes future minimum lease payments for our operating leases:



(In thousands)	Facilities		Equipment		Total
Year Ending March 31,
2014	$	1,764	$	141	$	1,905
2015	1,049		136		1,185
2016	994		135		1,129
2017	1,023		68		1,091
2018	1,044		—		1,044
	$	5,874	$	480	$	6,354

Unrecorded Unconditional Purchase Obligations Disclosure [Table Text Block]



(In thousands)
Year Ending March 31,
2014	1,136
2015	1,105
2016	1,074
2017	1,044
2018	1,013
Thereafter	1,542
	$	6,914

- Definition

Tabular disclosure of unconditional purchase obligations that are not recognized as a liability on the balance sheet, including the nature and significant terms of an unconditional purchase obligation; the amount of the fixed and determinable portion of the obligation as of the date of the latest balance sheet presented in the aggregate and, if determinable, for each of the five succeeding fiscal years; the nature of any variable components of the obligation; the amount purchased under the obligation (for example, the take-or-pay or throughput contract) for the reporting period; and may include the amount of imputed interest necessary to reduce the obligation to present value.

+ References+ Details

Business Segments (Tables)

12 Months Ended

Mar. 31, 2013

Segment Reporting [Abstract]

Information about our Operating and Reportable Segments

The table below summarizes information about our operating and reportable segments.



	Year Ended March 31, 2013
	OTC Healthcare		Household Cleaning		Consolidated
(In thousands)
Net sales	$	536,247	$	84,147	$	620,394
Other revenues	684		2,519		3,203
Total revenues	536,931		86,666		623,597
Cost of sales	211,654		64,727		276,381
Gross profit	325,277		21,939		347,216
Advertising and promotion	84,537		6,093		90,630
Contribution margin	$	240,740	$	15,846	256,586
Other operating expenses					64,702
Operating income					191,884
Other expenses					85,850
Provision for income taxes					40,529
Income from continuing operations					65,505
Income from discontinued operations, net of income tax					—
Loss on sale of discontinued operations, net of income tax benefit					—
Net income					$	65,505



	Year Ended March 31, 2012
	OTC Healthcare		Household Cleaning		Consolidated
(In thousands)
Net sales	$	344,282	$	93,556	$	437,838
Other revenues	719		2,528		3,247
Total revenues	345,001		96,084		441,085
Cost of sales	143,151		70,550		213,701
Gross profit	201,850		25,534		227,384
Advertising and promotion	51,895		5,232		57,127
Contribution margin	$	149,955	$	20,302	170,257
Other operating expenses					67,434
Operating income					102,823
Other expenses					41,666
Provision for income taxes					23,945
Income from continuing operations					37,212
Income from discontinued operations, net of income tax					—
Loss on sale of discontinued operations, net of income tax					—
Net income					$	37,212



	Year Ended March 31, 2011
	OTC Healthcare		Household Cleaning		Consolidated
(In thousands)
Net sales	$	234,042	$	99,673	$	333,715
Other revenues	543		2,252		2,795
Total revenues	234,585		101,925		336,510
Cost of sales	97,710		67,922		165,632
Gross profit	136,875		34,003		170,878
Advertising and promotion	36,752		6,145		42,897
Contribution margin	$	100,123	$	27,858	127,981
Other operating expenses					51,836
Operating income					76,145
Other expenses					27,617
Provision for income taxes					19,349
Income from continuing operations					29,179
Income from discontinued operations, net of income tax					591
Loss on sale of discontinued operations, net of income tax					(550		)
Net income					$	29,220

Information about our Revenues from Similar Product Groups



	Year Ended March 31,
(In thousands)	2013		2012		2011
Analgesics	$	108,144	$	18,930	$	3,063
Cough & Cold	126,974		116,669		75,013
Gastrointestinal	97,940		29,489		4,067
Eye & Ear Care	86,380		74,363		70,724
Dermatologicals	52,401		52,592		51,398
Oral Care	49,617		46,551		26,518
Other OTC	15,475		6,407		3,802
Total OTC Healthcare Segment	536,931		345,001		234,585
Household Cleaning Segment	86,666		96,084		101,925
Consolidated Net Revenues	$	623,597	$	441,085	$	336,510

Allocation of Long-Term Assets to Segments

At March 31, 2013, substantially all of our long-term assets were located in the United States of America and have been allocated to the operating segments as follows:



(In thousands)	OTC Healthcare		Household Cleaning		Consolidated
Goodwill	$	160,157	$	7,389	$	167,546

Intangible assets
Indefinite-lived	1,123,898		119,820		1,243,718
Finite-lived	101,611		27,911		129,522
	1,225,509		147,731		1,373,240

	$	1,385,666	$	155,120	$	1,540,786

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details

Unaudited Quarterly Financial Information (Tables)

12 Months Ended

Mar. 31, 2013

Quarterly Financial Information Disclosure [Abstract]

Schedule of Quarterly Financial Information

Unaudited quarterly financial information for 2013 and 2012 is as follows:

Year Ended March 31, 2013



	Quarterly Period Ended
(In thousands, except for per share data)	June 30, 2012			September 30, 2012		December 31, 2012			March 31, 2013
Total revenues	$	146,997		$	161,855	$	160,232		$	154,513
Cost of sales (exclusive of depreciation shown below)	63,393			71,310		75,235			66,443
Gross profit	83,604			90,545		84,997			88,070

Operating expenses
Advertising and promotion	20,325			23,508		23,538			23,259
General and administrative	16,151			12,585		11,378			11,353
Depreciation and amortization	3,295			3,296		3,359			3,285
	39,771			39,389		38,275			37,897
Operating income	43,833			51,156		46,722			50,173
Net interest expense	19,848			19,660		26,661			18,238
Gain on settlement	—			—		—			—
Loss on extinguishment of debt	—			—		—			1,443
Income before income taxes	23,985			31,496		20,061			30,492
Provision for income taxes	9,330			12,252		7,804			11,143
Net income	14,655			19,244		12,257			19,349


Earnings per share:
Basic	$	0.29		$	0.38	$	0.24		$	0.38
Diluted	$	0.29		$	0.38	$	0.24		$	0.37

Weighted average shares outstanding:
Basic	50,342			50,364		50,686			51,147
Diluted	51,106			51,225		51,523			51,913

Comprehensive income, net of tax:
Currency translation adjustments	(42		)	66		(1		)	(114		)
Total other comprehensive income (loss)	(42		)	66		(1		)	(114		)
Comprehensive income	14,613			19,310		12,256			19,235

Year Ended March 31, 2012



	Quarterly Period Ended
(In thousands, except for per share data)	June 30, 2011			September 30, 2011			December 31, 2011			March 31, 2012
Total revenues	$	95,295		$	105,544		$	106,250		$	133,996
Cost of sales (exclusive of depreciation shown below)	45,427			51,638			51,128			65,508
Gross profit	49,868			53,906			55,122			68,488

Operating expenses
Advertising and promotion	10,233			13,073			15,274			18,547
General and administrative	9,850			8,861			13,655			24,334
Depreciation and amortization	2,550			2,570			2,563			3,051
	22,633			24,504			31,492			45,932
Operating income	27,235			29,402			23,630			22,556
Net interest expense	8,578			8,279			8,116			16,347
Gain on settlement	(5,063		)	—			—			—
Loss on extinguishment of debt	—			—			—			5,409
Income before income taxes	23,720			21,123			15,514			800
Provision for income taxes	8,952			8,174			6,004			815
Net income (loss)	14,768			12,949			9,510			(15		)

Earnings per share:
Basic	$	0.29		$	0.26		$	0.19		$	—
Diluted	$	0.29		$	0.26		$	0.19		$	—

Weighted average shares outstanding:
Basic	50,183			50,278			50,307			50,314
Diluted	50,646			50,671			50,684			50,992

Comprehensive income, net of tax:
Currency translation adjustments	(10		)	(42		)	(18		)	57
Total other comprehensive income (loss)	(10		)	(42		)	(18		)	57
Comprehensive income	14,758			12,907			9,492			42

Condensed Consolidating Financial Statements (Tables)

12 Months Ended

Mar. 31, 2013

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Condensed Consolidating Statements of Income and Comprehensive Income

Condensed Consolidating Statement of Income and Comprehensive Income

Year Ended March 31, 2013



(In thousands)	Prestige Brands Holdings, Inc.			Prestige Brands, Inc., the issuer			Combined Subsidiary Guarantors			Combined Non- guarantor Subsidiaries			Eliminations			Consolidated
Revenues
Net sales	$	—		$	102,706		$	513,017		$	4,671		$	—		$	620,394
Other revenues	—			278			3,158			1,517			(1,750		)	3,203
Total Revenues	—			102,984			516,175			6,188			(1,750		)	623,597

Cost of Sales
Cost of sales (exclusive of depreciation shown below)	—			39,333			236,795			2,003			(1,750		)	276,381
Gross profit	—			63,651			279,380			4,185			—			347,216

Advertising and promotion	—			12,605			76,599			1,426			—			90,630
General and administrative	5,127			6,917			38,713			710			—			51,467
Depreciation and amortization	1,346			569			11,261			59			—			13,235
Total operating expenses	6,473			20,091			126,573			2,195			—			155,332

Operating income (loss)	(6,473		)	43,560			152,807			1,990			—			191,884

Other (income) expense
Interest income	(30,561		)	(57,496		)	—			(1		)	88,045			(13		)
Interest expense	34,671			84,420			53,374			—			(88,045		)	84,420
Loss on extinguishment of debt	—			1,443			—			—			—			1,443
Equity in income of subsidiaries	(72,295		)	(65,784		)	(1,482		)	—			139,561			—
Total other (income) expense	(68,185		)	(37,417		)	51,892			(1		)	139,561			85,850

Income (loss) before income taxes	61,712			80,977			100,915			1,991			(139,561		)	106,034

Provision (benefit) for income taxes	(3,793		)	5,807			38,006			509			—			40,529
Net income (loss)	65,505			75,170			62,909			1,482			(139,561		)	65,505

Comprehensive income, net of tax:
Currency translation adjustments	(91		)	—			—			(91		)	91			(91		)
Total other comprehensive income (loss)	(91		)	—			—			(91		)	91			(91		)
Comprehensive income (loss)	$	65,414		$	75,170		$	62,909		$	1,391		$	(139,470	)	$	65,414

Condensed Consolidating Statement of Income and Comprehensive Income

Year Ended March 31, 2012



(In thousands)	Prestige Brands Holdings, Inc.			Prestige Brands, Inc., the issuer			Combined Subsidiary Guarantors			Combined Non- guarantor Subsidiaries			Eliminations			Consolidated
Revenues
Net sales	$	—		$	100,542		$	333,407		$	3,889		$	—		$	437,838
Other revenues	—			229			3,212			1,475			(1,669		)	3,247
Total Revenues	—			100,771			336,619			5,364			(1,669		)	441,085

Cost of Sales
Cost of sales (exclusive of depreciation)	—			36,658			177,112			1,600			(1,669		)	213,701
Gross profit	—			64,113			159,507			3,764			—			227,384

Advertising and promotion	—			11,918			43,906			1,303			—			57,127
General and administrative	17,181			10,059			28,698			762			—			56,700
Depreciation and amortization	538			570			9,556			70			—			10,734
Total operating expenses (income)	17,719			22,547			82,160			2,135			—			124,561

Operating (loss) income	(17,719		)	41,566			77,347			1,629			—			102,823

Other (income) expense
Interest income	(50,357		)	(44,269		)	—			(221		)	94,829			(18		)
Interest expense	35,004			76,341			24,822			—			(94,829		)	41,338
Gain on settlement	(5,063		)	—			—			—			—			(5,063		)
Loss on extinguishment of debt	—			5,409			—			—			—			5,409
Equity in income of subsidiaries	(35,571		)	(37,192		)	(1,313		)	—			74,076			—
Total other (income) expense	(55,987		)	289			23,509			(221		)	74,076			41,666

Income (loss) from continuing operations before income taxes	38,268			41,277			53,838			1,850			(74,076		)	61,157

Provision (benefit) for income taxes	1,056			1,599			20,565			725			—			23,945
Net income (loss)	37,212			39,678			33,273			1,125			(74,076		)	37,212

Comprehensive income, net of tax:
Currency translation adjustments	(13		)	—			—			13			(13		)	(13		)
Total other comprehensive income (loss)	(13		)	—			—			13			(13		)	(13		)
Comprehensive income (loss)	$	37,199		$	39,678		$	33,273		$	1,138		$	(74,089	)	$	37,199

Condensed Consolidating Statement of Income and Comprehensive Income

Year Ended March 31, 2011



(In thousands)	Prestige Brands Holdings, Inc.			Prestige Brands, Inc., the issuer			Combined Subsidiary Guarantors			Combined Non- guarantor Subsidiaries			Eliminations			Consolidated
Revenues
Net sales	$	—		$	98,988		$	230,986		$	3,741		$	—		$	333,715
Other revenues	—			207			2,775			1,479			(1,666		)	2,795
Total Revenues	—			99,195			233,761			5,220			(1,666		)	336,510

Cost of Sales
Cost of sales (exclusive of depreciation)	—			37,268			128,527			1,503			(1,666		)	165,632
Gross profit	—			61,927			105,234			3,717			—			170,878

Advertising and promotion	—			11,642			29,762			1,493			—			42,897
General and administrative	4,003			10,883			27,190			(116		)	—			41,960
Depreciation and amortization	486			577			8,745			68			—			9,876
Total operating expenses	4,489			23,102			65,697			1,445			—			94,733

Operating (loss) income	(4,489		)	38,825			39,537			2,272			—			76,145

Other (income) expense
Interest income	(51,909		)	(44,453		)	—			(189		)	96,550			(1		)
Interest expense	35,149			62,467			26,248			4			(96,550		)	27,318
Loss on extinguishment of debt	—			300			—			—			—			300
Equity in income of subsidiaries	(21,842		)	(8,912		)	(1,928		)	—			32,682			—
Total other (income) expense	(38,602		)	9,402			24,320			(185		)	32,682			27,617

Income (loss) from continuing operations before income taxes	34,113			29,423			15,217			2,457			(32,682		)	48,528

Provision (benefit) for income taxes	4,893			8,177			5,299			980			—			19,349
Income (loss) from continuing operations	29,220			21,246			9,918			1,477			(32,682		)	29,179

Discontinued operations
Income (loss) from discontinued operations, net of income tax/(benefit)	—			—			591			—			—			591
Gain/(loss) on sale of discontinued operations, net of income tax/(benefit)	—			—			(550		)	—			—			(550		)
Net income (loss)	$	29,220		$	21,246		$	9,959		$	1,477		$	(32,682	)	$	29,220

Comprehensive income, net of tax:
Currency translation adjustments	—			—			—			—			—			—
Total other comprehensive income (loss)	—			—			—			—			—			—
Comprehensive income	$	29,220		$	21,246		$	9,959		$	1,477		$	(32,682	)	$	29,220

Condensed Consolidating Balance Sheet

March 31, 2013



(In thousands)	Prestige Brands Holdings, Inc.			Prestige Brands, Inc., the issuer			Combined Subsidiary Guarantors		Combined Non- guarantor Subsidiaries			Eliminations			Consolidated
Assets
Current assets
Cash and cash equivalents	$	14,720		$	—		$	—	$	950		$	—		$	15,670
Accounts receivable, net	21			13,875			58,345		812			—			73,053
Inventories	—			11,164			48,474		563			—			60,201
Deferred income tax assets	218			855			5,276		—			—			6,349
Prepaid expenses and other current assets	4,942			93			3,609		256			—			8,900
Total current assets	19,901			25,987			115,704		2,581			—			164,173

Property and equipment, net	9,609			34			253		—			—			9,896
Goodwill	—			66,007			101,539		—			—			167,546
Intangible assets, net	—			193,396			1,179,524		320			—			1,373,240
Other long-term assets	—			24,944			—		—			—			24,944
Intercompany receivable	653,049			1,911,573			415,587		7,316			(2,987,525		)	—
Investment in subsidiary	1,429,775			638,611			7,067		—			(2,075,453		)	—
Total Assets	$	2,112,334		$	2,860,552		$	1,819,674	$	10,217		$	(5,062,978	)	$	1,739,799

Liabilities and Stockholders' Equity
Current liabilities
Accounts payable	$	2,601		$	10,600		$	37,695	$	480		$	—		$	51,376
Accrued interest payable	—			13,894			—		—			—			13,894
Other accrued liabilities	12,694			1,684			16,107		913			—			31,398
Total current liabilities	15,295			26,178			53,802		1,393			—			96,668

Long-term debt
Principal amount	—			978,000			—		—			—			978,000
Less unamortized discount	—			(7,100		)	—		—			—			(7,100		)
Long-term debt, net of unamortized discount	—			970,900			—		—			—			970,900

Deferred income tax liabilities	—			55,291			138,924		73			—			194,288
Intercompany payable	1,619,096			447,419			920,865		145			(2,987,525		)	—
Total Liabilities	1,634,391			1,499,788			1,113,591		1,611			(2,987,525		)	1,261,856

Stockholders' Equity
Preferred share rights	283			—			—		—			—			283
Common Stock	513			—			—		—			—			513
Additional paid-in capital	401,691			1,280,945			624,742		1,111			(1,906,798		)	401,691
Treasury stock, at cost - 181 shares	(687		)	—			—		—			—			(687		)
Accumulated other comprehensive loss, net of tax	(104		)	—			—		(104		)	104			(104		)
Retained earnings (accumulated deficit)	76,247			79,819			81,341		7,599			(168,759		)	76,247
Total Stockholders' Equity	477,943			1,360,764			706,083		8,606			(2,075,453		)	477,943

Total Liabilities and Stockholders' Equity	$	2,112,334		$	2,860,552		$	1,819,674	$	10,217		$	(5,062,978	)	$	1,739,799

Condensed Consolidating Balance Sheet

March 31, 2012



(In thousands)	Prestige Brands Holdings, Inc.			Prestige Brands, Inc., the issuer			Combined Subsidiary Guarantors		Combined Non- guarantor Subsidiaries			Eliminations			Consolidated
Assets
Current assets
Cash and cash equivalents	$	18,221		$	—		$	—	$	794		$	—		$	19,015
Accounts receivable, net	25			13,502			45,954		747			—			60,228
Inventories	—			8,098			42,334		681			—			51,113
Deferred income tax assets	356			849			4,078		—			—			5,283
Prepaid expenses and other current assets	8,102			56			2,874		364			—			11,396
Total current assets	26,704			22,505			95,240		2,586			—			147,035

Property and equipment, net	934			22			346		2			—			1,304
Goodwill	—			66,007			107,695		—			—			173,702
Intangible assets, net	—			193,932			1,206,213		377			—			1,400,522
Other long-term assets	—			35,713			—		—			—			35,713
Intercompany receivable	683,358			1,449,005			312,581		5,935			(2,450,879		)	—
Investment in subsidiary	1,354,829			1,172,601			5,583		—			(2,533,013		)	—
Total Assets	$	2,065,825		$	2,939,785		$	1,727,658	$	8,900		$	(4,983,892	)	$	1,758,276

Liabilities and Stockholders' Equity
Current liabilities
Accounts payable	$	4,531		$	4,816		$	17,008	$	371		$	—		$	26,726
Accrued interest payable	—			13,889			—		—			—			13,889
Other accrued liabilities	11,758			1,687			8,944		919			—			23,308
Total current liabilities	16,289			20,392			25,952		1,290			—			63,923

Long-term debt
Principal amount	—			1,135,000			—		—			—			1,135,000
Less unamortized discount	—			(11,092		)	—		—			—			(11,092		)
Long-term debt, net of unamortized discount	—			1,123,908			—		—			—			1,123,908

Deferred income tax liabilities	—			50,944			116,690		83			—			167,717
Intercompany payable	1,646,808			458,993			344,766		312			(2,450,879		)	—
Total Liabilities	1,663,097			1,654,237			487,408		1,685			(2,450,879		)	1,355,548

Stockholders' Equity
Preferred share rights	283			—			—		—			—			283
Common Stock	505			—			—		—			—			505
Additional paid-in capital	391,898			1,280,719			1,239,497		1,111			(2,521,327		)	391,898
Treasury stock, at cost - 181 shares	(687		)	—			—		—			—			(687		)
Accumulated other comprehensive loss, net of tax	(13		)	—			—		(13		)	13			(13		)
Retained earnings (accumulated deficit)	10,742			4,829			753		6,117			(11,699		)	10,742
Total Stockholders' Equity	402,728			1,285,548			1,240,250		7,215			(2,533,013		)	402,728
Total Liabilities and Stockholders’ Equity	$	2,065,825		$	2,939,785		$	1,727,658	$	8,900		$	(4,983,892	)	$	1,758,276

Condensed Consolidating Statement of Cash Flows

Year Ended March 31, 2013



(In thousands)	Prestige Brands Holdings, Inc.			Prestige Brands, Inc., the issuer			Combined Subsidiary Guarantors			Combined Non- guarantor Subsidiaries			Eliminations			Consolidated
Operating Activities
Net income (loss)	$	65,505		$	75,170		$	62,909		$	1,482		$	(139,561	)	$	65,505
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	1,346			569			11,261			59			—			13,235
Deferred income taxes	138			4,341			21,036			(10		)	—			25,505
Amortization of deferred financing costs	—			9,832			—			—			—			9,832
Stock-based compensation costs	3,772			—			—			—			—			3,772
Loss on extinguishment of debt	—			1,443			—			—			—			1,443
Amortization of debt discount	—			4,632			—			—			—			4,632
Lease termination costs	975			—			—			—			—			975
Loss on disposal of equipment	82			—			21			—			—			103
Equity in income of subsidiaries	(72,295		)	(65,784		)	(1,482		)	—			139,561			—
Changes in operating assets and liabilities
Accounts receivable	4			(373		)	(12,391		)	(122		)	—			(12,882		)
Inventories	—			(3,066		)	(6,360		)	84			—			(9,342		)
Prepaid expenses and other current assets	3,160			(37		)	(135		)	108			—			3,096
Accounts payable	(1,930		)	5,784			20,687			136			—			24,677
Accrued liabilities	(39		)	2			7,069			22			—			7,054
Net cash provided by (used in) operating activities	718			32,513			102,615			1,759			—			137,605

Investing Activities
Purchases of property and equipment	(10,268		)	—			—			—			—			(10,268		)
Proceeds from the sale of property and equipment	—			—			15			—			—			15
Proceeds from the sale of the Phazyme brand	—			—			21,700			—			—			21,700
Acquisition of brands from GSK purchase price adjustments	—			—			(226		)	—			—			(226		)
Intercompany activity, net	(226		)	—			226			—			—			—
Net cash provided by (used in) investing activities	(10,494		)	—			21,715			—			—			11,221

Financing Activities
Repayments of long-term debt	—			(190,000		)	—			—			—			(190,000		)
Repayments under revolving credit agreement	—			(15,000		)	—			—			—			(15,000		)
Borrowings under revolving credit agreement	—			48,000			—			—			—			48,000
Payment of deferred financing costs	—			(1,146		)	—			—			—			(1,146		)
Proceeds from exercise of stock options	6,029			—			—			—			—			6,029
Intercompany activity, net	246			125,633			(124,330		)	(1,549		)	—			—
Net cash (used in) provided by financing activities	6,275			(32,513		)	(124,330		)	(1,549		)	—			(152,117		)

Effects of exchange rate changes on cash and cash equivalents	—			—			—			(54		)	—			(54		)
Increase (decrease) in cash and cash equivalents	(3,501		)	—			—			156			—			(3,345		)
Cash - beginning of period	18,221			—			—			794			—			19,015

Cash - end of period	$	14,720		$	—		$	—		$	950		$	—		$	15,670

Condensed Consolidating Statement of Cash Flows

Year Ended March 31, 2012



(In thousands)	Prestige Brands Holdings, Inc.			Prestige Brands, Inc., the issuer			Combined Subsidiary Guarantors			Combined Non- guarantor Subsidiaries			Eliminations			Consolidated
Operating Activities
Net income (loss)	$	37,212		$	39,678		$	33,273		$	1,125		$	(74,076	)	$	37,212
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	538			570			9,556			70			—			10,734
Deferred income taxes	290			3,514			10,000			(11		)	—			13,793
Amortization of deferred financing costs	—			1,630			—			—			—			1,630
Stock-based compensation costs	3,078			—			—			—			—			3,078
Loss on extinguishment of debt	—			5,409			—			—			—			5,409
Amortization of debt discount	—			1,030			—			—			—			1,030
Equity in income of subsidiaries	(35,571		)	(37,192		)	(1,313		)	—			74,076			—
Changes in operating assets and liabilities
Accounts receivable	(12		)	(3,412		)	(12,367		)	(63		)	—			(15,854		)
Inventories	—			1,459			2,252			(1		)	—			3,710
Prepaid expenses and other current assets	(3,598		)	(20		)	968			(359		)	—			(3,009		)
Accounts payable	2,611			(1,598		)	4,139			(25		)	—			5,127
Accrued liabilities	417			2,984			856			335			—			4,592
Intercompany activity, net	—			—			—			—			—			—
Net cash provided by operating activities	4,965			14,052			47,364			1,071			—			67,452

Investing Activities
Purchases of equipment	(367		)	—			(239		)	—			—			(606		)
Proceeds from escrow of Blacksmith acquisition	—			—			1,200			—			—			1,200
Acquisition of GSK Brands	—			—			(662,800		)	—			—			(662,800		)
Intercompany activity, net	1,200			(662,800		)	661,600			—			—			—
Net cash used in investing activities	833			(662,800		)	(239		)	—			—			(662,206		)

Financing Activities
Proceeds from issuance of 2012 Senior notes	—			250,000			—			—			—			250,000
Repayment of 2010 Senior Term Loan	—			(242,000		)	—			—			—			(242,000		)
Proceeds from issuance of 2012 Term Loan and 2010 Term Loan	—			650,100			—			—			—			650,100
Payment of deferred financing costs	—			(33,284		)	—			—			—			(33,284		)
Repayment of 2012 Term Loan	—			(25,000		)	—			—			—			(25,000		)
Proceeds from exercise of stock options	889			—			—			—			—			889
Shares surrendered as payment of tax withholding	(271		)	—			—			—			—			(271		)
Intercompany activity, net	(893		)	48,932			(47,125		)	(914		)	—			—
Net cash (used in) provided by financing activities	(275		)	648,748			(47,125		)	(914		)	—			600,434

Effect of exchange rate changes on cash and cash equivalents	—			—			—			1			—			1
Increase (decrease) in cash and cash equivalents	5,523			—			—			158			—			5,681
Cash - beginning of period	12,698			—			—			636			—			13,334

Cash - end of period	$	18,221		$	—		$	—		$	794		$	—		$	19,015

Condensed Consolidating Statement of Cash Flows

Year Ended March 31, 2011



(In thousands)	Prestige Brands Holdings, Inc.			Prestige Brands, Inc., the issuer			Combined Subsidiary Guarantors			Combined Non- guarantor Subsidiaries			Eliminations			Consolidated
Operating Activities
Net income (loss)	$	29,220		$	21,246		$	9,959		$	1,477		$	(32,682	)	$	29,220
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	486			577			8,973			72			—			10,108
Loss on sale of discontinued operations	—			—			890			—			—			890
Deferred income taxes	1,668			1,851			5,806			(1		)	—			9,324
Amortization of deferred financing costs	—			1,043			—			—			—			1,043
Stock-based compensation costs	3,575			—			—			—			—			3,575
Loss on extinguishment of debt	—			300			—			—			—			300
Amortization of debt discount	—			702			—			—			—			702
Loss on disposal of equipment	27			—			126			—			—			153
Equity in income of subsidiaries	(21,842		)	(8,912		)	(1,928		)	—			32,682			—
Changes in operating assets and liabilities
Accounts receivable	1,041			(1,949		)	5,852			(26		)	—			4,918
Inventories	—			1,852			10,648			(57		)	—			12,443
Prepaid expenses and other current assets	(63		)	92			97			28			—			154
Accounts payable	(605		)	2,538			(212		)	63			—			1,784
Accrued liabilities	4,113			9,776			(2,117		)	284			—			12,056
Net cash provided by operating activities	17,620			29,116			38,094			1,840			—			86,670

Investing Activities
Purchases of equipment	(595		)	—			(56		)	(4		)	—			(655		)
Proceeds from sale of property and equipment	12			—			—			—			—			12
Proceeds from sale of discontinued operations	—			—			4,122			—			—			4,122
Acquisition of Blacksmith, net of cash acquired	—			—			(202,044		)	—			—			(202,044		)
Acquisition of Dramamine	—			—			(77,115		)	—			—			(77,115		)
Intercompany activity, net	—			(202,044		)	202,044			—			—			—
Net cash (used in) provided by investing activities	(583		)	(202,044		)	(73,049		)	(4		)	—			(275,680		)

Financing Activities
Proceed from issuance of debt	—			100,250			—			—			—			100,250
Proceeds from issuance of senior term loan	—			112,936			—			—			—			112,936
Payment of deferred financing costs	—			(830		)	—			—			—			(830		)
Repayment of long-term debt	—			(51,087		)	—			—			—			(51,087		)
Proceeds from exercise of stock options	331			—			—			—			—			331
Purchase of treasury stock	(353		)	—			—			—			—			(353		)
Intercompany activity, net	(44,961		)	11,659			34,955			(1,653		)	—			—
Net cash (used in) provided by financing activities	(44,983		)	172,928			34,955			(1,653		)	—			161,247

Increase (decrease) in cash	(27,946		)	—			—			183			—			(27,763		)
Cash - beginning of period	40,644			—			—			453			—			41,097

Cash - end of period	$	12,698		$	—		$	—		$	636		$	—		$	13,334

Schedule of Quantifying Prior Year Misstatements Corrected in Current Year Financial Statements

The impact of these revisions as of March 31, 2012 and for each of the periods ended March 31, 2012 and 2011 are shown in the following tables:

Condensed Consolidating Statement of Income and Comprehensive Income for the year ended March 31, 2012;



(In thousands)	Prestige Brands Holdings, Inc.				Prestige Brands, Inc., the issuer				Combined Subsidiary Guarantors					Combined Non-Guarantor Subsidiaries				Eliminations
	Reported		Revised		Reported		Revised		Reported			Revised		Reported		Revised		Reported			Revised
Revenue	$	—	$	—	$	341,307	$	100,771	$	96,082		$	336,619	$	5,365	$	5,364	$	(1,669	)	$	(1,669	)
Income before income taxes	38,995		38,268		76,595		41,277		(4,905		)	53,838		1,656		1,850		(51,184		)	(74,076		)
Provision (benefit) for income taxes	1,783		1,056		23,643		1,599		(2,018		)	20,565		537		725		—			—
Net income	37,212		37,212		52,952		39,678		(2,887		)	33,273		1,119		1,125		(51,184		)	(74,076		)

Condensed Consolidating Statement of Income and Comprehensive Income for the year ended March 31, 2011;



(In thousands)	Prestige Brands Holdings, Inc.				Prestige Brands, Inc., the issuer					Combined Subsidiary Guarantors				Combined Non-Guarantor Subsidiaries				Eliminations
	Reported		Revised		Reported			Revised		Reported		Revised		Reported		Revised		Reported			Revised
Revenue	$	—	$	—	$	230,844		$	99,195	$	101,925	$	233,761	$	5,407	$	5,220	$	(1,666	)	$	(1,666	)
Income before income taxes	49,846		34,113		(6,252		)	29,423		602		15,217		2,457		2,457		1,875			(32,682		)
Provision (benefit) for income taxes	20,626		4,893		(2,081		)	8,177		274		5,299		530		980		—			—
Net income from continuing operations	29,220		29,220		(4,143		)	21,246		341		9,918		1,927		1,477		1,875			(32,682		)

Condensed Consolidating Balance sheet as of March 31, 2012;



(In thousands)	Prestige Brands Holdings, Inc.				Prestige Brands, Inc., the issuer				Combined Subsidiary Guarantors					Combined Non-Guarantor Subsidiaries				Eliminations
	Reported		Revised		Reported		Revised		Reported			Revised		Reported		Revised		Reported			Revised
Total current assets	$	26,704	$	26,704	$	98,887	$	22,505	$	19,222		$	95,240	$	2,222	$	2,586	$	—		$	—
Total assets	2,200,652		2,065,825		3,236,598		2,939,785		267,407			1,727,658		10,402		8,900		(3,956,783		)	(4,983,892		)
Total current liabilities	16,779		16,289		49,246		20,392		(3,446		)	25,952		1,344		1,290		—			—
Total liabilities	1,797,927		1,663,097		2,982,492		1,654,237		196,430			487,408		2,116		1,685		(3,623,417		)	(2,450,879		)
Total stockholder's equity	402,725		402,728		254,106		1,285,548		70,977			1,240,250		8,286		7,215		(333,366		)	(2,533,013		)

Condensed Consolidating Statement of Cash Flows for the Year Ended March 31, 2012;



(In thousands)	Prestige Brands Holdings, Inc.						Prestige Brands, Inc., the issuer						Combined Subsidiary Guarantors						Combined Non-Guarantor Subsidiaries						Eliminations
	Reported			Revised			Reported			Revised			Reported			Revised			Reported			Revised			Reported			Revised
Net cash provided by (used in) operating activities	$	60,323		$	4,965		$	51,023		$	14,052		$	(2,125	)	$	47,364		$	(230	)	$	1,071		$	(41,539	)	$	—
Net cash provided by (used in) investing activities	833			833			(239		)	(662,800		)	—			(239		)	—			—			(662,800		)	—
Net cash provided by (used in) financing activities	(55,633		)	(275		)	(50,784		)	648,748			2,125			(47,125		)	387			(914		)	704,339			—

Condensed Consolidating Statement of Cash Flows for the Year Ended March 31, 2011;



(In thousands)	Prestige Brands Holdings, Inc.						Prestige Brands, Inc., the issuer						Combined Subsidiary Guarantors						Combined Non-Guarantor Subsidiaries						Eliminations
	Reported			Revised			Reported			Revised			Reported			Revised			Reported			Revised			Reported			Revised
Net cash provided by (used in) operating activities	$	36,726		$	17,620		$	42,853		$	29,116		$	3,190		$	38,094		$	2,026		$	1,840		$	1,875		$	—
Net cash provided by (used in) investing activities	(803		)	(583		)	(274,873		)	(202,044		)	—			(73,049		)	(4		)	(4		)	—			—
Net cash provided by (used in) financing activities	(63,869		)	(44,983		)	232,020			172,928			(3,190		)	34,955			(1,839		)	(1,653		)	(1,875		)	—

Business and Basis of Presentation (Other Balance Sheet and Income Statement Items) (Details) (USD $)	12 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2011
Other Balance Sheet and Income Statement Items [Line Items]
Ownership percentage	100.00%
Term of original maturities, cash equivalents, up to and including	3 months
Shipping, warehousing and handling costs	$ 30,600,000	$ 27,800,000	$ 23,500,000
Accounts receivable, net	73,053,000	60,228,000
GSK Brands
Other Balance Sheet and Income Statement Items [Line Items]
Accounts receivable, net		$ 8,400,000

- Definition

Cost incurred during the reporting period in transporting goods and services to customers. Includes freight-out costs.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18726-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 22

-Paragraph 8

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 45

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6408196&loc=d3e61069-111654

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Handling Costs

-URI http://asc.fasb.org/extlink&oid=6514758

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 45

-Section 45

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=21915142&loc=d3e60635-111653

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 45

-Section S99

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6408413&loc=d3e221937-122793

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Shipping Costs

-URI http://asc.fasb.org/extlink&oid=6525344

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 00-10

-Paragraph 6

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Discontinued Operations and Sale of Certain Assets (Details) (USD $)	0 Months Ended	12 Months Ended
	Sep. 01, 2010	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2011
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from sale of brands		$ 21,700,000		$ 4,122,000
Loss on sale of discontinued operations, net of income tax		0	0	(550,000)
Components of Income
Revenues		0	0	4,027,000
Income (loss) from discontinued operations, net of income tax		0	0	41,000
Loss on sale of discontinued operations, net of income tax		0	0	591,000
Cutex
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from sale of brands	4,100,000	0	0	4,122,000
Loss on sale of discontinued operations, pre-tax basis	900,000
Loss on sale of discontinued operations, net of income tax	600,000
Loss on sale of discontinued operations, related tax effect	$ 300,000

- Definition

Amount of gain (loss), before tax expense or benefit and not previously recognized, resulting from the sale of a business component.

+ References+ Details

- Definition

Amount of gain (loss), after tax expense or benefit and not previously recognized, resulting from the sale of a business component.

+ References+ Details

- Definition

After tax income (loss) from operations of a business component (exclusive of any gain (loss) on disposal, or provision therefore) during the reporting period, until its disposal.

+ References+ Details

- Definition

Amount of tax expense or benefit on gain (loss), not previously recognized, resulting from the sale of a business component.

+ References+ Details

- Definition

Amount of income (loss) from a disposal group, net of income tax, reported as a separate component of income before extraordinary items after deduction or consideration of the amount allocable to noncontrolling interests. Includes, net of tax, income (loss) from operations during the phase-out period, gain (loss) on disposal, provision (or any reversals of earlier provisions) for loss on disposal, and adjustments of a prior period gain (loss) on disposal.

+ References+ Details

Acquisitions (Narrative) (Details) (USD $)	9 Months Ended	12 Months Ended			2 Months Ended	12 Months Ended			0 Months Ended		0 Months Ended	1 Months Ended	0 Months Ended		1 Months Ended	5 Months Ended	12 Months Ended	0 Months Ended	3 Months Ended	0 Months Ended	12 Months Ended
Acquisitions (Narrative) (Details) (USD $)	Dec. 31, 2012	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2011	May 31, 2012 GSK Brands	Mar. 31, 2013 GSK Brands	Mar. 31, 2012 GSK Brands	Dec. 20, 2011 GSK Brands agreement brand	Dec. 20, 2011 GSK	Mar. 31, 2013 GSK	Jan. 31, 2012 GSK Brands I brand	Apr. 30, 2012 GSK Brands I	Mar. 30, 2012 GSK Brands II	Nov. 01, 2010 Blacksmith brand	Sep. 30, 2011 Blacksmith	Mar. 31, 2011 Blacksmith	Mar. 31, 2013 Blacksmith	Jan. 06, 2011 Dramamine	Mar. 31, 2011 Dramamine	Mar. 30, 2012 GSK	Mar. 31, 2013 GSK
Business Acquisition [Line Items]
Number of purchase agreements								2
Number of brands acquired								17			15			5
Purchase price, gross									$ 660,000,000		$ 615,000,000		$ 45,000,000
Post-closing adjustments added to purchase price	200,000	226,000	0	0	3,000,000							2,800,000							100,000
Transitional services agreement, estimated monthly costs to be incurred																				2,500,000
Transitional services agreement, actual costs incurred																					6,900,000
Purchase price							663,026,000			663,026,000	578,688,000		84,338,000	203,351,000				77,115,000
Goodwill, expected tax deductible amount										20,200,000				4,600,000
Non-amortizable intangible assets										556,900,000								75,900,000
Amortizable intangible assets										67,200,000
Purchased amortizable intangible assets, weighted average useful life		19 years 3 months 18 days												15 years
Amortizable intangible assets, weighted average remaining life		12 years 0 months 0 days				18 years 0 months 0 days											12 years 7 months 6 days
Revenue of acquiree since acquisition date, actual						211,200,000										34,800,000
Net income of acquiree since acquisition date, actual						27,400,000										(4,800,000)
Percentage of capital stock acquired														100.00%
Purchase price, net														190,000,000				77,100,000
Payments for working capital adjustments														13,400,000
Payments of transaction costs of seller														1,100,000
Proceeds from escrow of Blacksmith acquisition		0	1,200,000	0											1,200,000
Trademark, nonamortizable														158,000,000
Trademarks, amortizable														7,300,000
Acquisition related costs																		$ 1,200,000

Acquisitions (Purchase Price Allocation) (Details) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2011	Mar. 31, 2010	Jan. 06, 2011 Dramamine	Mar. 31, 2012 GSK Brands	Jan. 31, 2012 GSK Brands I	Mar. 30, 2012 GSK Brands II	Nov. 01, 2010 Blacksmith
Business Acquisition [Line Items]
Cash acquired									$ 2,507
Accounts receivable, net									17,473
Other receivables									1,198
Income taxes receivable									5
Inventories					1,249	15,070	14,820	250	22,155
Prepaids and other current assets						3,575	3,575	0	44
Property, plant and equipment, net									226
Goodwill	167,546	173,702	154,896	111,489		20,232	17,401	2,831	42,207
Intangible assets, amortizable and unamortizable					75,866	624,149	542,892	81,257	165,346
Other long-term assets									19
Total assets acquired									251,180
Accounts payable									7,060
Accrued expenses									5,212
Income taxes payable									2,031
Deferred income taxes									33,526
Total liabilities assumed									47,829
Total purchase price					$ 77,115	$ 663,026	$ 578,688	$ 84,338	$ 203,351

Acquisitions (Pro Forma Information) (Details) (Blacksmith and GSK Brands, USD $) In Thousands, except Per Share data, unless otherwise specified	12 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Blacksmith and GSK Brands
Business Acquisition [Line Items]
Revenues	$ 616,849	$ 599,543
Income from continuing operations	$ 69,989	$ 34,913
Basic earnings per share:
Income from continuing operations (in USD per share)	$ 1.39	$ 0.70
Diluted earnings per share:
Income from continuing operations (in USD per share)	$ 1.38	$ 0.69

- Definition

The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.

+ References+ Details

- Definition

The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.

+ References+ Details

Divestitures (Narrative) (Details) (USD $) In Thousands, unless otherwise specified	0 Months Ended		12 Months Ended
	Jan. 04, 2013	Oct. 31, 2012	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2011
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from the sale of Phazyme brand			$ 21,700		$ 4,122
Phazyme
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from the sale of Phazyme brand	$ 600	$ 21,700	$ 21,700	$ 0	$ 0

Divestitures (Details) (Phazyme, USD $) In Thousands, unless otherwise specified	Oct. 31, 2012
Phazyme
Assets sold
Inventory	$ 220
Prepaid expenses	100
Trade names	15,604
Goodwill	$ 6,382

Accounts Receivable (Details) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2013	Mar. 31, 2012
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable, gross	$ 80,361	$ 65,089
Less allowances for discounts, returns and uncollectible accounts	(7,308)	(4,861)
Accounts receivable, net	73,053	60,228
Trade Accounts Receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable, gross	79,746	55,721
Other Receivables
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable, gross	$ 615	$ 9,368

Inventories (Details) (USD $)	Mar. 31, 2013	Mar. 31, 2012
Inventory Disclosure [Abstract]
Packaging and raw materials	$ 1,875,000	$ 1,189,000
Finished goods	58,326,000	49,924,000
Inventories	60,201,000	51,113,000
Inventory valuation reserves related to obsolete and slow-moving inventory	$ 1,300,000	$ 1,600,000

- Definition

The amount of the valuation account as of the balance sheet date which reduces the carrying amount of inventory to net realizable value; takes into consideration such factors as market value, excessive quantities based on expected sales, technological obsolescence, and shrinkage. May also provide for estimated product returns or price concessions pertaining to product cost.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 6

-Subparagraph a

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 43

-Section A

-Paragraph 9

-Chapter 3

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 5.BB)

-URI http://asc.fasb.org/extlink&oid=6386940&loc=d3e100047-122729

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 4

-Subparagraph (SX 210.12-09)

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e24092-122690

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 35

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6386567&loc=d3e3927-108312

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 43

-Paragraph 14

-Chapter 4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 43

-Paragraph 8, 9, 14

-Chapter 4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 09

-Article 12

+ Details

Property and Equipment (Details) (USD $)	12 Months Ended
Property and Equipment (Details) (USD $)	Mar. 31, 2013	Mar. 31, 2011	Mar. 31, 2012
Components of Property and Equipment
Property and equipment, gross	$ 14,362,000		$ 4,824,000
Accumulated depreciation	(4,466,000)		(3,520,000)
Property and equipment, net	9,896,000		1,304,000
Depreciation	1,600,000	700,000
Machinery
Components of Property and Equipment
Property and equipment, gross	1,580,000		1,454,000
Computer Equipment
Components of Property and Equipment
Property and equipment, gross	6,559,000		2,693,000
Furniture and Fixtures
Components of Property and Equipment
Property and equipment, gross	1,510,000		241,000
Leasehold Improvements
Components of Property and Equipment
Property and equipment, gross	4,713,000		436,000
Impairment of assets	$ 100,000

- Definition

The cumulative amount of depreciation, depletion and amortization (related to property, plant and equipment, but not including land) that has been recognized in the income statement.

+ References+ Details

- Definition

The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.

+ References+ Details

- Definition

The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=8077374&loc=d3e2420-110228

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6391110&loc=d3e2921-110230

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 144

-Paragraph 26

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 958

-SubTopic 225

-Section 45

-Paragraph 11

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6743430&loc=d3e92212-112881

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Impairment

-URI http://asc.fasb.org/extlink&oid=6515133

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 144

-Paragraph 7, 25

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

- Definition

Gross amount of long-lived physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.

+ References+ Details

- Definition

Amount, net of accumulated depreciation, depletion and amortization, of long-lived physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.

+ References+ Details

Goodwill (Narrative) (Details) (USD $)	12 Months Ended			0 Months Ended	3 Months Ended		0 Months Ended		9 Months Ended
Goodwill (Narrative) (Details) (USD $)	Mar. 31, 2013 unit	Mar. 31, 2012	Mar. 31, 2011	Nov. 01, 2010 Blacksmith	Jun. 30, 2012 GSK Brands	Mar. 31, 2012 GSK Brands	Jan. 31, 2012 GSK Brands I	Mar. 30, 2012 GSK Brands II	Dec. 31, 2012 Phazyme	Oct. 31, 2012 Phazyme	Mar. 31, 2013 Reporting Unit One	Mar. 31, 2013 Reporting Unit Two
Goodwill [Line Items]
Percentage of capital stock acquired				100.00%
Goodwill recorded in period				$ 42,200,000
Increase (decrease) to goodwill due to settlement of working capital adjustments				1,200,000
Purchase price, gross							615,000,000	45,000,000
Goodwill acquired during period	226,000	20,006,000	43,407,000			20,000,000
Goodwill, post-closing inventory and apportionment adjustment					200,000
Brand divested, sale price										22,300,000
Reduction in goodwill	(6,382,000)								(6,400,000)
Excess of fair value over carrying value, percentage	57.60%
Number of reporting units with fair value greater than carrying value	2
Intangible assets, net (including goodwill)	$ 1,540,786,000										$ 8,000,000	$ 58,400,000

Goodwill (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2011
Goodwill [Roll Forward]
Goodwill, gross, beginning	$ 369,032	$ 350,226	$ 306,819
Accumulated impairment losses, beginning	(195,330)	(195,330)	(195,330)
Goodwill, net, beginning	173,702	154,896	111,489
Additions	226	20,006	43,407
Reductions	(6,382)
Goodwill, gross, ending	362,876	369,032	350,226
Accumulated impairment losses, ending	(195,330)	(195,330)	(195,330)
Goodwill, net, ending	167,546	173,702	154,896
OTC Healthcare
Goodwill [Roll Forward]
Goodwill, gross, beginning	296,483	277,677	234,270
Accumulated impairment losses, beginning	(130,170)	(130,170)	(130,170)
Goodwill, net, beginning	166,313	147,507	104,100
Additions	226	20,006	43,407
Reductions	(6,382)
Goodwill, gross, ending	290,327	296,483	277,677
Accumulated impairment losses, ending	(130,170)	(130,170)	(130,170)
Goodwill, net, ending	160,157	166,313	147,507
Household Cleaning
Goodwill [Roll Forward]
Goodwill, gross, beginning	72,549	72,549	72,549
Accumulated impairment losses, beginning	(65,160)	(65,160)	(65,160)
Goodwill, net, beginning	7,389	7,389	7,389
Additions	0	0	0
Reductions	0
Goodwill, gross, ending	72,549	72,549	72,549
Accumulated impairment losses, ending	(65,160)	(65,160)	(65,160)
Goodwill, net, ending	$ 7,389	$ 7,389	$ 7,389

- Definition

Carrying amount as of the balance sheet date, which is the cumulative amount paid and (if applicable) the fair value of any noncontrolling interest in the acquiree, adjusted for any amortization recognized prior to the adoption of any changes in generally accepted accounting principles (as applicable) and for any impairment charges, in excess of the fair value of net assets acquired in one or more business combination transactions.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141R

-Paragraph 68

-Subparagraph l

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=14024403&loc=d3e13816-109267

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 142

-Paragraph 45

-Subparagraph e

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 142

-Paragraph 43

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141R

-Paragraph 72

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 142

-Paragraph 45

-Subparagraph e

-Clause 1

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141R

-Paragraph 34

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

- Definition

The aggregate amount of goodwill acquired in the period and allocated to the reportable segment. The value is stated at fair value based on the purchase price allocation.

+ References+ Details

- Definition

Write-off of the carrying amount of goodwill associated with all or a portion of a reporting unit that is sold in the period.

+ References+ Details

Intangible Assets (Narrative) (Details) (USD $)	0 Months Ended	3 Months Ended	12 Months Ended		0 Months Ended					12 Months Ended
Intangible Assets (Narrative) (Details) (USD $)	Oct. 31, 2012	Mar. 31, 2012	Mar. 31, 2012	Mar. 31, 2011	Jan. 31, 2012 GSK Brands I	Mar. 30, 2012 GSK Brands II	Jan. 06, 2011 Dramamine	Nov. 01, 2010 Blacksmith	Oct. 31, 2012 Phazyme	Mar. 31, 2013 Finite Lived Trademarks
Schedule of Intangible Assets [Line Items]
Purchase price, gross					$ 615,000,000	$ 45,000,000
Nonamortizable intangible assets acquired during period							75,900,000
Percentage of capital stock acquired								100.00%
Intangible assets acquired during period		624,100,000	624,149,000	241,212,000				165,300,000
Brand divested, sale price									22,300,000
Intangible assets, reductions, net	15,600,000
Finite-lived intangibles, reclassified from indefinite-lived during period										$ 1,696,000

Intangible Assets (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended	12 Months Ended
	Mar. 31, 2012	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2011
Indefinite-Lived Intangible Assets [Abstract]
Indefinite-lived intangibles, ending		$ 1,243,718
Finite-lived Intangible Assets, Accumulated Amortization [Abstract]
Intangible assets, accumulated amortization, additions		11,678	9,988	9,210
Intangible Assets, Gross [Abstract]
Intangible assets, gross, beginning		1,463,084	838,935	605,993
Intangible assets, additions, gross	624,100		624,149	241,212
Intangible assets, reclassifications, gross		0
Intangible assets, reductions or disposals, gross		(16,142)		(8,270)
Intangible assets, gross, ending	1,463,084	1,446,942	1,463,084	838,935
Intangible Assets, Accumulated Amortization [Abstract]
Intangible assets, accumulated amortization, beginning		62,562	52,574	46,764
Intangible assets, accumulated amortization, additions		11,678	9,988	9,210
Intangible assets, accumulated amortization, reductions or disposals		(538)		(3,400)
Intangible assets, accumulated amortization, ending	62,562	73,702	62,562	52,574
Finite-Lived Intangible Assets, Net [Abstract]
Intangible assets, net		129,522
Intangible Assets, Net [Abstract]
Intangible assets, net (excluding goodwill)	1,400,522	1,373,240	1,400,522	786,361
Finite Lived Trademarks
Finite-Lived Intangible Assets, Gross [Abstract]
Finite-lived intangibles, gross, beginning		217,512	150,293	151,264
Finite-lived intangibles, additions, gross			67,219	7,299
Finite-lived intangibles, reclassifications, gross		1,696
Finite-lived intangibles, reductions or disposals, gross		(16,142)		(8,270)
Finite-lived intangibles, gross, ending	217,512	203,066	217,512	150,293
Finite-lived Intangible Assets, Accumulated Amortization [Abstract]
Finite-lived intangibles, accumulated amortization, beginning		62,404	52,416	46,606
Intangible assets, accumulated amortization, additions		11,678	9,988	9,210
Finite-lived intangibles, accumulated amortization, reductions or disposals		(538)		(3,400)
Finite-lived intangibles, accumulated amortization, ending	62,404	73,544	62,404	52,416
Intangible Assets, Accumulated Amortization [Abstract]
Intangible assets, accumulated amortization, additions		11,678	9,988	9,210
Finite-Lived Intangible Assets, Net [Abstract]
Intangible assets, net	155,108	129,522	155,108	97,877
Noncompete Agreements
Finite-Lived Intangible Assets, Gross [Abstract]
Finite-lived intangibles, gross, beginning		158	158	158
Finite-lived intangibles, additions, gross			0	0
Finite-lived intangibles, reclassifications, gross		0
Finite-lived intangibles, reductions or disposals, gross		0		0
Finite-lived intangibles, gross, ending	158	158	158	158
Finite-lived Intangible Assets, Accumulated Amortization [Abstract]
Finite-lived intangibles, accumulated amortization, beginning		158	158	158
Intangible assets, accumulated amortization, additions		0	0	0
Finite-lived intangibles, accumulated amortization, reductions or disposals		0		0
Finite-lived intangibles, accumulated amortization, ending	158	158	158	158
Intangible Assets, Accumulated Amortization [Abstract]
Intangible assets, accumulated amortization, additions		0	0	0
Finite-Lived Intangible Assets, Net [Abstract]
Intangible assets, net	0	0	0	0
Indefinite Lived Trademarks
Indefinite-Lived Intangible Assets [Abstract]
Indefinite-lived intangibles, beginning		1,245,414	688,484	454,571
Indefinite-lived intangibles, additions			556,930	233,913
Indefinite-lived intangibles, reclassifications		(1,696)
Indefinite-lived intangibles, reductions or disposals		0		0
Indefinite-lived intangibles, ending	$ 1,245,414	$ 1,243,718	$ 1,245,414	$ 688,484

Intangible Assets (Expected Amortization Expense) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2011
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, weighted average remaining period	12 years 0 months 0 days
Amortization of intangible assets	$ 11,678	$ 9,988	$ 9,210
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
2014	10,210
2015	8,834
2016	8,834
2017	8,834
2018	8,834
Thereafter	83,976
Intangible assets, net	$ 129,522
Minimum
Finite-Lived Intangible Assets [Line Items]
Intangible assets, useful lives	3 years
Maximum
Finite-Lived Intangible Assets [Line Items]
Intangible assets, useful lives	30 years

Other Accrued Liabilities (Details) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2013	Mar. 31, 2012
Payables and Accruals [Abstract]
Accrued marketing costs	$ 17,187	$ 10,554
Accrued compensation costs	8,847	7,181
Accrued broker commissions	1,028	415
Income taxes payable	493	577
Accrued professional fees	1,846	3,821
Deferred rent	1,268	9
Accrued severance costs	0	461
Accrued lease termination costs	729	290
Other accrued liabilities	$ 31,398	$ 23,308

Long-Term Debt (Narrative) (Details) (USD $)	0 Months Ended	3 Months Ended								12 Months Ended							0 Months Ended												0 Months Ended				0 Months Ended	1 Months Ended	3 Months Ended	12 Months Ended	3 Months Ended										0 Months Ended	12 Months Ended
Long-Term Debt (Narrative) (Details) (USD $)	Mar. 24, 2010	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2011	Jan. 31, 2012	Nov. 01, 2010	Jan. 31, 2012 2012 Senior Notes	Jan. 31, 2012 Term Loan and ABL Revolver 2012	Nov. 01, 2010 Senior Notes 2010 Senior Notes	Mar. 24, 2010 Senior Notes 2010 Senior Notes	Mar. 31, 2011 Senior Notes 2010 Senior Notes	Mar. 24, 2010 Senior Notes 2010 Senior Notes Prior To April 1, 2014	Mar. 24, 2010 Senior Notes 2010 Senior Notes Twelve Months Beginning April 1, 2014	Mar. 24, 2010 Senior Notes 2010 Senior Notes Twelve Months Beginning April 1, 2015	Mar. 24, 2010 Senior Notes 2010 Senior Notes On or After April 1, 2016	Mar. 24, 2010 Senior Notes 2010 Senior Notes Prior to April 1, 2013	Jan. 31, 2012 Senior Notes 2012 Senior Notes	Jan. 31, 2012 Senior Notes 2012 Senior Notes Prior To April 1, 2014	Jan. 31, 2012 Senior Notes 2012 Senior Notes Prior to April 1, 2013	Jan. 31, 2012 Senior Notes 2012 Senior Notes Upon Change in Control	Jan. 31, 2012 Term Loans 2010 Term Loan	Nov. 01, 2010 Term Loans 2010 Term Loan	Mar. 24, 2010 Term Loans 2010 Term Loan	Mar. 24, 2010 Term Loans 2010 Term Loan LIBOR	Jan. 31, 2012 Term Loans 2012 Term Loan	Mar. 31, 2012 Term Loans 2012 Term Loan	Dec. 31, 2011 Term Loans 2012 Term Loan	Mar. 31, 2013 Term Loans 2012 Term Loan	Mar. 31, 2013 Term Loans Amended 2012 Term Loan	Feb. 21, 2013 Term Loans Amended 2012 Term Loan	Feb. 21, 2013 Term Loans Amended 2012 Term Loan LIBOR	Feb. 21, 2013 Term Loans Amended 2012 Term Loan LIBOR Minimum	Feb. 21, 2013 Term Loans Amended 2012 Term Loan Base Rate	Jan. 31, 2012 Term Loans Amended 2012 Term Loan Base Rate Federal Funds Rate	Jan. 31, 2012 Term Loans Amended 2012 Term Loan Base Rate LIBOR	Apr. 15, 2010 Senior Subordinated Notes Senior Subordinated Notes Due in 2012	Nov. 01, 2010 Revolving Credit Facility 2010 Revolving Credit Facility	Mar. 24, 2010 Revolving Credit Facility 2010 Revolving Credit Facility	Jan. 31, 2012 Revolving Credit Facility 2012 ABL Revolver	Mar. 31, 2013 Revolving Credit Facility 2012 ABL Revolver	Dec. 31, 2012 Revolving Credit Facility 2012 ABL Revolver	Sep. 30, 2012 Revolving Credit Facility 2012 ABL Revolver	Sep. 29, 2012 Revolving Credit Facility 2012 ABL Revolver	Jan. 31, 2012 Revolving Credit Facility 2012 ABL Revolver LIBOR	Jan. 31, 2012 Revolving Credit Facility 2012 ABL Revolver LIBOR Minimum	Jan. 31, 2012 Revolving Credit Facility 2012 ABL Revolver LIBOR Maximum	Jan. 31, 2012 Revolving Credit Facility 2012 ABL Revolver Base Rate	Jan. 31, 2012 Revolving Credit Facility 2012 ABL Revolver Base Rate Minimum	Jan. 31, 2012 Revolving Credit Facility 2012 ABL Revolver Base Rate Maximum	Jan. 31, 2012 Revolving Credit Facility 2012 ABL Revolver Base Rate Federal Funds Rate	Jan. 31, 2012 Revolving Credit Facility 2012 ABL Revolver Base Rate LIBOR
Debt Instrument [Line Items]
Debt instrument, face amount																		$ 150,000,000.0							$ 250,000,000.0						$ 150,000,000.0		$ 660,000,000.0
Debt instrument, stated interest rate																		8.25%							8.125%																			9.25%
Debt instrument, increase, additional borrowings																	100,000,000.0													115,000,000.0
Debt instrument, unamortized discount		7,100,000				11,092,000				7,100,000	11,092,000							2,200,000													1,800,000
Debt instrument, unamortized premium																		300,000
Proceeds from issuance of long-term debt																	100,300,000	147,800,000													148,200,000		650,100,000
Debt instrument, effective interest rate																			8.50%												5.00%
Percentage of subsidiary owned		100.00%								100.00%			100.00%
Debt instrument, basis spread on variable rate																																3.25%							2.75%	1.00%
Debt instrument, reference rate floor																															1.50%							1.00%
Loss on extinguishment of debt		1,443,000	0	0	0	5,409,000	0	0	0	1,443,000	5,409,000	300,000																	5,400,000								(1,400,000)
Line of credit facility, maximum borrowing capacity																																													40,000,000.0	30,000,000.0	50,000,000			75,000,000
Line of credit facility, increase in borrowing capacity																																													10,000,000.0						25,000,000.0
Debt instrument, discount, percentage																																	1.50%
Debt issuance costs capitalized	6,600,000													600,000	12,600,000	20,600,000									12,600,000								18,800,000														1,800,000
Debt issuance costs	7,300,000
Debt issuance costs charged to expense	700,000
Debt instrument, basis spread on variable rate, fixed component																																									2.00%	0.50%	1.00%															0.50%	1.00%
Repayments of long-term debt										190,000,000	25,000,000	51,087,000																						25,000,000		190,000,000
Debt instrument, variable rate																																																				1.75%			0.75%
Debt instrument, conditional variable rate																																																					2.00%	2.25%		1.00%	1.25%
Line of credit facility, commitment fee percentage																																															0.50%
Line of credit facility, conditional commitment fee percentage																																															0.375%
Line of credit facility, interest rate at period end																																					5.20%												2.20%
Quarterly payment, percent of original principal amount																																	0.25%
Accelerated amortization of deferred financing costs																																			5,100,000
Debt instrument, maturity term																																	7 years														5 years
Debt instrument, redemption price, percentage of principal amount																				100.00%	104.125%	102.063%	100.00%	108.25%		100.00%	108.125%	101.00%
Debt instrument, percentage of principal amount eligible for redemption																								35.00%			35.00%
Line of credit facility, net amount borrowed in period																																																33,000,000
Accelerated amortization of debt discount																																			$ 2,600,000

Long-Term Debt (Schedule of Long-term Debt) (Details) (USD $)	Mar. 31, 2013	Mar. 31, 2012	Mar. 24, 2010
Debt Instrument [Line Items]
Long-term debt, gross	$ 978,000,000	$ 1,135,000,000
Current portion of long-term debt	0	0
Long-term debt, gross, excluding current maturities	978,000,000	1,135,000,000
Less: unamortized discount	(7,100,000)	(11,092,000)
Long-term debt, net of unamortized discount	970,900,000	1,123,908,000
Senior Notes \| 2012 Senior Notes
Debt Instrument [Line Items]
Long-term debt, gross	250,000,000	250,000,000
Senior Notes \| 2010 Senior Notes
Debt Instrument [Line Items]
Long-term debt, gross	250,000,000	250,000,000
Less: unamortized discount			(2,200,000)
Term Loans \| 2012 Term Loan
Debt Instrument [Line Items]
Long-term debt, gross	445,000,000	635,000,000
Revolving Credit Facility \| 2012 ABL Revolver
Debt Instrument [Line Items]
Long-term debt, gross	$ 33,000,000	$ 0

- Definition

Including current and noncurrent portions, aggregate carrying amount of long-term borrowings as of the balance sheet date before deducting unamortized discount or premiums (if any). May include notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt, which had initial maturities beyond one year or beyond the normal operating cycle, if longer.

+ References+ Details

- Definition

The amount of debt discount that was originally recognized at the issuance of the instrument that has yet to be amortized.

+ References+ Details

Long-Term Debt (Maturities of Long-term Debt) (Details) (USD $)	Mar. 31, 2013	Mar. 31, 2012
Debt Disclosure [Abstract]
2014	$ 0
2015	0
2016	0
2017	33,000,000
2018	0
Thereafter	945,000,000
Long-term debt, gross	$ 978,000,000	$ 1,135,000,000

- Definition

+ References+ Details

Fair Value Measurements (Details) (USD $) In Millions, unless otherwise specified	Mar. 31, 2013	Mar. 31, 2012
Senior Notes \| 2012 Senior Notes \| Carrying (Reported) Amount, Fair Value Disclosure
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Loans payable, fair value disclosure	$ 250.0	$ 250.0
Senior Notes \| 2010 Senior Notes \| Carrying (Reported) Amount, Fair Value Disclosure
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Loans payable, fair value disclosure	250.0	250.0
Senior Notes \| Fair Value, Measurements, Nonrecurring \| Fair Value, Inputs, Level 2 \| 2012 Senior Notes \| Portion at Fair Value, Fair Value Disclosure
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Loans payable, fair value disclosure	281.9	270.6
Senior Notes \| Fair Value, Measurements, Nonrecurring \| Fair Value, Inputs, Level 2 \| 2010 Senior Notes \| Portion at Fair Value, Fair Value Disclosure
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Loans payable, fair value disclosure	271.9	272.5
Term Loans \| 2012 Term Loan \| Carrying (Reported) Amount, Fair Value Disclosure
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Loans payable, fair value disclosure	445.0	635.0
Term Loans \| Fair Value, Measurements, Nonrecurring \| Fair Value, Inputs, Level 2 \| 2012 Term Loan \| Portion at Fair Value, Fair Value Disclosure
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Loans payable, fair value disclosure	451.1	639.0
Revolving Credit Facility \| 2012 ABL Revolver \| Carrying (Reported) Amount, Fair Value Disclosure
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Line of credit, fair value disclosure	33.0
Revolving Credit Facility \| 2012 ABL Revolver \| Portion at Fair Value, Fair Value Disclosure
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Line of credit, fair value disclosure	$ 33.0

Stockholders' Equity (Details) (USD $)	1 Months Ended	12 Months Ended		12 Months Ended
Stockholders' Equity (Details) (USD $)	Mar. 31, 2012	Mar. 31, 2013	Feb. 26, 2012	Mar. 31, 2013 Restricted Shares	Mar. 31, 2012 Restricted Shares	Mar. 31, 2011 Restricted Shares	Mar. 31, 2013 Series A Preferred Stock
Class of Stock [Line Items]
Common stock, shares authorized	250,000,000	250,000,000
Common stock, par value (in USD per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, par value (in USD per share)	$ 0.01	$ 0.01
Voting rights, number of votes per common share owned		1
Dividends declared on common stock		$ 0
Dividends paid on common stock		0
Dividend distribution, number of preferred share rights per common share owned, declared			1
Preferred share right, number of shares of stock called by right							0.001
Dividend distribution, exercise price (in USD per right)		65.00
Period after acquisition until preferred share rights become exercisable		10 days
Threshold percentage of common stock acquired which constitutes an acquisition event		10.00%
Initial cash redemption price (in USD per right)		0.01
Charge against retained earnings to reflect fair value of preferred share rights upon declaration of dividends	$ 283,000
Restricted stock repurchased during period, shares				0	20,999	36,032
Restricted stock acquired, average cost per share				$ 12.86	$ 9.81

Earnings Per Share (Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended								12 Months Ended
	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2011
Numerator
Income from continuing operations									$ 65,505	$ 37,212	$ 29,179
Income from discontinued operations and loss on sale of discontinued operations									0	0	41
Net income	$ 19,349	$ 12,257	$ 19,244	$ 14,655	$ (15)	$ 9,510	$ 12,949	$ 14,768	$ 65,505	$ 37,212	$ 29,220
Denominator
Denominator for basic earnings per share- weighted average shares (in shares)	51,147	50,686	50,364	50,342	50,314	50,307	50,278	50,183	50,633	50,270	50,081
Dilutive effect of unvested restricted common stock (including restricted stock units) and options issued to employees and directors (in shares)									807	478	257
Denominator for diluted earnings per share (in shares)	51,913	51,523	51,225	51,106	50,992	50,684	50,671	50,646	51,440	50,748	50,338
Earnings per Common Share:
Basic earnings per share from continuing operations (in USD per share)									$ 1.29	$ 0.74	$ 0.58
Basic earnings per share from discontinued operations and loss on sale of discontinued operations (in USD per share)									$ 0.00	$ 0.00	$ 0.00
Basic net earnings per share (in USD per share)	$ 0.38	$ 0.24	$ 0.38	$ 0.29	$ 0.00	$ 0.19	$ 0.26	$ 0.29	$ 1.29	$ 0.74	$ 0.58
Diluted earnings per share from continuing operations (in USD per share)									$ 1.27	$ 0.73	$ 0.58
Diluted earnings per share from discontinued operations and loss on sale of discontinued operations (in USD per share)									$ 0.00	$ 0.00	$ 0.00
Diluted net earnings per share (in USD per share)	$ 0.37	$ 0.24	$ 0.38	$ 0.29	$ 0.00	$ 0.19	$ 0.26	$ 0.29	$ 1.27	$ 0.73	$ 0.58

Earnings Per Share Antidilutive Securities (Details) (Outstanding Stock Awards) In Millions, unless otherwise specified	12 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2011
Outstanding Stock Awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, shares (fewer than 0.1 million shares for the three and nine months ended December 31, 2012)	0	0.4	0.5

- Definition

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Antidilution

-URI http://asc.fasb.org/extlink&oid=6505113

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Diluted Earnings Per Share

-URI http://asc.fasb.org/extlink&oid=6510752

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Contingent Stock Agreement

-URI http://asc.fasb.org/extlink&oid=6508534

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 128

-Paragraph 40

-Subparagraph c

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 128

-Paragraph 13, 14

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 07-4

-Paragraph 4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 128

-Paragraph 171

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Share-Based Compensation (Narrative) (Details) (USD $)	0 Months Ended	12 Months Ended											0 Months Ended			12 Months Ended	0 Months Ended
Share-Based Compensation (Narrative) (Details) (USD $)	May 09, 2012	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2011	Mar. 31, 2010	Mar. 31, 2013 Restricted Shares	Mar. 31, 2011 Restricted Shares	Mar. 31, 2010 Restricted Shares	Mar. 31, 2013 Restricted Shares Minimum	Mar. 31, 2013 Restricted Shares Maximum	Mar. 31, 2013 Stock Options Minimum	Mar. 31, 2013 Stock Options Maximum	May 09, 2012 Employee Restricted Stock Units (RSUs)	Jan. 25, 2012 Management Restricted Stock Units (RSUs)	Jun. 29, 2012 Director Restricted Stock Units (RSUs)	Mar. 31, 2013 Director Restricted Stock Units (RSUs)	Aug. 06, 2012 Executive Compensation Contracts	Aug. 06, 2012 Executive Compensation Contracts Restricted Stock Units (RSUs)	Aug. 06, 2012 Executive Compensation Contracts Stock Options	Aug. 06, 2012 Executive Compensation Contracts Stock Options Maximum	Aug. 06, 2012 Common Stock Executive Compensation Contracts Stock Options
Share-based Compensation, Aggregate Disclosures:
Number of shares authorized for grant under 2005 Long-Term Equity Incentive Plan		5,000,000
Share-based compensation costs charged against income		$ 3,772,000	$ 3,078,000	$ 3,575,000
Tax benefit recognized from share-based compensation expense		1,200,000	1,200,000	1,400,000
Award vesting period		10 months 24 days							3 years	5 years	3 years	5 years	3 years			1 year			3 years
Unrecognized compensation costs related to nonvested awards		3,000,000
Total fair value of vested shares		2,500,000	2,900,000	2,300,000
Shares available for issuance under the Plan		1,900,000
Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock and Restricted Stock Units, Additional Disclosures [Abstract]
Restricted common stock units granted in period, shares						128,900	217,500	125,000					111,152	95,000	12,652			5,109
Granted, weighted-average grant-date fair value (in USD per share)		$ 13.59	$ 11.81	$ 8.99		$ 13.59	$ 11.81	$ 8.99
Options, Additional Disclosures:
Award exercisability period, from date of grant												10 years								10 years
Options granted, shares	422,962		444,900	308,200	418,600
Options granted, weighted-average exercise price (in USD per share)	$ 13.24		$ 13.36	$ 11.27	$ 9.26
Common shares to be issued upon exercise																					21,978
Options granted, weighted-average grant-date fair value (in USD per share)		$ 6.03	$ 5.83	$ 4.91													$ 15.66
Percentage of options vesting annually																	33.30%
Options exercised, aggregate intrinsic value		3,800,000
Options granted, grant-date aggregate intrinsic value		5,500,000
Cash received from exercise of stock options		6,000,000	600,000	300,000
Tax benefit realized from exercise of stock options		$ 11,300,000	$ 300,000	$ 200,000

Share-Based Compensation (Restricted Shares Activity) (Details) (USD $)	12 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2011	Mar. 31, 2013 Restricted Shares	Mar. 31, 2011 Restricted Shares	Mar. 31, 2010 Restricted Shares	Mar. 31, 2012 Restricted Shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Outstanding, beginning of period				363,400	287,100
Granted				128,900	217,500	125,000
Vested and issued				(58,700)	(103,400)	(88,200)
Forfeited				(12,300)	(26,100)	(48,500)
Outstanding, end of period				421,300	275,400	287,100
Vested, end of period				70,400	29,200		54,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]
Outstanding, beginning of period, weighted-average grant-date fair value (in USD per share)				$ 9.92	$ 8.86
Granted, weighted-average grant-date fair value (in USD per share)	$ 13.59	$ 11.81	$ 8.99	$ 13.59	$ 11.81	$ 8.99
Vested, weighted-average grant-date fair value (in USD per share)				$ 9.99	$ 9.93	$ 9.63
Forfeited, weighted-average grant-date fair value (in USD per share)				$ 10.69	$ 10.17	$ 10.10
Outstanding, end of period, weighted-average grant-date fair value (in USD per share)				$ 11.01	$ 8.46	$ 8.86
Vested, end of period, weighted-average grant-date fair value (in USD per share)				$ 8.52	$ 6.84		$ 7.40

Share-Based Compensation (Stock Option Valuation Assumptions) (Details) (Stock Options, USD $)	12 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility	44.00%	53.00%
Expected dividends	$ 0	$ 0
Expected term in years	6 years 6 months	6 years 6 months
Risk-free rate	1.20%	2.40%

- Definition

The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.

+ References+ Details

Share-Based Compensation (Stock Option Activity) (Details) (USD $) In Thousands, except Share data, unless otherwise specified	0 Months Ended	12 Months Ended
	May 09, 2012	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2011	Mar. 31, 2010
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Options granted, weighted-average grant-date fair value (in USD per share)		$ 6.03	$ 5.83	$ 4.91
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Outstanding, beginning of period		1,745,400	1,621,500	1,584,200
Granted	422,962		444,900	308,200	418,600
Exercised			(786,500)	(86,900)	(33,800)
Forfeited or expired			(17,400)	(97,400)	(347,500)
Outstanding, end of period		1,386,400	1,745,400	1,621,500	1,584,200
Exercisable, end of period		254,400
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]
Outstanding, beginning of period, weighted-average exercise price (in USD per share)		$ 8.44	$ 8.19	$ 8.50
Granted, weighted-average exercise price (in USD per share)	$ 13.24		$ 13.36	$ 11.27	$ 9.26
Exercised, weighted-average exercise price (in USD per share)			$ 7.67	$ 10.24	$ 9.79
Forfeited or expired, weighted-average exercise price (in USD per share)			$ 11.21	$ 11.57	$ 10.74
Outstanding, end of period, weighted-average exercise price (in USD per share)		$ 10.43	$ 8.44	$ 8.19	$ 8.50
Exercisable, end of period, weighted-average exercise price (in USD per share)		$ 10.81
Options, Additional Disclosures:
Outstanding, end of period, weighted-average remaining contractual term		7 years 7 months 9 days
Exercisable, end of period, weighted-average remaining contractual term		6 years 6 months 20 days
Outstanding, end of period, aggregate intrinsic value		$ 10,468
Exercisable, end of period, aggregate intrinsic value		$ 1,666

Income Taxes (Narrative) (Details) (USD $)	12 Months Ended
Income Taxes (Narrative) (Details) (USD $)	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2011
Income Tax Disclosure [Abstract]
Ownership percentage	100.00%
Effective income tax rate	38.20%	39.20%	39.90%
Net operating loss carryforwards	$ 1,200,000
Operating loss carryforwards, limitation on use, annual amount	200,000
Uncertain tax liability	$ 1,016,000	$ 292,000	$ 456,000

- Definition

A ratio calculated by dividing the reported amount of income tax expense attributable to continuing operations for the period by GAAP-basis pretax income from continuing operations.

+ References+ Details

Income Taxes (Components of Provision for Income Taxes) (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended								12 Months Ended
	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2011
Current
Federal									$ 12,520	$ 8,127	$ 8,793
State									1,972	1,396	1,496
Foreign									532	630	522
Deferred
Federal									23,845	13,100	7,211
State									1,660	692	1,327
Total provision for income taxes from continuing operations	$ 11,143	$ 7,804	$ 12,252	$ 9,330	$ 815	$ 6,004	$ 8,174	$ 8,952	$ 40,529	$ 23,945	$ 19,349

- Definition

The component of income tax expense for the period representing amounts paid or payable (or refundable) as determined by applying the provisions of enacted federal tax law to the domestic taxable Income or Loss from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 6.I.7)

-URI http://asc.fasb.org/extlink&oid=6889476&loc=d3e330036-122817

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Tax Expense (or Benefit)

-URI http://asc.fasb.org/extlink&oid=6509736

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 45

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph h

-Article 4

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 289

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 6

-Section I

-Paragraph Question 1-7

+ Details

- Definition

The component of income tax expense for the period representing amounts paid or payable (or refundable) as determined by applying the provisions of foreign enacted tax law to the foreign taxable Income or Loss from continuing operations.

+ References+ Details

- Definition

The component of income tax expense for the period representing amounts paid or payable (or refundable) as determined by applying the provisions of enacted state and local tax law to relevant amounts of taxable Income or Loss from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 6.I.7)

-URI http://asc.fasb.org/extlink&oid=6889476&loc=d3e330036-122817

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Tax Expense (or Benefit)

-URI http://asc.fasb.org/extlink&oid=6509736

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 45

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph h

-Article 4

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 6

-Section I

-Subsection 7

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 289

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

- Definition

The component of total income tax expense for the period comprised of the increase (decrease) during the period in the entity's domestic deferred tax assets and liabilities attributable to continuing operations as determined by applying the provisions of the federally enacted tax law.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 6.I.7)

-URI http://asc.fasb.org/extlink&oid=6889476&loc=d3e330036-122817

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph h

-Article 4

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 6

-Section I

-Subsection 7

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Deferred Tax Expense (or Benefit)

-URI http://asc.fasb.org/extlink&oid=6510177

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 8, 16, 17, 289

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 45

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

- Definition

The component of total income tax expense for the period comprised of the increase (decrease) in the entity's state and local deferred tax assets and liabilities attributable to continuing operations as determined by applying the provisions of the applicable enacted tax laws.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 6.I.7)

-URI http://asc.fasb.org/extlink&oid=6889476&loc=d3e330036-122817

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph h

-Article 4

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 6

-Section I

-Subsection 7

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Deferred Tax Expense (or Benefit)

-URI http://asc.fasb.org/extlink&oid=6510177

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 8, 16, 17, 289

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 45

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

- Definition

The sum of the current income tax expense or benefit and the deferred income tax expense or benefit pertaining to continuing operations.

+ References+ Details

Income Taxes (Components of Deferred Tax Balances) (Details) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2013	Mar. 31, 2012
Deferred Tax Assets
Allowance for doubtful accounts and sales returns	$ 2,807	$ 1,931
Inventory capitalization	1,370	1,184
Inventory reserves	525	635
Net operating loss carryforwards	411	495
State income taxes	7,364	7,103
Accrued liabilities	1,896	1,762
Stock compensation	2,367	2,536
Other	496	1
Total deferred tax assets	17,236	15,647
Deferred Tax Liabilities
Property and equipment	(1,504)	(155)
Intangible assets	(203,671)	(177,926)
Total deferred tax liabilities	205,175	178,081
Net deferred tax liability	$ (187,939)	$ (162,434)

Income Taxes (Reconciliation of Effective Tax Rate) (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended								12 Months Ended
	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2011
Income Tax Disclosure [Abstract]
Income tax provision at statutory rate									$ 37,112	$ 21,405	$ 17,008
Income tax provision at statutory rate, percentage									35.00%	35.00%	35.00%
Foreign tax (benefit) provision									0	191	(42)
Foreign tax (benefit) provision, percentage									0.00%	0.30%	(0.10%)
State income taxes, net of federal income tax benefit									3,413	2,073	1,615
State income taxes, net of federal income tax benefit, percentage									3.20%	3.40%	3.30%
(Decrease) increase in net deferred tax liability resulting from a change in the effective state tax rate									(1,741)	(1,177)	302
(Decrease) increase in net deferred tax liability resulting from a change in the effective state tax rate, percentage									(1.60%)	(1.90%)	0.60%
Nondeductible compensation									1,684	1,305	0
Nondeductible compensation, percentage									1.60%	2.10%	0.00%
Transaction costs									0	0	367
Transaction costs, percentage									0.00%	0.00%	0.80%
Other									61	148	124
Other, percentage									0.00%	0.30%	0.30%
Total provision for income taxes									40,529	23,945	19,374
Total provision for income taxes, percentage									38.20%	39.20%	39.90%
Amount included in discontinued operations									0	0	25
Amount included in discontinued operations, percentage									0.00%	0.00%	38.20%
Total provision for income taxes from continuing operations	$ 11,143	$ 7,804	$ 12,252	$ 9,330	$ 815	$ 6,004	$ 8,174	$ 8,952	$ 40,529	$ 23,945	$ 19,349
Provision for income taxes from continuing operations, percentage									38.20%	39.20%	39.90%

Income Taxes (Uncertain Tax Liability Activity) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Balance – beginning of year	$ 292	$ 456
Additions based on tax positions related to the current year	831	45
Reductions based on lapse of statute of limitations	(107)	(209)
Balance – end of year	$ 1,016	$ 292

Commitments and Contingencies (Future Minimum Rental Payments) (Details) (USD $)	12 Months Ended				3 Months Ended	1 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2011	Mar. 31, 2013 Office Facilities	Dec. 31, 2012 New York	May 31, 2012 Arkansas	Mar. 31, 2013 Equipment
Operating Leased Assets [Line Items]
Operating lease, term					5 years 6 months	3 years
2014	$ 1,905,000			$ 1,764,000			$ 141,000
2015	1,185,000			1,049,000			136,000
2016	1,129,000			994,000			135,000
2017	1,091,000			1,023,000			68,000
2018	1,044,000			1,044,000			0
Total future minimum payments due	6,354,000			5,874,000			480,000
Operating leases, rent expense	$ 1,200,000	$ 900,000	$ 800,000

- Definition

Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.

+ References+ Details

- Definition

Amount of required minimum rental payments maturing in the fifth fiscal year following the latest fiscal year for operating leases having an initial or remaining non-cancelable letter-terms in excess of one year.

+ References+ Details

- Definition

Amount of required minimum rental payments maturing in the forth fiscal year following the latest fiscal year for operating leases having an initial or remaining non-cancelable letter-terms in excess of one year.

+ References+ Details

- Definition

Amount of required minimum rental payments maturing in the third fiscal year following the latest fiscal year for operating leases having an initial or remaining non-cancelable letter-terms in excess of one year.

+ References+ Details

- Definition

Amount of required minimum rental payments maturing in the second fiscal year following the latest fiscal year for operating leases having an initial or remaining non-cancelable letter-terms in excess of one year.

+ References+ Details

Commitments and Contingencies (Long-term Supply Agreement) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Mar. 31, 2013
Long-term Purchase Commitment [Line Items]
2014	$ 1,136
2015	1,105
2016	1,074
2017	1,044
2018	1,013
Thereafter	1,542
Total purchase commitment	$ 6,914
Third-party Manufacturing
Long-term Purchase Commitment [Line Items]
Supply agreement, term	10 years

Concentrations of Risk (Details)	12 Months Ended
Concentrations of Risk (Details)	Mar. 31, 2013 brand	Mar. 31, 2012	Mar. 31, 2011
Concentration Risk [Line Items]
Number of third-party manufacturers	66
Sales \| Product Concentration Risk
Concentration Risk [Line Items]
Concentration risk, percentage	40.50%	51.30%	63.30%
Number of highest selling brands comprising group against which concentration risk is measured	5
Sales \| Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk, percentage	15.90%	18.90%	20.30%
Number of customers exceeding concentration risk benchmark	1	1	1
Sales \| Supplier Concentration Risk
Concentration Risk [Line Items]
Concentration risk, percentage	75.30%	70.60%
Number of third-party manufacturers with long-term contracts	22	20
Accounts Receivable \| Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk, percentage	24.50%

Business Segments (Information on Operating and Reportable Segments) (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended								12 Months Ended
	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2011	Mar. 31, 2013 OTC Healthcare	Mar. 31, 2012 OTC Healthcare	Mar. 31, 2011 OTC Healthcare	Mar. 31, 2013 Household Cleaning	Mar. 31, 2012 Household Cleaning	Mar. 31, 2011 Household Cleaning	Mar. 31, 2013 Geographic Concentration Risk Sales United States	Mar. 31, 2012 Geographic Concentration Risk Sales United States	Mar. 31, 2010 Geographic Concentration Risk Sales United States	Mar. 31, 2013 Geographic Concentration Risk Sales Canada	Mar. 31, 2012 Geographic Concentration Risk Sales Canada	Mar. 31, 2010 Geographic Concentration Risk Sales Canada
Segment Reporting Information, Profit (Loss):
Net sales									$ 620,394	$ 437,838	$ 333,715	$ 536,247	$ 344,282	$ 234,042	$ 84,147	$ 93,556	$ 99,673
Other revenues									3,203	3,247	2,795	684	719	543	2,519	2,528	2,252
Total revenues	154,513	160,232	161,855	146,997	133,996	106,250	105,544	95,295	623,597	441,085	336,510	536,931	345,001	234,585	86,666	96,084	101,925
Cost of sales (exclusive of depreciation shown below)	66,443	75,235	71,310	63,393	65,508	51,128	51,638	45,427	276,381	213,701	165,632	211,654	143,151	97,710	64,727	70,550	67,922
Gross profit	88,070	84,997	90,545	83,604	68,488	55,122	53,906	49,868	347,216	227,384	170,878	325,277	201,850	136,875	21,939	25,534	34,003
Advertising and promotion	23,259	23,538	23,508	20,325	18,547	15,274	13,073	10,233	90,630	57,127	42,897	84,537	51,895	36,752	6,093	5,232	6,145
Contribution margin									256,586	170,257	127,981	240,740	149,955	100,123	15,846	20,302	27,858
Other operating expenses									64,702	67,434	51,836
Operating income	50,173	46,722	51,156	43,833	22,556	23,630	29,402	27,235	191,884	102,823	76,145
Other expenses									85,850	41,666	27,617
Provision for income taxes	11,143	7,804	12,252	9,330	815	6,004	8,174	8,952	40,529	23,945	19,349
Income from continuing operations									65,505	37,212	29,179
Loss on sale of discontinued operations, net of income tax									0	0	591
Loss on sale of discontinued operations, net of income tax									0	0	(550)
Net income	$ 19,349	$ 12,257	$ 19,244	$ 14,655	$ (15)	$ 9,510	$ 12,949	$ 14,768	$ 65,505	$ 37,212	$ 29,220
Geographic Areas, Revenues from External Customers [Abstract]
Concentration risk, percentage																		89.90%	90.20%	89.30%	7.40%	6.30%	6.50%

Business Segments (Revenue by Product) (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended								12 Months Ended
	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2011
Revenue from External Customer [Line Items]
Revenues	$ 154,513	$ 160,232	$ 161,855	$ 146,997	$ 133,996	$ 106,250	$ 105,544	$ 95,295	$ 623,597	$ 441,085	$ 336,510
OTC Healthcare
Revenue from External Customer [Line Items]
Revenues									536,931	345,001	234,585
OTC Healthcare \| Analgesics
Revenue from External Customer [Line Items]
Revenues									108,144	18,930	3,063
OTC Healthcare \| Cough & Cold
Revenue from External Customer [Line Items]
Revenues									126,974	116,669	75,013
OTC Healthcare \| Gastrointestinal
Revenue from External Customer [Line Items]
Revenues									97,940	29,489	4,067
OTC Healthcare \| Eye & Ear Care
Revenue from External Customer [Line Items]
Revenues									86,380	74,363	70,724
OTC Healthcare \| Dermatologicals
Revenue from External Customer [Line Items]
Revenues									52,401	52,592	51,398
OTC Healthcare \| Oral Care
Revenue from External Customer [Line Items]
Revenues									49,617	46,551	26,518
OTC Healthcare \| Other OTC
Revenue from External Customer [Line Items]
Revenues									15,475	6,407	3,802
Household Cleaning
Revenue from External Customer [Line Items]
Revenues									$ 86,666	$ 96,084	$ 101,925

Business Segments (Assets by Segment) (Details) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2011	Mar. 31, 2010
Segment Reporting, Asset Reconciling Item [Line Items]
Goodwill	$ 167,546	$ 173,702	$ 154,896	$ 111,489
Indefinite-lived intangibles	1,243,718
Finite-lived intangibles	129,522
Intangible assets, net (excluding goodwill)	1,373,240	1,400,522	786,361
Intangible assets, net (including goodwill)	1,540,786
OTC Healthcare
Segment Reporting, Asset Reconciling Item [Line Items]
Goodwill	160,157	166,313	147,507	104,100
Indefinite-lived intangibles	1,123,898
Finite-lived intangibles	101,611
Intangible assets, net (excluding goodwill)	1,225,509
Intangible assets, net (including goodwill)	1,385,666
Household Cleaning
Segment Reporting, Asset Reconciling Item [Line Items]
Goodwill	7,389	7,389	7,389	7,389
Indefinite-lived intangibles	119,820
Finite-lived intangibles	27,911
Intangible assets, net (excluding goodwill)	147,731
Intangible assets, net (including goodwill)	$ 155,120

- Definition

+ References

+ Details

Gain on Settlement (Details) (USD $)	0 Months Ended	3 Months Ended								12 Months Ended
Gain on Settlement (Details) (USD $)	Jun. 15, 2011	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2011
Loss Contingencies [Line Items]
Proceeds from settlement of pending litigation	$ 8,000,000
Litigation settlement, costs incurred											2,900,000
Gain on settlement		0	0	0	0	0	0	0	5,063,000	0	5,063,000	0
Gain on settlement, net of tax											3,200,000
Individual Counterparty
Loss Contingencies [Line Items]
Number of defendants	2
Other (Income) Expense
Loss Contingencies [Line Items]
Gain on settlement											$ 5,100,000

Unaudited Quarterly Financial Information (Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended								12 Months Ended
	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2011
Quarterly Financial Information Disclosure [Abstract]
Revenues	$ 154,513	$ 160,232	$ 161,855	$ 146,997	$ 133,996	$ 106,250	$ 105,544	$ 95,295	$ 623,597	$ 441,085	$ 336,510
Cost of sales (exclusive of depreciation shown below)	66,443	75,235	71,310	63,393	65,508	51,128	51,638	45,427	276,381	213,701	165,632
Gross profit	88,070	84,997	90,545	83,604	68,488	55,122	53,906	49,868	347,216	227,384	170,878
Operating Expenses
Advertising and promotion	23,259	23,538	23,508	20,325	18,547	15,274	13,073	10,233	90,630	57,127	42,897
General and administrative	11,353	11,378	12,585	16,151	24,334	13,655	8,861	9,850	51,467	56,700	41,960
Depreciation and amortization	3,285	3,359	3,296	3,295	3,051	2,563	2,570	2,550	13,235	10,734	9,876
Total operating expenses	37,897	38,275	39,389	39,771	45,932	31,492	24,504	22,633	155,332	124,561	94,733
Operating income	50,173	46,722	51,156	43,833	22,556	23,630	29,402	27,235	191,884	102,823	76,145
Net interest expense	18,238	26,661	19,660	19,848	16,347	8,116	8,279	8,578
Gain on settlement	0	0	0	0	0	0	0	(5,063)	0	(5,063)	0
Loss on extinguishment of debt	1,443	0	0	0	5,409	0	0	0	1,443	5,409	300
Income before income taxes	30,492	20,061	31,496	23,985	800	15,514	21,123	23,720	106,034	61,157	48,528
Provision for income taxes	11,143	7,804	12,252	9,330	815	6,004	8,174	8,952	40,529	23,945	19,349
Net income	19,349	12,257	19,244	14,655	(15)	9,510	12,949	14,768	65,505	37,212	29,220
Earnings per share:
Basic	$ 0.38	$ 0.24	$ 0.38	$ 0.29	$ 0.00	$ 0.19	$ 0.26	$ 0.29	$ 1.29	$ 0.74	$ 0.58
Diluted	$ 0.37	$ 0.24	$ 0.38	$ 0.29	$ 0.00	$ 0.19	$ 0.26	$ 0.29	$ 1.27	$ 0.73	$ 0.58
Weighted average shares outstanding:
Basic (in shares)	51,147	50,686	50,364	50,342	50,314	50,307	50,278	50,183	50,633	50,270	50,081
Diluted (in shares)	51,913	51,523	51,225	51,106	50,992	50,684	50,671	50,646	51,440	50,748	50,338
Comprehensive income, net of tax:
Currency translation adjustments	(114)	(1)	66	(42)	57	(18)	(42)	(10)	(91)	(13)	0
Total other comprehensive loss	(114)	(1)	66	(42)	57	(18)	(42)	(10)	(91)	(13)	0
Comprehensive income	$ 19,235	$ 12,256	$ 19,310	$ 14,613	$ 42	$ 9,492	$ 12,907	$ 14,758	$ 65,414	$ 37,199	$ 29,220

Condensed Consolidating Financial Statements (Condensed Consolidating Statements of Income and Comprehensive Income) (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended								12 Months Ended
	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2011
Revenues
Net sales									$ 620,394	$ 437,838	$ 333,715
Other revenues									3,203	3,247	2,795
Total revenues	154,513	160,232	161,855	146,997	133,996	106,250	105,544	95,295	623,597	441,085	336,510
Cost of Sales
Cost of sales (exclusive of depreciation shown below)	66,443	75,235	71,310	63,393	65,508	51,128	51,638	45,427	276,381	213,701	165,632
Gross profit	88,070	84,997	90,545	83,604	68,488	55,122	53,906	49,868	347,216	227,384	170,878
Operating Expenses
Advertising and promotion	23,259	23,538	23,508	20,325	18,547	15,274	13,073	10,233	90,630	57,127	42,897
General and administrative	11,353	11,378	12,585	16,151	24,334	13,655	8,861	9,850	51,467	56,700	41,960
Depreciation and amortization	3,285	3,359	3,296	3,295	3,051	2,563	2,570	2,550	13,235	10,734	9,876
Total operating expenses	37,897	38,275	39,389	39,771	45,932	31,492	24,504	22,633	155,332	124,561	94,733
Operating income	50,173	46,722	51,156	43,833	22,556	23,630	29,402	27,235	191,884	102,823	76,145
Other (income) expense
Interest income									(13)	(18)	(1)
Interest expense									84,420	41,338	27,318
Gain on settlement	0	0	0	0	0	0	0	(5,063)	0	(5,063)	0
Loss on extinguishment of debt	1,443	0	0	0	5,409	0	0	0	1,443	5,409	300
Equity in income of subsidiaries									0	0	0
Total other expense									(85,850)	(41,666)	(27,617)
Income before income taxes	30,492	20,061	31,496	23,985	800	15,514	21,123	23,720	106,034	61,157	48,528
Provision (benefit) for income taxes	11,143	7,804	12,252	9,330	815	6,004	8,174	8,952	40,529	23,945	19,349
Income from continuing operations									65,505	37,212	29,179
Income (loss) from discontinued operations, net of income tax/(benefit)									0	0	591
Gain/(loss) on sale of discontinued operations, net of income tax/(benefit)									0	0	(550)
Net income	19,349	12,257	19,244	14,655	(15)	9,510	12,949	14,768	65,505	37,212	29,220
Comprehensive income, net of tax:
Currency translation adjustments									(91)	(13)	0
Total other comprehensive loss	(114)	(1)	66	(42)	57	(18)	(42)	(10)	(91)	(13)	0
Comprehensive income	19,235	12,256	19,310	14,613	42	9,492	12,907	14,758	65,414	37,199	29,220
Prestige Brands Holdings, Inc.
Revenues
Net sales									0	0	0
Other revenues									0	0	0
Total revenues									0	0	0
Cost of Sales
Cost of sales (exclusive of depreciation shown below)									0	0	0
Gross profit									0	0	0
Operating Expenses
Advertising and promotion									0	0	0
General and administrative									5,127	17,181	4,003
Depreciation and amortization									1,346	538	486
Total operating expenses									6,473	17,719	4,489
Operating income									(6,473)	(17,719)	(4,489)
Other (income) expense
Interest income									(30,561)	(50,357)	(51,909)
Interest expense									34,671	35,004	35,149
Gain on settlement										(5,063)
Loss on extinguishment of debt									0	0	0
Equity in income of subsidiaries									(72,295)	(35,571)	(21,842)
Total other expense									68,185	55,987	38,602
Income before income taxes									61,712	38,268	34,113
Provision (benefit) for income taxes									(3,793)	1,056	4,893
Income from continuing operations											29,220
Income (loss) from discontinued operations, net of income tax/(benefit)											0
Gain/(loss) on sale of discontinued operations, net of income tax/(benefit)											0
Net income									65,505	37,212	29,220
Comprehensive income, net of tax:
Currency translation adjustments									(91)	(13)	0
Total other comprehensive loss									(91)	(13)	0
Comprehensive income									65,414	37,199	29,220
Prestige Brands, Inc., the issuer
Revenues
Net sales									102,706	100,542	98,988
Other revenues									278	229	207
Total revenues									102,984	100,771	99,195
Cost of Sales
Cost of sales (exclusive of depreciation shown below)									39,333	36,658	37,268
Gross profit									63,651	64,113	61,927
Operating Expenses
Advertising and promotion									12,605	11,918	11,642
General and administrative									6,917	10,059	10,883
Depreciation and amortization									569	570	577
Total operating expenses									20,091	22,547	23,102
Operating income									43,560	41,566	38,825
Other (income) expense
Interest income									(57,496)	(44,269)	(44,453)
Interest expense									84,420	76,341	62,467
Gain on settlement										0
Loss on extinguishment of debt									1,443	5,409	300
Equity in income of subsidiaries									(65,784)	(37,192)	(8,912)
Total other expense									37,417	(289)	(9,402)
Income before income taxes									80,977	41,277	29,423
Provision (benefit) for income taxes									5,807	1,599	8,177
Income from continuing operations											21,246
Income (loss) from discontinued operations, net of income tax/(benefit)											0
Gain/(loss) on sale of discontinued operations, net of income tax/(benefit)											0
Net income									75,170	39,678	21,246
Comprehensive income, net of tax:
Currency translation adjustments									0	0	0
Total other comprehensive loss									0	0	0
Comprehensive income									75,170	39,678	21,246
Combined Subsidiary Guarantors
Revenues
Net sales									513,017	333,407	230,986
Other revenues									3,158	3,212	2,775
Total revenues									516,175	336,619	233,761
Cost of Sales
Cost of sales (exclusive of depreciation shown below)									236,795	177,112	128,527
Gross profit									279,380	159,507	105,234
Operating Expenses
Advertising and promotion									76,599	43,906	29,762
General and administrative									38,713	28,698	27,190
Depreciation and amortization									11,261	9,556	8,745
Total operating expenses									126,573	82,160	65,697
Operating income									152,807	77,347	39,537
Other (income) expense
Interest income									0	0	0
Interest expense									53,374	24,822	26,248
Gain on settlement										0
Loss on extinguishment of debt									0	0	0
Equity in income of subsidiaries									(1,482)	(1,313)	(1,928)
Total other expense									(51,892)	(23,509)	(24,320)
Income before income taxes									100,915	53,838	15,217
Provision (benefit) for income taxes									38,006	20,565	5,299
Income from continuing operations											9,918
Income (loss) from discontinued operations, net of income tax/(benefit)											591
Gain/(loss) on sale of discontinued operations, net of income tax/(benefit)											(550)
Net income									62,909	33,273	9,959
Comprehensive income, net of tax:
Currency translation adjustments									0	0	0
Total other comprehensive loss									0	0	0
Comprehensive income									62,909	33,273	9,959
Combined Non-Guarantor Subsidiaries
Revenues
Net sales									4,671	3,889	3,741
Other revenues									1,517	1,475	1,479
Total revenues									6,188	5,364	5,220
Cost of Sales
Cost of sales (exclusive of depreciation shown below)									2,003	1,600	1,503
Gross profit									4,185	3,764	3,717
Operating Expenses
Advertising and promotion									1,426	1,303	1,493
General and administrative									710	762	(116)
Depreciation and amortization									59	70	68
Total operating expenses									2,195	2,135	1,445
Operating income									1,990	1,629	2,272
Other (income) expense
Interest income									(1)	(221)	(189)
Interest expense									0	0	4
Gain on settlement										0
Loss on extinguishment of debt									0	0	0
Equity in income of subsidiaries									0	0	0
Total other expense									1	221	185
Income before income taxes									1,991	1,850	2,457
Provision (benefit) for income taxes									509	725	980
Income from continuing operations											1,477
Income (loss) from discontinued operations, net of income tax/(benefit)											0
Gain/(loss) on sale of discontinued operations, net of income tax/(benefit)											0
Net income									1,482	1,125	1,477
Comprehensive income, net of tax:
Currency translation adjustments									(91)	13	0
Total other comprehensive loss									(91)	13	0
Comprehensive income									1,391	1,138	1,477
Eliminations
Revenues
Net sales									0	0	0
Other revenues									(1,750)	(1,669)	(1,666)
Total revenues									(1,750)	(1,669)	(1,666)
Cost of Sales
Cost of sales (exclusive of depreciation shown below)									(1,750)	(1,669)	(1,666)
Gross profit									0	0	0
Operating Expenses
Advertising and promotion									0	0	0
General and administrative									0	0	0
Depreciation and amortization									0	0	0
Total operating expenses									0	0	0
Operating income									0	0	0
Other (income) expense
Interest income									88,045	94,829	96,550
Interest expense									(88,045)	(94,829)	(96,550)
Gain on settlement										0
Loss on extinguishment of debt									0	0	0
Equity in income of subsidiaries									139,561	74,076	32,682
Total other expense									(139,561)	(74,076)	(32,682)
Income before income taxes									(139,561)	(74,076)	(32,682)
Provision (benefit) for income taxes									0	0	0
Income from continuing operations											(32,682)
Income (loss) from discontinued operations, net of income tax/(benefit)											0
Gain/(loss) on sale of discontinued operations, net of income tax/(benefit)											0
Net income									(139,561)	(74,076)	(32,682)
Comprehensive income, net of tax:
Currency translation adjustments									91	(13)	0
Total other comprehensive loss									91	(13)	0
Comprehensive income									$ (139,470)	$ (74,089)	$ (32,682)

Condensed Consolidating Financial Statements (Condensed Consolidating Balance Sheet) (Details) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2011	Mar. 31, 2010
Condensed Financial Statements, Captions [Line Items]
Ownership percentage	100.00%
Current assets
Cash and cash equivalents	$ 15,670	$ 19,015	$ 13,334	$ 41,097
Accounts receivable, net	73,053	60,228
Inventories	60,201	51,113
Deferred income tax assets	6,349	5,283
Prepaid expenses and other current assets	8,900	11,396
Total current assets	164,173	147,035
Property and equipment, net	9,896	1,304
Goodwill	167,546	173,702	154,896	111,489
Intangible assets, net	1,373,240	1,400,522	786,361
Other long-term assets	24,944	35,713
Intercompany receivable	0	0
Investment in subsidiary	0	0
Total Assets	1,739,799	1,758,276
Current liabilities
Accounts payable	51,376	26,726
Accrued interest payable	13,894	13,889
Other accrued liabilities	31,398	23,308
Total current liabilities	96,668	63,923
Long-term debt
Principal amount	978,000	1,135,000
Less unamortized discount	(7,100)	(11,092)
Long-term debt, net of unamortized discount	970,900	1,123,908
Deferred income tax liabilities	194,288	167,717
Intercompany payable	0	0
Total Liabilities	1,261,856	1,355,548
Stockholders' Equity
Preferred share rights	283	283
Common Stock	513	505
Additional paid-in capital	401,691	391,898
Treasury stock, at cost – 181 shares	(687)	(687)
Accumulated other comprehensive loss, net of tax	(104)	(13)
Retained earnings	76,247	10,742
Total Stockholders’ Equity	477,943	402,728	361,832	329,059
Total Liabilities and Stockholders’ Equity	1,739,799	1,758,276
Prestige Brands Holdings, Inc.
Current assets
Cash and cash equivalents	14,720	18,221	12,698	40,644
Accounts receivable, net	21	25
Inventories	0	0
Deferred income tax assets	218	356
Prepaid expenses and other current assets	4,942	8,102
Total current assets	19,901	26,704
Property and equipment, net	9,609	934
Goodwill	0	0
Intangible assets, net	0	0
Other long-term assets	0	0
Intercompany receivable	653,049	683,358
Investment in subsidiary	1,429,775	1,354,829
Total Assets	2,112,334	2,065,825
Current liabilities
Accounts payable	2,601	4,531
Accrued interest payable	0	0
Other accrued liabilities	12,694	11,758
Total current liabilities	15,295	16,289
Long-term debt
Principal amount	0	0
Less unamortized discount	0	0
Long-term debt, net of unamortized discount	0	0
Deferred income tax liabilities	0	0
Intercompany payable	1,619,096	1,646,808
Total Liabilities	1,634,391	1,663,097
Stockholders' Equity
Preferred share rights	283	283
Common Stock	513	505
Additional paid-in capital	401,691	391,898
Treasury stock, at cost – 181 shares	(687)	(687)
Accumulated other comprehensive loss, net of tax	(104)	(13)
Retained earnings	76,247	10,742
Total Stockholders’ Equity	477,943	402,728
Total Liabilities and Stockholders’ Equity	2,112,334	2,065,825
Prestige Brands, Inc., the issuer
Condensed Financial Statements, Captions [Line Items]
Ownership percentage	100.00%
Current assets
Cash and cash equivalents	0	0	0	0
Accounts receivable, net	13,875	13,502
Inventories	11,164	8,098
Deferred income tax assets	855	849
Prepaid expenses and other current assets	93	56
Total current assets	25,987	22,505
Property and equipment, net	34	22
Goodwill	66,007	66,007
Intangible assets, net	193,396	193,932
Other long-term assets	24,944	35,713
Intercompany receivable	1,911,573	1,449,005
Investment in subsidiary	638,611	1,172,601
Total Assets	2,860,552	2,939,785
Current liabilities
Accounts payable	10,600	4,816
Accrued interest payable	13,894	13,889
Other accrued liabilities	1,684	1,687
Total current liabilities	26,178	20,392
Long-term debt
Principal amount	978,000	1,135,000
Less unamortized discount	(7,100)	(11,092)
Long-term debt, net of unamortized discount	970,900	1,123,908
Deferred income tax liabilities	55,291	50,944
Intercompany payable	447,419	458,993
Total Liabilities	1,499,788	1,654,237
Stockholders' Equity
Preferred share rights	0	0
Common Stock	0	0
Additional paid-in capital	1,280,945	1,280,719
Treasury stock, at cost – 181 shares	0	0
Accumulated other comprehensive loss, net of tax	0	0
Retained earnings	79,819	4,829
Total Stockholders’ Equity	1,360,764	1,285,548
Total Liabilities and Stockholders’ Equity	2,860,552	2,939,785
Combined Subsidiary Guarantors
Condensed Financial Statements, Captions [Line Items]
Ownership percentage	100.00%
Current assets
Cash and cash equivalents	0	0	0	0
Accounts receivable, net	58,345	45,954
Inventories	48,474	42,334
Deferred income tax assets	5,276	4,078
Prepaid expenses and other current assets	3,609	2,874
Total current assets	115,704	95,240
Property and equipment, net	253	346
Goodwill	101,539	107,695
Intangible assets, net	1,179,524	1,206,213
Other long-term assets	0	0
Intercompany receivable	415,587	312,581
Investment in subsidiary	7,067	5,583
Total Assets	1,819,674	1,727,658
Current liabilities
Accounts payable	37,695	17,008
Accrued interest payable	0	0
Other accrued liabilities	16,107	8,944
Total current liabilities	53,802	25,952
Long-term debt
Principal amount	0	0
Less unamortized discount	0	0
Long-term debt, net of unamortized discount	0	0
Deferred income tax liabilities	138,924	116,690
Intercompany payable	920,865	344,766
Total Liabilities	1,113,591	487,408
Stockholders' Equity
Preferred share rights	0	0
Common Stock	0	0
Additional paid-in capital	624,742	1,239,497
Treasury stock, at cost – 181 shares	0	0
Accumulated other comprehensive loss, net of tax	0	0
Retained earnings	81,341	753
Total Stockholders’ Equity	706,083	1,240,250
Total Liabilities and Stockholders’ Equity	1,819,674	1,727,658
Combined Non-Guarantor Subsidiaries
Current assets
Cash and cash equivalents	950	794	636	453
Accounts receivable, net	812	747
Inventories	563	681
Deferred income tax assets	0	0
Prepaid expenses and other current assets	256	364
Total current assets	2,581	2,586
Property and equipment, net	0	2
Goodwill	0	0
Intangible assets, net	320	377
Other long-term assets	0	0
Intercompany receivable	7,316	5,935
Investment in subsidiary	0	0
Total Assets	10,217	8,900
Current liabilities
Accounts payable	480	371
Accrued interest payable	0	0
Other accrued liabilities	913	919
Total current liabilities	1,393	1,290
Long-term debt
Principal amount	0	0
Less unamortized discount	0	0
Long-term debt, net of unamortized discount	0	0
Deferred income tax liabilities	73	83
Intercompany payable	145	312
Total Liabilities	1,611	1,685
Stockholders' Equity
Preferred share rights	0	0
Common Stock	0	0
Additional paid-in capital	1,111	1,111
Treasury stock, at cost – 181 shares	0	0
Accumulated other comprehensive loss, net of tax	(104)	(13)
Retained earnings	7,599	6,117
Total Stockholders’ Equity	8,606	7,215
Total Liabilities and Stockholders’ Equity	10,217	8,900
Eliminations
Current assets
Cash and cash equivalents	0	0	0	0
Accounts receivable, net	0	0
Inventories	0	0
Deferred income tax assets	0	0
Prepaid expenses and other current assets	0	0
Total current assets	0	0
Property and equipment, net	0	0
Goodwill	0	0
Intangible assets, net	0	0
Other long-term assets	0	0
Intercompany receivable	(2,987,525)	(2,450,879)
Investment in subsidiary	(2,075,453)	(2,533,013)
Total Assets	(5,062,978)	(4,983,892)
Current liabilities
Accounts payable	0	0
Accrued interest payable	0	0
Other accrued liabilities	0	0
Total current liabilities	0	0
Long-term debt
Principal amount	0	0
Less unamortized discount	0	0
Long-term debt, net of unamortized discount	0	0
Deferred income tax liabilities	0	0
Intercompany payable	(2,987,525)	(2,450,879)
Total Liabilities	(2,987,525)	(2,450,879)
Stockholders' Equity
Preferred share rights	0	0
Common Stock	0	0
Additional paid-in capital	(1,906,798)	(2,521,327)
Treasury stock, at cost – 181 shares	0	0
Accumulated other comprehensive loss, net of tax	104	13
Retained earnings	(168,759)	(11,699)
Total Stockholders’ Equity	(2,075,453)	(2,533,013)
Total Liabilities and Stockholders’ Equity	$ (5,062,978)	$ (4,983,892)

Condensed Consolidating Financial Statements (Condensed Consolidating Statement of Cash Flows) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2011	Mar. 31, 2013 Prestige Brands Holdings, Inc.	Mar. 31, 2012 Prestige Brands Holdings, Inc.	Mar. 31, 2011 Prestige Brands Holdings, Inc.	Mar. 31, 2013 Prestige Brands, Inc., the issuer	Mar. 31, 2012 Prestige Brands, Inc., the issuer	Mar. 31, 2011 Prestige Brands, Inc., the issuer	Mar. 31, 2013 Combined Subsidiary Guarantors	Mar. 31, 2012 Combined Subsidiary Guarantors	Mar. 31, 2011 Combined Subsidiary Guarantors	Mar. 31, 2013 Combined Non-Guarantor Subsidiaries	Mar. 31, 2012 Combined Non-Guarantor Subsidiaries	Mar. 31, 2011 Combined Non-Guarantor Subsidiaries	Mar. 31, 2013 Eliminations	Mar. 31, 2012 Eliminations	Mar. 31, 2011 Eliminations	Mar. 31, 2013 Blacksmith	Mar. 31, 2012 Blacksmith	Mar. 31, 2011 Blacksmith	Mar. 31, 2011 Blacksmith Prestige Brands Holdings, Inc.	Mar. 31, 2011 Blacksmith Prestige Brands, Inc., the issuer	Mar. 31, 2011 Blacksmith Combined Subsidiary Guarantors	Mar. 31, 2011 Blacksmith Combined Non-Guarantor Subsidiaries	Mar. 31, 2011 Blacksmith Eliminations	Mar. 31, 2013 Dramamine	Mar. 31, 2012 Dramamine	Mar. 31, 2011 Dramamine	Mar. 31, 2011 Dramamine Prestige Brands Holdings, Inc.	Mar. 31, 2011 Dramamine Prestige Brands, Inc., the issuer	Mar. 31, 2011 Dramamine Combined Subsidiary Guarantors	Mar. 31, 2011 Dramamine Combined Non-Guarantor Subsidiaries	Mar. 31, 2011 Dramamine Eliminations
Operating Activities
Net income	$ 65,505	$ 37,212	$ 29,220	$ 65,505	$ 37,212	$ 29,220	$ 75,170	$ 39,678	$ 21,246	$ 62,909	$ 33,273	$ 9,959	$ 1,482	$ 1,125	$ 1,477	$ (139,561)	$ (74,076)	$ (32,682)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	13,235	10,734	10,108	1,346	538	486	569	570	577	11,261	9,556	8,973	59	70	72	0	0	0
Loss on sale of discontinued operations	0	0	890			0			0			890			0			0
Deferred income taxes	25,505	13,793	9,324	138	290	1,668	4,341	3,514	1,851	21,036	10,000	5,806	(10)	(11)	(1)	0	0	0
Amortization of deferred financing costs	9,832	1,630	1,043	0	0	0	9,832	1,630	1,043	0	0	0	0	0	0	0	0	0
Stock-based compensation costs	3,772	3,078	3,575	3,772	3,078	3,575	0	0	0	0	0	0	0	0	0	0	0	0
Loss on extinguishment of debt	1,443	5,409	300	0	0	0	1,443	5,409	300	0	0	0	0	0	0	0	0	0
Amortization of debt discount	4,632	1,030	702	0	0	0	4,632	1,030	702	0	0	0	0	0	0	0	0	0
Lease termination costs	975	0	0	975			0			0			0			0
Loss on disposal of equipment	103	0	153	82		27	0		0	21		126	0		0	0		0
Equity in income of subsidiaries	0	0	0	(72,295)	(35,571)	(21,842)	(65,784)	(37,192)	(8,912)	(1,482)	(1,313)	(1,928)	0	0	0	139,561	74,076	32,682
Changes in operating assets and liabilities, net of effects from acquisitions
Accounts receivable	(12,882)	(15,854)	4,918	4	(12)	1,041	(373)	(3,412)	(1,949)	(12,391)	(12,367)	5,852	(122)	(63)	(26)	0	0	0
Inventories	(9,342)	3,710	12,443	0	0	0	(3,066)	1,459	1,852	(6,360)	2,252	10,648	84	(1)	(57)	0	0	0
Prepaid expenses and other current assets	3,096	(3,009)	154	3,160	(3,598)	(63)	(37)	(20)	92	(135)	968	97	108	(359)	28	0	0	0
Accounts payable	24,677	5,127	1,784	(1,930)	2,611	(605)	5,784	(1,598)	2,538	20,687	4,139	(212)	136	(25)	63	0	0	0
Accrued liabilities	7,054	4,592	12,056	(39)	417	4,113	2	2,984	9,776	7,069	856	(2,117)	22	335	284	0	0	0
Intercompany activity, net		0			0			0			0			0			0
Net cash provided by operating activities	137,605	67,452	86,670	718	4,965	17,620	32,513	14,052	29,116	102,615	47,364	38,094	1,759	1,071	1,840	0	0	0
Investing Activities
Purchases of property and equipment	(10,268)	(606)	(655)	(10,268)	(367)	(595)	0	0	0	0	(239)	(56)	0	0	(4)	0	0	0
Proceeds from escrow of Blacksmith acquisition	0	1,200	0		0			0			1,200			0			0
Proceeds from the sale of property and equipment	15	0	12	0		12	0		0	15		0	0		0	0		0
Proceeds from sale of brands	21,700		4,122	0		0	0		0	21,700		4,122	0		0	0		0
Acquisition of brands from GSK purchase price adjustments	(226)	0	0	0			0			(226)			0			0
Acquisition of brands		(662,800)			0			0			(662,800)			0			0		0	0	(202,044)	0	0	(202,044)	0	0	0	0	(77,115)	0	0	(77,115)	0	0
Intercompany activity, net	0	0	0	(226)	1,200	0	0	(662,800)	202,044	226	661,600	(202,044)	0	0	0	0	0	0
Net cash provided by (used in) investing activities	11,221	(662,206)	(275,680)	(10,494)	833	(583)	0	(662,800)	(202,044)	21,715	(239)	(73,049)	0	0	(4)	0	0	0
Financing Activities
Proceeds from issuance of Senior Notes	0	250,000	100,250		0	0		250,000	100,250		0	0		0	0		0	0
Repayment of 2010 Term Loan	0	(242,000)	0		0			(242,000)			0			0			0
Proceeds from issuance of 2012 Term Loan and 2010 Term Loan	0	650,100	112,936		0	0		650,100	112,936		0	0		0	0		0	0
Payment of deferred financing costs	(1,146)	(33,284)	(830)	0	0	0	(1,146)	(33,284)	(830)	0	0	0	0	0	0	0	0	0
Issuance of intercompany loan	0						0			0			0			0
Repayment of long-term debt	(190,000)	(25,000)	(51,087)	0	0	0	(190,000)	(25,000)	(51,087)	0	0	0	0	0	0	0	0	0
Repayments under revolving credit agreement	(15,000)	0	0	0			(15,000)			0			0			0
Borrowings under revolving credit agreement	48,000	0	0	0			48,000			0			0			0
Proceeds from exercise of stock options	6,029	889	331	6,029	889	331	0	0	0	0	0	0	0	0	0	0	0	0
Shares surrendered as payment of tax withholding	0	(271)	(353)		(271)	(353)		0	0		0	0		0	0		0	0
Intercompany activity, net	0	0	0	246	(893)	(44,961)	125,633	48,932	11,659	(124,330)	(47,125)	34,955	(1,549)	(914)	(1,653)	0	0	0
Net cash (used in) provided by financing activities	(152,117)	600,434	161,247	6,275	(275)	(44,983)	(32,513)	648,748	172,928	(124,330)	(47,125)	34,955	(1,549)	(914)	(1,653)	0	0	0
Effects of exchange rate changes on cash and cash equivalents	(54)	1	0	0	0		0	0		0	0		(54)	1		0	0
(Decrease) increase in cash and cash equivalents	(3,345)	5,681	(27,763)	(3,501)	5,523	(27,946)	0	0	0	0	0	0	156	158	183	0	0	0
Cash - beginning of year	19,015	13,334	41,097	18,221	12,698	40,644	0	0	0	0	0	0	794	636	453	0	0	0
Cash - end of year	$ 15,670	$ 19,015	$ 13,334	$ 14,720	$ 18,221	$ 12,698	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 950	$ 794	$ 636	$ 0	$ 0	$ 0

Condensed Consolidating Financial Statements (Revisions) (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended								12 Months Ended
	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2011	Mar. 31, 2010
Income Statement [Abstract]
Revenue	$ 154,513	$ 160,232	$ 161,855	$ 146,997	$ 133,996	$ 106,250	$ 105,544	$ 95,295	$ 623,597	$ 441,085	$ 336,510
Income from continuing operations before income taxes	30,492	20,061	31,496	23,985	800	15,514	21,123	23,720	106,034	61,157	48,528
Provision (benefit) for income taxes	11,143	7,804	12,252	9,330	815	6,004	8,174	8,952	40,529	23,945	19,349
Net income	19,349	12,257	19,244	14,655	(15)	9,510	12,949	14,768	65,505	37,212	29,220
Statement of Financial Position [Abstract]
Total current assets	164,173				147,035				164,173	147,035
Total Assets	1,739,799				1,758,276				1,739,799	1,758,276
Total current liabilities	96,668				63,923				96,668	63,923
Total Liabilities	1,261,856				1,355,548				1,261,856	1,355,548
Total Stockholders’ Equity	477,943				402,728				477,943	402,728	361,832	329,059
Statement of Cash Flows [Abstract]
Net cash provided by (used in) operating activities									137,605	67,452	86,670
Net cash provided by (used in) investing activities									11,221	(662,206)	(275,680)
Net cash provided by (used in) financing activities									(152,117)	600,434	161,247
Prestige Brands Holdings, Inc.
Income Statement [Abstract]
Revenue									0	0	0
Income from continuing operations before income taxes									61,712	38,268	34,113
Provision (benefit) for income taxes									(3,793)	1,056	4,893
Net income									65,505	37,212	29,220
Statement of Financial Position [Abstract]
Total current assets	19,901				26,704				19,901	26,704
Total Assets	2,112,334				2,065,825				2,112,334	2,065,825
Total current liabilities	15,295				16,289				15,295	16,289
Total Liabilities	1,634,391				1,663,097				1,634,391	1,663,097
Total Stockholders’ Equity	477,943				402,728				477,943	402,728
Statement of Cash Flows [Abstract]
Net cash provided by (used in) operating activities									718	4,965	17,620
Net cash provided by (used in) investing activities									(10,494)	833	(583)
Net cash provided by (used in) financing activities									6,275	(275)	(44,983)
Prestige Brands Holdings, Inc. \| Reported
Income Statement [Abstract]
Revenue										0	0
Income from continuing operations before income taxes										38,995	49,846
Provision (benefit) for income taxes										1,783	20,626
Net income										37,212	29,220
Statement of Financial Position [Abstract]
Total current assets					26,704					26,704
Total Assets					2,200,652					2,200,652
Total current liabilities					16,779					16,779
Total Liabilities					1,797,927					1,797,927
Total Stockholders’ Equity					402,725					402,725
Statement of Cash Flows [Abstract]
Net cash provided by (used in) operating activities										60,323	36,726
Net cash provided by (used in) investing activities										833	(803)
Net cash provided by (used in) financing activities										(55,633)	(63,869)
Prestige Brands Holdings, Inc. \| Revised
Income Statement [Abstract]
Revenue										0	0
Income from continuing operations before income taxes										38,268	34,113
Provision (benefit) for income taxes				600						1,056	4,893
Net income										37,212	29,220
Statement of Financial Position [Abstract]
Total current assets					26,704					26,704
Total Assets					2,065,825					2,065,825
Total current liabilities					16,289					16,289
Total Liabilities					1,663,097					1,663,097
Total Stockholders’ Equity					402,728					402,728
Statement of Cash Flows [Abstract]
Net cash provided by (used in) operating activities										4,965	17,620
Net cash provided by (used in) investing activities										833	(583)
Net cash provided by (used in) financing activities										(275)	(44,983)
Prestige Brands Holdings, Inc. \| Adjustment
Income Statement [Abstract]
Provision (benefit) for income taxes				4,300
Prestige Brands, Inc., the issuer
Income Statement [Abstract]
Revenue									102,984	100,771	99,195
Income from continuing operations before income taxes									80,977	41,277	29,423
Provision (benefit) for income taxes									5,807	1,599	8,177
Net income									75,170	39,678	21,246
Statement of Financial Position [Abstract]
Total current assets	25,987				22,505				25,987	22,505
Total Assets	2,860,552				2,939,785				2,860,552	2,939,785
Total current liabilities	26,178				20,392				26,178	20,392
Total Liabilities	1,499,788				1,654,237				1,499,788	1,654,237
Total Stockholders’ Equity	1,360,764				1,285,548				1,360,764	1,285,548
Statement of Cash Flows [Abstract]
Net cash provided by (used in) operating activities									32,513	14,052	29,116
Net cash provided by (used in) investing activities									0	(662,800)	(202,044)
Net cash provided by (used in) financing activities									(32,513)	648,748	172,928
Prestige Brands, Inc., the issuer \| Reported
Income Statement [Abstract]
Revenue										341,307	230,844
Income from continuing operations before income taxes										76,595	(6,252)
Provision (benefit) for income taxes										23,643	(2,081)
Net income										52,952	(4,143)
Statement of Financial Position [Abstract]
Total current assets					98,887					98,887
Total Assets					3,236,598					3,236,598
Total current liabilities					49,246					49,246
Total Liabilities					2,982,492					2,982,492
Total Stockholders’ Equity					254,106					254,106
Statement of Cash Flows [Abstract]
Net cash provided by (used in) operating activities										51,023	42,853
Net cash provided by (used in) investing activities										(239)	(274,873)
Net cash provided by (used in) financing activities										(50,784)	232,020
Prestige Brands, Inc., the issuer \| Revised
Income Statement [Abstract]
Revenue										100,771	99,195
Income from continuing operations before income taxes										41,277	29,423
Provision (benefit) for income taxes				(3,000)						1,599	8,177
Net income										39,678	21,246
Statement of Financial Position [Abstract]
Total current assets					22,505					22,505
Total Assets					2,939,785					2,939,785
Total current liabilities					20,392					20,392
Total Liabilities					1,654,237					1,654,237
Total Stockholders’ Equity					1,285,548					1,285,548
Statement of Cash Flows [Abstract]
Net cash provided by (used in) operating activities										14,052	29,116
Net cash provided by (used in) investing activities										(662,800)	(202,044)
Net cash provided by (used in) financing activities										648,748	172,928
Prestige Brands, Inc., the issuer \| Adjustment
Income Statement [Abstract]
Provision (benefit) for income taxes				(4,400)
Combined Subsidiary Guarantors
Income Statement [Abstract]
Revenue									516,175	336,619	233,761
Income from continuing operations before income taxes									100,915	53,838	15,217
Provision (benefit) for income taxes									38,006	20,565	5,299
Net income									62,909	33,273	9,959
Statement of Financial Position [Abstract]
Total current assets	115,704				95,240				115,704	95,240
Total Assets	1,819,674				1,727,658				1,819,674	1,727,658
Total current liabilities	53,802				25,952				53,802	25,952
Total Liabilities	1,113,591				487,408				1,113,591	487,408
Total Stockholders’ Equity	706,083				1,240,250				706,083	1,240,250
Statement of Cash Flows [Abstract]
Net cash provided by (used in) operating activities									102,615	47,364	38,094
Net cash provided by (used in) investing activities									21,715	(239)	(73,049)
Net cash provided by (used in) financing activities									(124,330)	(47,125)	34,955
Combined Subsidiary Guarantors \| Reported
Income Statement [Abstract]
Revenue										96,082	101,925
Income from continuing operations before income taxes										(4,905)	602
Provision (benefit) for income taxes										(2,018)	274
Net income										(2,887)	341
Statement of Financial Position [Abstract]
Total current assets					19,222					19,222
Total Assets					267,407					267,407
Total current liabilities					(3,446)					(3,446)
Total Liabilities					196,430					196,430
Total Stockholders’ Equity					70,977					70,977
Statement of Cash Flows [Abstract]
Net cash provided by (used in) operating activities										(2,125)	3,190
Net cash provided by (used in) investing activities										0	0
Net cash provided by (used in) financing activities										2,125	(3,190)
Combined Subsidiary Guarantors \| Revised
Income Statement [Abstract]
Revenue										336,619	233,761
Income from continuing operations before income taxes										53,838	15,217
Provision (benefit) for income taxes										20,565	5,299
Net income										33,273	9,918
Statement of Financial Position [Abstract]
Total current assets					95,240					95,240
Total Assets					1,727,658					1,727,658
Total current liabilities					25,952					25,952
Total Liabilities					487,408					487,408
Total Stockholders’ Equity					1,240,250					1,240,250
Statement of Cash Flows [Abstract]
Net cash provided by (used in) operating activities										47,364	38,094
Net cash provided by (used in) investing activities										(239)	(73,049)
Net cash provided by (used in) financing activities										(47,125)	34,955
Combined Non-Guarantor Subsidiaries
Income Statement [Abstract]
Revenue									6,188	5,364	5,220
Income from continuing operations before income taxes									1,991	1,850	2,457
Provision (benefit) for income taxes									509	725	980
Net income									1,482	1,125	1,477
Statement of Financial Position [Abstract]
Total current assets	2,581				2,586				2,581	2,586
Total Assets	10,217				8,900				10,217	8,900
Total current liabilities	1,393				1,290				1,393	1,290
Total Liabilities	1,611				1,685				1,611	1,685
Total Stockholders’ Equity	8,606				7,215				8,606	7,215
Statement of Cash Flows [Abstract]
Net cash provided by (used in) operating activities									1,759	1,071	1,840
Net cash provided by (used in) investing activities									0	0	(4)
Net cash provided by (used in) financing activities									(1,549)	(914)	(1,653)
Combined Non-Guarantor Subsidiaries \| Reported
Income Statement [Abstract]
Revenue										5,365	5,407
Income from continuing operations before income taxes										1,656	2,457
Provision (benefit) for income taxes										537	530
Net income										1,119	1,927
Statement of Financial Position [Abstract]
Total current assets					2,222					2,222
Total Assets					10,402					10,402
Total current liabilities					1,344					1,344
Total Liabilities					2,116					2,116
Total Stockholders’ Equity					8,286					8,286
Statement of Cash Flows [Abstract]
Net cash provided by (used in) operating activities										(230)	2,026
Net cash provided by (used in) investing activities										0	(4)
Net cash provided by (used in) financing activities										387	(1,839)
Combined Non-Guarantor Subsidiaries \| Revised
Income Statement [Abstract]
Revenue										5,364	5,220
Income from continuing operations before income taxes										1,850	2,457
Provision (benefit) for income taxes										725	980
Net income										1,125	1,477
Statement of Financial Position [Abstract]
Total current assets					2,586					2,586
Total Assets					8,900					8,900
Total current liabilities					1,290					1,290
Total Liabilities					1,685					1,685
Total Stockholders’ Equity					7,215					7,215
Statement of Cash Flows [Abstract]
Net cash provided by (used in) operating activities										1,071	1,840
Net cash provided by (used in) investing activities										0	(4)
Net cash provided by (used in) financing activities										(914)	(1,653)
Eliminations
Income Statement [Abstract]
Revenue									(1,750)	(1,669)	(1,666)
Income from continuing operations before income taxes									(139,561)	(74,076)	(32,682)
Provision (benefit) for income taxes									0	0	0
Net income									(139,561)	(74,076)	(32,682)
Statement of Financial Position [Abstract]
Total current assets	0				0				0	0
Total Assets	(5,062,978)				(4,983,892)				(5,062,978)	(4,983,892)
Total current liabilities	0				0				0	0
Total Liabilities	(2,987,525)				(2,450,879)				(2,987,525)	(2,450,879)
Total Stockholders’ Equity	(2,075,453)				(2,533,013)				(2,075,453)	(2,533,013)
Statement of Cash Flows [Abstract]
Net cash provided by (used in) operating activities									0	0	0
Net cash provided by (used in) investing activities									0	0	0
Net cash provided by (used in) financing activities									0	0	0
Eliminations \| Reported
Income Statement [Abstract]
Revenue										(1,669)	(1,666)
Income from continuing operations before income taxes										(51,184)	1,875
Provision (benefit) for income taxes										0	0
Net income										(51,184)	1,875
Statement of Financial Position [Abstract]
Total current assets					0					0
Total Assets					(3,956,783)					(3,956,783)
Total current liabilities					0					0
Total Liabilities					(3,623,417)					(3,623,417)
Total Stockholders’ Equity					(333,366)					(333,366)
Statement of Cash Flows [Abstract]
Net cash provided by (used in) operating activities										(41,539)	1,875
Net cash provided by (used in) investing activities										(662,800)	0
Net cash provided by (used in) financing activities										704,339	(1,875)
Eliminations \| Revised
Income Statement [Abstract]
Revenue										(1,669)	(1,666)
Income from continuing operations before income taxes										(74,076)	(32,682)
Provision (benefit) for income taxes										0	0
Net income										(74,076)	(32,682)
Statement of Financial Position [Abstract]
Total current assets					0					0
Total Assets					(4,983,892)					(4,983,892)
Total current liabilities					0					0
Total Liabilities					(2,450,879)					(2,450,879)
Total Stockholders’ Equity					(2,533,013)					(2,533,013)
Statement of Cash Flows [Abstract]
Net cash provided by (used in) operating activities										0	0
Net cash provided by (used in) investing activities										0	0
Net cash provided by (used in) financing activities										$ 0	$ 0

Subsequent Events Subsequent Events (Details) (USD $)	12 Months Ended			0 Months Ended
Subsequent Events Subsequent Events (Details) (USD $)	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2011	May 09, 2012 Employee Restricted Stock Units (RSUs)	May 14, 2013 Employee Restricted Stock Units (RSUs) Subsequent Event	May 14, 2013 Employee Stock Options Subsequent Event	May 14, 2013 Group One Employee Restricted Stock Units (RSUs) Subsequent Event	May 14, 2013 Group Two Employee Restricted Stock Units (RSUs) Subsequent Event
Subsequent Event [Line Items]
Restricted common stock units granted in period, shares				111,152	113,637		55,637	58,000
Options granted in period						227,672
Award vesting period	10 months 24 days			3 years		3 years	3 years	3 years
Percentage of options vesting annually						33.30%		33.30%
Award exercisability period, from date of grant						10 years
Options granted, weighted-average grant-date fair value (in USD per share)	$ 6.03	$ 5.83	$ 4.91			$ 29.94

Schedule II Valuation and Qualifying Accounts (Details) (USD $)
In Thousands, unless otherwise specified

12 Months Ended

Mar. 31, 2013

Mar. 31, 2012

Mar. 31, 2011

Reserves for Sales Returns and Allowances

Movement in Valuation Allowances and Reserves [Roll Forward]

Valuation allowances and reserves, balance at beginning of year

$ 4,257

$ 6,208

$ 6,221

Amounts charged to expense

33,165

23,457

17,316

Deductions

(30,976)

(25,408)

(17,746)

Other

417

^[1]

Valuation allowances and reserves, balance at end of year

6,446

4,257

6,208

Reserves for Trade Promotions

Movement in Valuation Allowances and Reserves [Roll Forward]

Valuation allowances and reserves, balance at beginning of year

5,506

4,853

2,051

Amounts charged to expense

41,041

32,185

23,906

^[2]

Deductions

(38,024)

(31,532)

(23,350)

Other

2,246

^[1]

Valuation allowances and reserves, balance at end of year

8,523

5,506

4,853

Reserves for Consumer Coupon Redemptions

Movement in Valuation Allowances and Reserves [Roll Forward]

Valuation allowances and reserves, balance at beginning of year

3,509

2,723

263

Amounts charged to expense

8,282

7,180

3,932

^[2]

Deductions

(7,542)

(6,394)

(3,090)

Other

1,618

^[1]

Valuation allowances and reserves, balance at end of year

4,249

3,509

2,723

Allowance for Doubtful Accounts

Movement in Valuation Allowances and Reserves [Roll Forward]

Valuation allowances and reserves, balance at beginning of year

604

444

273

Amounts charged to expense

265

200

180

Deductions

(6)

(40)

(16)

Other

^[1]

Valuation allowances and reserves, balance at end of year

863

604

444

PediaCare | Reserves for Trade Promotions

Movement in Valuation Allowances and Reserves [Roll Forward]

Amounts charged to expense

3,000

^[2]

PediaCare | Reserves for Consumer Coupon Redemptions

Movement in Valuation Allowances and Reserves [Roll Forward]

Amounts charged to expense

$ 2,000

[1]	Reflect the applicable amounts acquired from the purchase of Blacksmith on November 1, 2010.
[2]	We increased our reserves for Trade Promotion and Consumer Coupon Redemption by $3.0 million and $2.0 million, respectively, in an effort to gain market share for the PediaCare brand.

Business and Basis of Presentation (Property and Equipment) (Details)	12 Months Ended			9 Months Ended
	Mar. 31, 2013 Machinery	Mar. 31, 2013 Computer Equipment	Mar. 31, 2013 Furniture and Fixtures	Dec. 31, 2012 Leasehold Improvements
Property, Plant and Equipment [Line Items]
Property and equipment, useful lives	5 years	3 years	7 years